<SEC-DOCUMENT>0001493152-20-014354.txt : 20200731
<SEC-HEADER>0001493152-20-014354.hdr.sgml : 20200731
<ACCEPTANCE-DATETIME>20200731165827
ACCESSION NUMBER:		0001493152-20-014354
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200731
FILED AS OF DATE:		20200731
DATE AS OF CHANGE:		20200731
EFFECTIVENESS DATE:		20200731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		201066703

	BUSINESS ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>def14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Rule
14a-101)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
REQUIRED IN PROXY STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant To Section 14(a) of the Securities Exchange Act of 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Check
the appropriate box:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commissions Only (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to Section 240.14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>MICROBOT
    MEDICAL INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Registrant as Specified in its Charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N/A</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
of filing fee (Check the appropriate box):</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    number of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
    the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    maximum aggregate value of transaction:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    fee paid:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if any part of the fee is offset as provided by Exchange Act Rule 0-11 (a)(2) and identify the filing for which the offsetting
    fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
    of its filing.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form,
    Schedule or Registration Statement No.:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
    Party:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Filed:</FONT></TD></TR>
</TABLE>

<P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
Recreation Park Drive, Unit 108</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
MA 02043</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE HELD ON SEPTEMBER 1, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Shareholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN, that the 2020 Annual Meeting of Shareholders (the &ldquo;Annual Meeting&rdquo;) of Microbot Medical Inc. (the
&ldquo;Company&rdquo;) will be held at 10:00 A.M., Eastern Time on September 1, 2020 at the offices of the Company, located at
25 Recreation Park Drive, Unit 108, Hingham, MA 02043. At the Annual Meeting, you will be asked to vote on:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    election of two Class II directors to the Board of Directors of the Company to serve until the 2023 Annual Meeting of Shareholders;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ratification of Brightman Almagor Zohar &amp; Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as
    the Company&rsquo;s independent registered public accounting firm for the year ending December 31, 2020;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    approval of a non-binding advisory resolution supporting the compensation of the Company&rsquo;s named executive officers;
    </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve the Microbot Medical Inc. 2020 Omnibus Performance Award Plan; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    transact such other and further business as may properly come before the meeting or any adjournment thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has fixed the close of business on July 20, 2020 as the record date for determining shareholders who are entitled
to receive notice of, and to vote at, the Annual Meeting or any adjournment or postponement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
vote is important to us. Whether or not you intend to be present at the meeting, please sign and date the enclosed proxy card
and return it in the enclosed envelope. Returning a proxy will not deprive you of your right to attend the Annual Meeting and
vote your shares in person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing items of business are more fully described in the accompanying proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
Order of the Board of Directors,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
Gadot</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
President and Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
July 31, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hingham,
Massachusetts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25
Recreation Park Drive, Unit 108</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hingham,
MA 02043</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
ANNUAL MEETING OF SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>July
31,</B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement and the accompanying proxy card is furnished in connection with the solicitation by the Board of Directors (the
&ldquo;Board&rdquo;) of Microbot Medical Inc., a Delaware corporation (the &ldquo;Company&rdquo;), of proxies for use at the 2020
Annual Meeting of Shareholders (the &ldquo;Annual Meeting&rdquo;) to be held at the offices of the Company, located at 25 Recreation
Park Drive, Unit 108, Hingham, MA 02043, at 10:00 A.M., Eastern Time, on September 1, 2020, or at any adjournment or postponement
thereof, for the purposes set forth in this proxy statement and the accompanying Notice of Annual Meeting of Shareholders. This
proxy statement and the accompanying proxy card is first being mailed on or about August 3, 2020 to all Shareholders of
the Company entitled to vote at the Annual Meeting (the &ldquo;Shareholders&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will bear the cost of solicitation of proxies. Directors, officers and employees of the Company may solicit proxies by
telephone, email, facsimile, in person or otherwise for no additional compensation. The Company has retained Morrow Sodali LLC
to act as a proxy solicitor in conjunction with the annual stockholders meeting at an estimated cost of $7,000 plus expenses.
The Company will pay the entire costs of such solicitation as well as the costs of printing and filing this proxy statement and
proxy card. The Company will reimburse banks, brokerage firms, proxy solicitors, and other custodians, nominees and fiduciaries
for reasonable expenses incurred by them in sending proxy materials to the beneficial owners of shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has fixed the close of business on July 20, 2020, as the record date for determining stockholders entitled
to notice of, and to vote at, the Annual Meeting or at any postponement or adjournment thereof. There were 7,103,260 shares of
our common stock, $.01 par value, outstanding on July 20, 2020, each of which is entitled to one vote for each share on the matters
to be voted upon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are being asked to vote on four proposals at the Company&rsquo;s 2020 Annual Meeting. The proposals to be voted on and related
recommendations from the Board of Directors are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    Number 1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    election of two Class II directors to the Board of the Company to serve until the 2023 Annual Meeting of Shareholders. The
    Board recommends that you vote &ldquo;FOR&rdquo; each of the nominees.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    Number 2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ratification of Brightman Almagor Zohar &amp; Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as
    the Company&rsquo;s independent registered public accounting firm for the year ending December 31, 2020. The Board recommends
    that you vote &ldquo;FOR&rdquo; this proposal.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    Number 3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    approval of a non-binding advisory resolution supporting the compensation of the Company&rsquo;s named executive officers.
    The Board recommends that you vote &ldquo;FOR&rdquo; this proposal.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    Number 4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve the Microbot Medical Inc. 2020 Omnibus Performance Award Plan. The Board recommends that you vote &ldquo;FOR&rdquo;
    this proposal.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the election of directors, which is Proposal Number 1, you may vote &ldquo;FOR&rdquo; both of the nominees or your vote may be
&ldquo;WITHHELD&rdquo; with respect to one or both of the nominees. For Proposal Number 2, Proposal Number 3, and Proposal Number
4, you may vote &ldquo;FOR,&rdquo; vote &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo; If you &ldquo;ABSTAIN&rdquo; as to Proposal
Number 2, Proposal Number 3, or Proposal Number 4, the abstention will have no effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock represented by proxies in the form enclosed that are properly executed and returned to us and not revoked
will be voted as specified in the proxy by the stockholder. In the absence of contrary instructions, or in instances where no
specifications are made, the shares will be voted:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    the election of two Class II directors to the Board of the Company to serve until the 2023 Annual Meeting of Shareholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    the ratification of Brightman Almagor Zohar &amp; Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate,
    as the Company&rsquo;s independent registered public accounting firm for the year ending December 31, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
                                         the approval of a non-binding advisory resolution supporting the compensation of the
                                         Company&rsquo;s named executive officers.</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the approval of the Microbot Medical Inc. 2020 Omnibus Performance Award Plan.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the discretion of the named proxies as to any other matter that may properly come before the Annual Meeting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
stockholder signing and delivering a proxy may revoke it at any time before it is voted by delivering to the Company&rsquo;s corporate
secretary a written revocation or a duly executed proxy bearing a date later than the date of the proxy being revoked. Any stockholder
attending the Annual Meeting in person may revoke his, her or its proxy and vote his, her or its shares at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
to vote shares at our 2020 Annual Meeting.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
at the Annual Meeting</I>. All Company stockholders are invited to attend the Annual Meeting in person. Any stockholder that attends
the meeting in person may deliver a completed proxy card in person or vote by completing a ballot, which will be available at
the meeting. However, each stockholder intending to vote in person at the Annual Meeting should note that if his, her or its shares
are held in the name of a bank, broker or other nominee, such stockholder must obtain a legal proxy, executed in his, her or its
favor, from the holder of record to be able to vote at the Annual Meeting. Stockholders should allow enough time prior to the
Annual Meeting to obtain this proxy from the holder of record, if needed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
year, registered stockholders of the Company, meaning stockholders who hold the Company&rsquo;s stock directly (not through a
bank, broker, or other nominee) may cast their vote in any of the following ways:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vote
by Internet</I>. Registered stockholders can vote over the Internet at www.envisionreports.com/MBOT by following the instructions
on the proxy card. Internet voting facilities for registered stockholders of record will be available 24 hours a day and will
close at 3:00 p.m. (EDT) on August 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vote
by Mail</I>. Registered stockholders can vote by mail by signing, dating and mailing the enclosed proxy card in the postage-paid
envelope provided. If the envelope is missing, such a stockholder can mail the completed proxy card or voting instruction card
to Computershare, C/O Shareholder Services, P.O. Box 505000, Louisville, KY 40233-5000. The completed card must be received no
later than August 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vote
by Telephone</I>. Registered stockholders can vote by telephone by calling the phone number located on the top of your proxy card
and following the voice prompts. You will need information from your proxy card to submit your proxy by telephone. Telephone voting
facilities for registered stockholders of record will be available 24 hours a day and will close at 3:00 p.m. (EDT) on August
31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
year, beneficial stockholders of the Company, meaning stockholders who hold the Company&rsquo;s stock in the name of a bank, broker,
or other nominee (commonly referred to as holding shares in &ldquo;street name&rdquo;) may cast their vote in any of the following
ways:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vote
by Internet</I>. Beneficial stockholders can vote over the Internet at www.proxyvote.com by following the online instructions.
Internet voting facilities for beneficial stockholders of record will be available 24 hours a day and will close at 3:00 p.m.
(EDT) on August 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vote
by Mail</I>. Beneficial stockholders can vote by mail by signing, dating and mailing the enclosed voting instruction form (&ldquo;VIF&rdquo;)
in the postage-paid envelope provided. The completed card must be received no later than August 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vote
by Telephone</I>. Beneficial stockholders can vote by telephone by calling the phone number located on the top of your VIF and
following the voice prompts. Telephone voting facilities for beneficial stockholders of record will be available 24 hours a day
and will close at 3:00 p.m. (EDT) on August 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares voted electronically or represented by the proxy cards received, properly marked, dated, signed and not revoked, will be
voted at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Quorum,
Required Votes and Method of Tabulation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consistent
with Delaware law and the Company&rsquo;s amended and restated by-laws, a majority of the votes entitled to be cast on a particular
matter, present in person or represented by proxy, constitutes a quorum as to such matter. The Company will appoint one or more
election inspectors for the meeting to count votes cast by proxy or in person at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold shares beneficially in street name and do not provide your broker or nominee with voting instructions, your shares may
constitute &ldquo;broker non-votes.&rdquo; Generally, broker non-votes occur on a matter when a broker is not permitted to vote
on that matter without instructions from the beneficial owner and instructions have not been given. This year if you hold shares
beneficially in street name and do not vote your shares, your broker or nominee can vote your shares at its discretion on Proposal
Number 2. In tabulating the voting result for any proposal for which the required vote is based on the number of shares present,
shares that constitute broker non-votes are not considered entitled to vote on that proposal. However, for proposals for which
the required vote is based on the number of shares of common stock issued and outstanding, broker non-votes have the same effect
as a vote &ldquo;AGAINST&rdquo; the proposal. Abstentions and broker non-votes will be counted as present for purposes of establishing
a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
Vote is Required to Approve Each Item?</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
of directors by stockholders, which is Proposal Number 1, will be determined by a plurality of the votes cast by the stockholders
entitled to vote at the election that are either present in person or represented by proxy. Consequently, any shares not voted
at the annual meeting, whether due to abstentions, broker non-votes or otherwise, will have no impact on the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal Number 2, the affirmative &ldquo;FOR&rdquo; vote is required by the holders of a majority of the shares present at the
Annual Meeting in person or by proxy and voting. Abstentions will have no effect on the outcome of this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal Number 3, the affirmative &ldquo;FOR&rdquo; vote is required by the holders of a majority of the shares present at the
Annual Meeting in person or by proxy and voting. Abstentions will have no effect on the outcome of this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal Number 4, the affirmative &ldquo;FOR&rdquo; vote is required by the holders of a majority of the shares present at the
Annual Meeting in person or by proxy and voting. Because this vote is advisory only, it will not be binding on the Company, the
Board or the Compensation Committee of the Board. However, the Board and the Compensation Committee will review the voting results
and take them into consideration when making future decisions about executive compensation. Abstentions will have no effect on
the outcome of this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not know of any matters to be presented at this year&rsquo;s Annual Meeting other than those set forth in this proxy statement
and in the notice accompanying this proxy statement. Stockholders will have no appraisal rights under Delaware law with respect
to any of the matters expected to be voted on at the Annual Meeting. If other matters should properly come before the meeting,
the proxy holders will vote such matters in their discretion. Any stockholder has the right to revoke his, her or its proxy at
any time until it is voted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the number of shares of our common stock beneficially owned, as of July 30, 2020, by (i) each of
our directors and director nominees, (ii) each of our named executive officers, (iii) all of our current directors and
executive officers as a group, and (iv) all those known by us to be to a beneficial owner of more than 5% of the Company&rsquo;s
common stock. In general, &ldquo;beneficial ownership&rdquo; refers to shares that an individual or entity has the power to vote
or dispose of, and any rights to acquire common stock that are currently exercisable or will become exercisable within 60 days
of July 30, 2020. We calculated percentage ownership in accordance with the rules of the SEC. The percentage of common
stock beneficially owned is based on 7,103,260 shares outstanding as of July 30, 2020. In addition, shares issuable pursuant
to options or other convertible securities that may be acquired within 60 days of July 30, 2020 are deemed to be issued
and outstanding and have been treated as outstanding in calculating and determining the beneficial ownership and percentage ownership
of those persons possessing those securities, but not for any other persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
table is based on information supplied by each director, officer and principal stockholder of the Company. Except as indicated
in footnotes to this table, the Company believes that the stockholders named in this table have sole voting and investment power
with respect to all shares of Common Stock shown to be beneficially owned by them, based on information provided by such stockholders.
Unless otherwise indicated, the address for each director, executive officer and 5% or greater stockholders of the Company listed
is: c/o Microbot Medical Inc., 25 Recreation Park Drive, Unit 108, Hingham, MA 02043.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
    Owner</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares Beneficially Owned</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    of Common Stock Beneficially Owned</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors and Executive Officers</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel Gadot<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">309,809</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.26</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph Bornstein<SUP>(2)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">306,628</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.31</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Burell<SUP>(3)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,600</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin Madden<SUP>(3)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,600</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Ben Naim<SUP>(3)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,250</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prattipati Laxminarain<SUP>(3)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,600</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aileen Stockburger</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Eyal Morag</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hezi Himelfarb<SUP>(4)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tal Wenderow<SUP>(5)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All current directors and executive officers
    as a group (8 persons)<SUP>(6)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">634,487</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.69</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1%.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 136,847 shares of our common stock owned by MEDX Ventures Group LLC, (ii) 77,846 shares of our common stock issuable
    upon the exercise of options granted to MEDX Ventures Group LLC, and (iii) 95,116 shares of our common stock issuable
    upon the exercise of options granted to Mr. Gadot. Mr. Gadot is the Chief Executive Officer, Company Group Chairman and majority
    equity owner of MEDX Venture Group, LLC and thus may be deemed to share voting and investment power over the shares and options
    beneficially owned by this entity.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    (i) 302,028 shares of our common stock owned by LSA - Life Science Accelerator Ltd. and (ii) 4,600 shares of our common
    stock issuable to Mr. Bornstein upon exercise of options. Based on representations and other information made or provided
    to the Company by Mr. Bornstein, Mr. Bornstein is the CEO and Director of LSA - Life Science Accelerator Ltd. and of Shizim
    Ltd., and Mr. Bornstein is the majority equity owner of Shizim Ltd. Shizim Ltd. is the majority equity owner of LSA - Life
    Science Accelerator Ltd. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially
    owned by these entities and has an address of 16 Irus Street, Rosh-Ha&rsquo;Ayin Israel 4858022.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    options to acquire shares of our common stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    as of February 1, 2019, Mr. Himelfarb, a member of the Board of Directors of the Company, and the Company&rsquo;s then-Chief
    Operating Officer, resigned from all positions with the Company and from his position as General Manager of Microbot Medical
    Ltd., a wholly-owned subsidiary of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(5)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Mr. Wenderow&rsquo;s term as a director is commencing
    August 1, 2020.</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    shares of our common stock issuable upon the exercise of options as set forth in footnotes (1), (2) and (3).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BOARD
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have six directors serving on our Board, with one vacancy expected to be filled on August 1, 2020. The following
table lists the names, ages and positions of the individuals who serve as directors of the Company, as of July 30, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Chairman of the Board of Directors</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph
    Bornstein(1)(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Burell(1)(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Madden(1)(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prattipati
    Laxminarain(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Aileen Stockburger</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">57</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Director</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Audit Committee.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Corporate Governance Committee.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of Compensation Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2020, the Board appointed Mr. Tal Wenderow, age 46, to fill a vacancy on the Board and to serve as a Class I director
of the Company, with a term commencing on August 1, 2020 and expiring at our 2022 annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have a classified Board, with each of our directors serving a staggered three-year term, only our Class II Directors are standing
for election at our 2020 Annual Meeting. The following table shows the current composition of the three classes of our Board:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
I Directors (terms scheduled to expire in 2022):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Madden</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Tal Wenderow (term scheduled to commence on August
    1, 2020)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
II Directors (term scheduled to expire in 2020):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
                                         Burell (term scheduled to expire in 2020, but nominated to stand for re-election at our
                                         2020 Annual Meeting) Aileen Stockburger (term scheduled to expire in 2020, but nominated
                                         to stand for re-election at our 2020 Annual Meeting)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
III Directors (term scheduled to expire in 2021):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph
    Bornstein </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prattipati
    Laxminarain</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
independent members of our Board, as determined by the Board in accordance with the existing Nasdaq Listing rules, are Messrs.
Bornstein, Burell, Madden, Laxminarain and Wenderow, and Ms. Stockburger. The Board held approximately thirteen regular
and special meetings during the fiscal year ended December 31, 2019 and acted by unanimous written consent five times. Each of
our then-directors attended over 80% of such meetings of the Board. While we encourage our directors to attend the Company&rsquo;s
annual Shareholder meeting, we do not have a policy requiring that they do so. All of our then-directors attended in person
or by telephone the Company&rsquo;s 2019 annual stockholder meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Committees
of the Board of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presently,
the Board has three standing committees &mdash; the Audit Committee, the Compensation and Stock Option Committee (the &ldquo;Compensation
Committee&rdquo;), and the Corporate Governance and Nominating Committee (the &ldquo;Corporate Governance Committee&rdquo;). All
members of the Audit Committee, the Compensation Committee, and the Corporate Governance Committee are, and are required by the
charters of the respective committees to be, independent as determined under Nasdaq Listing rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Audit
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee is composed of Messrs. Burell, Madden and Bornstein. Each of the members of the Audit Committee is independent,
and the Board has determined that Mr. Burell is an &ldquo;audit committee financial expert,&rdquo; as defined in SEC rules. The
Audit Committee acts pursuant to a written charter which is available through our website at www.microbotmedical.com. The Audit
Committee held four meetings during the fiscal year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary function of the Audit Committee is to assist the Board of Directors in fulfilling its oversight responsibilities. The
Audit Committee does this primarily by reviewing the Company&rsquo;s financial reports and other financial information as well
as the Company&rsquo;s systems of internal controls regarding finance, accounting, legal compliance, and ethics that management
and the Board of Directors have established. The Audit Committee also assesses the Company&rsquo;s auditing, accounting and financial
processes more generally. The Audit Committee recommends to the Board of Directors the appointment of a firm of independent auditors
to audit the financial statements of the Company and meets with such personnel of the Company to review the scope and the results
of the annual audit, the amount of audit fees, the company&rsquo;s internal accounting controls, the Company&rsquo;s financial
statements contained in this proxy statement, and other related matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee is composed of Messrs. Madden and Bornstein. Each of the members of the Compensation Committee is independent.
The Compensation Committee acts pursuant to a written charter which is available through our website at www.microbotmedical.com.
The Compensation Committee held four meetings during the fiscal year ended December 31, 2019 and acted by unanimous written consent
one time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee acts pursuant to a written charter. The Compensation Committee makes recommendations to the Board of Directors
and management concerning salaries in general, determines executive compensation and approves incentive compensation for employees
and consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
Governance Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Committee is composed of Messrs. Laxminarain and Burell. Each of the members of the Corporate Governance
Committee is independent. The Corporate Governance Committee acts pursuant to a written charter which is available through our
website at www.microbotmedical.com. The Corporate Governance Committee acted by unanimous written consent one time during the
fiscal year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Committee oversees nominations to the Board and considers the experience, ability and character of potential
nominees to serve as directors, as well as particular skills or knowledge that may be desirable in light of the Company&rsquo;s
position at any time. From time to time, the Corporate Governance Committee may engage the services of a paid search firm to help
the Corporate Governance Committee identify potential nominees to the Board. The Corporate Governance Committee and Board seek
to nominate and appoint candidates to the Board who have significant business experience, technical expertise or personal attributes,
or a combination of these, sufficient to suggest, in the Board&rsquo;s judgment, that the candidate would have the ability to
help direct the affairs of the Company and enhance the Board as a whole. The Corporate Governance Committee may identify potential
candidates through any reliable means available, including recommendations of past or current members of the Board from their
knowledge of the industry and of the Company. The Corporate Governance Committee also considers past service on the Board or on
the board of directors of other publicly traded or technology focused companies. The Corporate Governance Committee has not adopted
a formulaic approach to evaluating potential nominees to the Board; it does not have a formal policy concerning diversity, for
example. Rather, the Corporate Governance Committee weighs and considers the experience, expertise, intellect, and judgment of
potential nominees irrespective of their race, gender, age, religion, or other personal characteristics. The Corporate Governance
Committee may look for nominees that can bring new skill sets or diverse business perspectives. Potential candidates recommended
by security holders will be considered as provided in the company&rsquo;s &ldquo;Policy Regarding Shareholder Candidates for Nomination
as a Director,&rdquo; which sets forth the procedures and conditions for such recommendations. This policy is available through
our website at www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Corporate Governance Committee have approved the nomination of the Class II directors standing for election or
reelection, as the case may be, at our 2020 Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
Oversight and Qualifications</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">While
management is responsible for the day-to-day management of the risks the company faces, the Board, as a whole and through its
committees, has responsibility for the oversight of risk management. An important part of risk management is not only understanding
the risks facing the company and what steps management is taking to manage those risks, but also understanding what level of risk
is appropriate for the company. In support of this oversight function, the Board receives regular reports from our Chief Executive
Officer and members of senior management on operational, financial, legal, and regulatory issues and risks. The Audit Committee
additionally is charged under its charter with oversight of financial risk, including the company&rsquo;s internal controls, and
it receives regular reports from management, the company&rsquo;s internal auditors and the company&rsquo;s independent auditors.
The chairman of the Board and independent members of the Board work together to provide strong, independent oversight of the company&rsquo;s
management and affairs through its standing committees and, when necessary, special meetings of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
believe each of our directors brings valuable skills, experience, judgment, and perspectives to our company. The Board took the
following qualifications into consideration, among other things, when nominating or appointing our current directors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Harel
Gadot</I><FONT STYLE="background-color: white">, became President, Chief Executive Officer and Chairman of the Company&rsquo;s
Board following the consummation of the merger of C&amp;RD Israel Ltd, a wholly owned subsidiary of the Company, with and into
Microbot Medical Ltd. (&ldquo;Microbot Israel&rdquo;), with Microbot Israel surviving as a wholly owned subsidiary of the Company
(the &ldquo;Merger&rdquo;). Mr. Gadot is a co-founder of Microbot Israel and has served as Microbot Israel&rsquo;s Chief Executive
Officer since Microbot Israel was founded in November 2010. He has been the Chairman of Microbot Israel&rsquo;s board of directors
since July 2014. He also serves as the Chairman of XACT Robotics Ltd., an Israel-based private company seeking to develop a novel
platform technology for robotic needle steering in minimally invasive interventional procedures such as biopsies and ablations,
since August 2013 and MEDX Xelerator L.P., a medical device and digital health Israeli incubator, since July 2016. From December
2007 to April 2010 Mr. Gadot was a Worldwide Group Marketing Director at Ethicon Inc., a Johnson and Johnson Company, where he
was responsible for the global strategic marketing of the Company. Mr. Gadot also held management positions, as well as leading
regional strategic position for Europe, Middle-East and Africa, as well as In Israel, while at Johnson and Johnson. Mr. Gadot
served as director for ConTIPI Ltd. from August 2010 until November 2013 when ConTIPI Ltd. was acquired by Kimberly-Clark Corporation.
Mr. Gadot holds a B.Sc.in Business from Siena College, Loudonville NY, and an M.B.A. from the University of Manchester, UK. The
Company believes that Mr. Gadot is qualified to serve as Chairman of the Board and as President and Chief Executive Officer of
the Company due to his extensive experience in strategic marketing and general management in the medical device industry.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Yoseph
Bornstein</I><FONT STYLE="background-color: white">, became a director of the Company following the Merger. Mr. Bornstein is a
co-founder of Microbot Israel and has been a member of the Board of Directors since Microbot Israel was founded in November 2010.
Mr. Bornstein founded Shizim Ltd., a life science holding group in October 2000 and has served as its president since then. Mr.
Bornstein is the Chairman of GCP Clinical Studies Ltd., a provider of clinical research services and educational programs in Israel
since January 2002. He is the Chairman of Biotis Ltd., a service company for the bio-pharmaceutical industry, since June 2000.
In addition, he is the Chairman of Dolphin Medical Ltd., a service company for the medical device industry, since April 2012,
and the Chairman of ASIS Enterprises B.B.G. Ltd., a business development company focusing on creating business ties between Israeli
and Japanese entities, since August 2007. Mr. Bornstein is a co-founder and director of XACT Robotics Ltd., an Israeli- based
private company seeking to develop a novel platform technology for robotic needle steering in minimally invasive interventional
procedures, and is the founder of ShizimXL Innovation Center. In October 1992, Mr. Bornstein founded Pharmateam Ltd., an Israeli
company that specialized in representing international pharmaceutical companies which was sold in 2000. Mr. Bornstein is also
a founder of a number of other privately held life-science companies. Mr. Bornstein served as the Biotechnology Committee Chairman
of the Unites States-Israel Science &amp; Technology Commission (the &ldquo;USISTF&rdquo;) from September 2002 to February 2005
as well as a consultant for USISTF from September 2002 to February 2005. He is also the founder of ILSI-Israel Life Science Industry
Organization (who was integrated into IATI) and ITTN-Israel Tech Transfer Organization. The Company believes that Mr. Bornstein
is qualified to serve as a member of the Board due to his extensive experience in, and knowledge of, the life sciences industry
and international business.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Scott
R. Burell</I>, became a director of the Company following the Merger. Since August 1, 2018, Mr. Burell has been the Chief Financial
Officer of AIVITA Biomedical, Inc., a private biopharmaceutical company. From November 2006 until its sale to Invitae Corp. in
November 2017, he was the Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation (NASDAQ: CBMX), a family
health-focused clinical molecular diagnostic laboratory specializing in pre-implantation genetic screening, prenatal diagnosis,
miscarriage analysis, and pediatric developmental disorders. He successfully led the split-off of CombiMatrix in 2007 from its
former parent, has led several successful public and private debt and equity financing transactions as well as CombiMatrix&rsquo;s
reorganization in 2010. Prior to this, Mr. Burell had served as CombiMatrix&rsquo;s Vice President of Finance since November 2001
and as its Controller from February 2001 to November 2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell
was the Controller for Network Commerce, Inc., a publicly traded technology and information infrastructure company located in
Seattle. Prior to this, Mr. Burell spent 9 years with Arthur Andersen&rsquo;s Audit and Business Advisory practice in Seattle.
During his tenure in public accounting, Mr. Burell worked with many clients, both public and private, in the high-tech and healthcare
markets, and was involved in numerous public offerings, spin-offs, mergers and acquisitions. Mr. Burell is a Board member of Mer
Telemanagement Solutions Ltd. (Nasdaq: MTSL), an Israeli-based publicly traded telecommunications services company. Mr. Burell
obtained his Washington state CPA license in 1992 and is a certified public accountant (currently inactive). He holds Bachelor
of Science degrees in Accounting and Business Finance from Central Washington University. The Company believes Mr. Burell&rsquo;s
qualifications to serve on the Board include his experience as an executive of a public life sciences company and knowledge of
financial accounting in the medical technology field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Martin
Madden</I>, has been a director of the Company since February 6, 2017. Mr. Madden has held various positions at Johnson &amp;
Johnson and its affiliates from 1986 to January 2017, most recently as Vice President, Research &amp; Development of DePuy Synthes,
a Johnson &amp; Johnson Company, from February 2016 to January 2017. Prior to that, from July 2015 to February 2016, Mr. Madden
was the Vice President, New Product Development of Johnson &amp; Johnson Medical Devices. From January 2012 to July 2015, Mr.
Madden was the Vice President, Research &amp; Development of Johnson &amp; Johnson&rsquo;s Global Surgery Group. Mr. Madden holds
a MBA from Columbia University, a M.S. from Carnegie Mellon University in Mechanical Engineering, and a B.S. from the University
of Dayton in Mechanical Engineering. The Company believes that Mr. Madden is qualified to serve as a member of the Board due to
his extensive experience in research and development, portfolio planning, technology assessment and assimilation, and project
management and budgeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Prattipati
Laxminarain</I>, has been a director of the Company since December 6, 2017. From April 2006 through October 2017, Mr. Laxminarain
served as Worldwide President at Codman Neuro, a global neurosurgery and neurovascular company that offers a portfolio of devices
for hydrocephalus management, neuro intensive care and cranial surgery and other technologies, and which was part of DePuy Synthes
Companies of Johnson &amp; Johnson. Mr. Laxminarain is currently the CEO of Deinde Medical Corporation, and is a Board Member
of Oculogica Inc., Millar Inc., and GT Medical Inc. He has a degree in Mechanical Engineering from Osmania University, Hyderabad,
India and an MBA from Indian Institute of Management. The Company believes that Mr. Laxminarain is qualified as a Board member
of the Company because of his extensive experience working with medical device companies and knowledge of the industries in which
the Company intends to compete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Aileen
Stockburger</I> was appointed by the Board on March 26, 2020 to fill a vacancy on the Board and to serve as a Class II director
of the Company, with a term commencing on April 1, 2020. Since February 2018, Ms. Stockburger has provided M&amp;A consulting
and advisory services through Aileen Stockburger LLC. Prior to that, from 1989 through January 2018, Ms. Stockburger held various
positions in Johnson &amp; Johnson, most recently as Vice President, Wordwide Business Development &amp; Strategic Planning for
the DePuy Synthes Group of Johnson &amp; Johnson, and as a member of its Worldwide Board and Group Operating Committee, from 2010-2018.
In that role, she oversaw the group&rsquo;s merger and acquisition activities, including deal structuring, negotiations, contract
design and review, and deal terms. Before joining Johnson &amp; Johnson, Ms. Stockburger spent several years at PriceWaterhouseCoopers,
and earned her CPA certification. She is also a Non-Executive Director of Next Science Limited (ASX: NXS), a medical technology
company headquartered in Sydney, Australia, with a primary focus in the development and continued commercialization of its proprietary
technology to reduce the impact of biofilm based infections in human health. Ms. Stockburger received her MBA and BS from The
Wharton School, University of Pennsylvania. The Company believes that Ms. Stockburger is qualified as a Board member of the Company
because of her extensive experience in strategizing, managing and closing sizable, complex worldwide mergers and acquisitions,
licensing agreements and divestitures, as well as her expertise in business development, strategic planning and finance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tal
Wenderow</I> was appointed by the Board on July 29, 2020 to fill a vacancy on the Board and to serve as a Class I director of
the Company, with a term commencing on August 1, 2020. Since February 2019, Mr. Wenderow serves as the President and CEO of Vocalis
Health Inc., an AI healthtech company pioneering the development of vocal biomarkers. Previously, Mr. Wenderow co-founded Corindus
Vascular Robotics  in 2002, which was a New York Stock Exchange-listed company upon its acquisition by Siemens Healthineers
in 2019. Mr. Wenderow held various positions at Corindus from founder, Chief Executive Officer and director at inception, Executive
Vice President Product &amp; Business Development to his most recent role as Executive Vice President of International &amp; Business
Development. Mr. Wenderow received a B.Sc. in Mechanical Engineering at the Technion &ndash; Israel Institute of Technology, Haifa,
Israel. The Company believes that Mr. Wenderow is qualified as a Board member of the Company because of his extensive knowledge
of the medical robotics space with specific focus on interventional procedures, as well as his medical devices start up experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Executive
Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
are the name, age and other information for our executive officers, as of July 30, 2020. All company officers have been
appointed to serve until their successors are elected and qualified or until their earlier resignation or removal. Information
regarding Harel Gadot, our Chairman, President and Chief Executive Officer, is set forth above under &ldquo;Board of Directors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 62%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Chairman of the Board of Directors</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Ben Naim</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eyal
    Morag</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>David
Ben Naim</I><FONT STYLE="background-color: white">, became the Company&rsquo;s part-time Chief Financial Officer following the
consummation of the Merger. Mr. Ben Naim is the general manager of DBN Finance Services Ltd., a company which provides outsourcing
financial services to public and private companies, since 2014, including the Company. Through DBN Finance Services, Mr. Ben Naim
has acted as the outsourced CFO for Emerald Medical Applications Corp. (OTC:MRLA), a digital health startup company engaged in
the development, sale and service of imaging solutions, Tempramed Inc., a private medical device company, Vonetize PLC (TASE:VNTZ),
an Israeli company that offers video on demand and over-the-top content services, Unet Credit Finance Services Ltd. (TASE:UNCR-M),
and Todos Medical Ltd. (OTC:TOMDF), an Israeli cancer in-vitro-diagnostic company engaging in the development of a series of blood
tests for the early detection of a variety of cancers. Prior to that, Mr. Ben Naim served as Chief Financial Officer for several
companies in the biomedical and technology industries. From July 2012 to September 2014, Mr. Ben Naim served as Chief Financial
Officer for Insuline Medical Ltd. (TASE: INSL), an Israel-based company focused on improving performance of insulin treatment
methods. From 2008 until 2011, Mr. Ben Naim served as Chief Financial Officer of Crow Technologies 1977 Ltd. (OTC:CRWTF), a company
that designs, develops, manufactures and sells a broad range of security and alarm systems. From 2007 to 2008, Mr. Ben Naim served
as Chief Financial Officer of Ilex Medical Ltd. (TASE:ILX), a leading company in the medical diagnostics field. From 2003 to 2007,
Mr. Ben Naim was the Corporate Controller of Tadiran Telecom Ltd. He started his career in 1998 at Deloitte &amp; Touche where
he left in 2003 as an Audit Senior Manager. Mr. Ben Naim holds a B.A. in social sciences from Open University, Israel, a CPA license
from Ramat Gan College, Israel, and an M.B.A. from Ono Academic College, Israel.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Eyal
Morag</I>, has </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">served as the Company&rsquo;s
Chief Medical Officer (&ldquo;CMO&rdquo;) since May 2020<FONT STYLE="background-color: white">. As CMO, Dr. Morag will lead the
development and execution of the clinical strategy of the Company, including its current development of the SCS and LIBERTY products
as well as its future pipeline. Dr. Morag is a member of the Company&rsquo;s Scientific Advisory Board since November 1, 2017.
Dr. Morag is certified by the American Board of Radiology, and from March 2017 through May 2020 has been the Chairman of Radiology
at Assuta Ashdod Medical Center, Ashdod, Israel. Previously, from July 2014 through March 2017, he was the senior Radiologist
at URG Teleradiology LLC, the largest provider of subspecialty radiology and teleradiology services in New Jersey. He is a graduate
of Boston University School of Medicine and completed both his Radiology residency and Fellowship in Cardiovascular &amp; Interventional
Radiology at the Beth Israel Deaconess Medical Center &amp; Harvard Medical School. Following his clinical training, Dr. Morag
then joined a private practice in western Massachusetts, where he served as Chief of Radiology at Holyoke Medical Center for several
years. He has also served as the Regional Radiology Director at Mercy Health Partners Hospitals in Toledo, Ohio, and was a member
of the University Radiology Group where he headed the International Investment efforts for the Ventures division. Dr. Morag&rsquo;s
international experience developing and establishing radiology-related businesses includes teleradiology, interventional Radiology
services, and free-standing imaging centers. During his fellowship, Dr. Morag co-founded InTek Technology, a medical device startup
company. Later he founded Global Versa Radiology (&ldquo;GVR&rdquo;), an Israeli and U.S. based teleradiology company. GVR has
established imaging centers in Russia and Ukraine and provided teleradiology services in countries outside the U.S. and Israel.
Dr. Morag served as GVR&rsquo;s Chief Medical Officer and Vice-President. He continues to be involved in several startup companies
ranging from AI to medical devices. Dr. Morag is also a member of the Advisory Board of MEDX Xelerator, a medical device and digital
health incubator, of which Mr. Gadot is Chairman.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
16(a) Beneficial Ownership Reporting Compliance</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Section
16(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), requires our executive officers, directors,
and persons who own more than 10% of a registered class of our equity securities, to file with the SEC reports of ownership of
our securities and changes in reported ownership. Executive officers, directors and greater than 10% beneficial owners are required
by SEC rules to furnish us with copies of all Section 16(a) reports they file. Based solely on a review of the copies of such
forms furnished to us, or written representations from the reporting persons that no Form 5 was required, we believe that, during
the fiscal year ended December 31, 2019, all Section 16(a) filing requirements applicable to our officers, directors and greater
than 10% beneficial owners have been met.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Code
of Business Conduct and Ethics</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Ethics and Conduct that applies to all of our directors, officers, employees, and consultants. A copy of
our code of ethics is posted on our website at www.microbotmedical.com. We intend to disclose any substantive amendment or waivers
to this code on our website. There were no substantive amendments or waivers to this code in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding each element of compensation that was paid or awarded to the named executive
officers of the Company for the periods indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
    and Principal Position</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Salary
    ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bonus
    ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    Awards ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards ($) (1)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-Equity
    Incentive Plan Compensation ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
    Other Compensation ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 28%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Harel
    Gadot</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">360,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">482,493</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,800
                                         </FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,293</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CEO,
    President &amp; Chairman</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">360,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">580,667</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,800
                                         </FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,009,467</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hezi
    Himelfarb(4)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">201,868</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">322,119</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,082
                                         </FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">532,069</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Former
    Chief Operating Officer &amp; General Manager</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">280,067</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,931</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">425,101</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000
                                         </FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">718,101</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">David
    Ben Naim</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74,268</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,308</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94,076</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief
    Financial Officer</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,026</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,890</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">96,916</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
shown do not reflect cash compensation actually received by the named executive officer. Instead, the amounts shown are the non-cash
aggregate grant date fair values of stock option awards made during the periods presented as determined pursuant to ASC Topic
718 and excludes the effect of forfeiture assumptions. The assumptions used to calculate the fair value of stock option awards
are set forth under Note 9 to the Consolidated Financial Statements of the Company included in its Annual Report on Form 10-K
for the fiscal year ended December 31, 2019.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Other Compensation includes Mr. Gadot&rsquo;s monthly automobile allowance and tax gross-up.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
the remaining portion of Mr. Gadot&rsquo;s 2017 bonus, which was paid in 2018. Mr. Gadot&rsquo;s bonus for the 2018 fiscal year
was paid in 2019.</FONT></TD></TR>
</TABLE>

<P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    as of February 1, 2019, Mr. Himelfarb, a member of the Board of Directors of the Company, and the Company&rsquo;s then-Chief
    Operating Officer, resigned from all positions with the Company and from his position as General Manager of Microbot Medical
    Ltd., a wholly-owned subsidiary of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Other Compensation includes Mr. Himelfarb&rsquo;s yearly automobile allowance.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the remaining portion of Mr. Himelfarb&rsquo;s 2017 bonus, which was paid in 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year-End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the outstanding equity awards held by each of the named executive officers as of the end of the fiscal
year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="18" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    Awards</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Securities Underlying Unexercised Options Exercisable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Securities Underlying Unexercised Options Unexercisable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Exercise Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Expiration Date</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares or Units of Stock That Have Not Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Market
    value of Shares of Units of Stock That Have Not Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity
    Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity
    Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Harel
    Gadot</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">77,846</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/01/2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81,752</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.75</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/14/2027</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hezi
    Himelfarb</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">David
    Ben Naim</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.30</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/28/2027</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Employment Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Harel
Gadot Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an employment agreement (the &ldquo;Gadot Agreement&rdquo;) with Harel Gadot on November 28, 2016, to serve
as the Company&rsquo;s Chairman of the Board of Directors and Chief Executive Officer, on an indefinite basis subject to the termination
provisions described in the Agreement. Pursuant to the terms of the Gadot Agreement, as amended on February 25, 2020, Mr. Gadot
shall receive an annual base salary of $450,000. The salary will be reviewed on an annual basis by the Compensation Committee
of the Company to determine potential increases taking into account such performance metrics and criteria as established by the
Executive and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Gadot shall also be entitled to receive a target annual cash bonus of up to a maximum amount of 40% of base salary, which maximum
amount was paid for the 2019 fiscal year. Effective as of January 1, 2020, Mr. Gadot&rsquo;s annual bonus pursuant to the Gadot
Agreement was increased from 40% of his annual salary to 60% of his annual salary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Gadot shall be further entitled to a monthly automobile allowance and tax gross up on such allowance of $1,150, and shall be granted
options to purchase shares of common stock of the Company representing 5% of the issued and outstanding shares of the Company,
based on vesting and other terms to be determined by the Compensation Committee of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated as a result of death, Mr. Gadot&rsquo;s estate would be entitled to receive
any earned annual salary, bonus, reimbursement of business expenses and accrued vacation, if any, that is unpaid up to the date
of Mr. Gadot&rsquo;s death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated as a result of disability, Mr. Gadot would be entitled to receive any earned
annual salary, bonus, reimbursement of business expenses and accrued vacation, if any, incurred up to the date of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated by the Company for cause, Mr. Gadot would be entitled to receive any compensation
then due and payable incurred up to the date of termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Gadot&rsquo;s employment is terminated by the Company without cause, he would be entitled to receive (i) any earned
annual salary; (ii) 12 months&rsquo; pay and full benefits, (iii) a pro rata bonus equal to the maximum target bonus for that
calendar year; (iv) the dollar value of unused and accrued vacation days; and (v) applicable premiums (inclusive of premiums for
Mr. Gadot&rsquo;s dependents) pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended, for twelve (12)
months from the date of termination for any benefits plan sponsored by the Company. In addition, 100% of any unvested portion
of his stock options shall immediately vest and become exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement contains customary non-competition and non-solicitation provisions pursuant to which Mr. Gadot agrees not to compete
and solicit with the Company. Mr. Gadot also agreed to customary terms regarding confidentiality and ownership of intellectual
property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>David
Ben Naim Services Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into a services agreement (the &ldquo;Services Agreement&rdquo;) with DBN Finance Services effective October 31, 2016,
to provide outsourced CFO services. Pursuant to the terms of the Services Agreement, DBN Finance Services will provide its services
exclusively through Mr. David Ben Naim, who will serve as the principal financial and accounting officer of Microbot Israel and
the Company. Mr. Ben Naim&rsquo;s engagement will continue on an indefinite basis subject to the termination provisions described
in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Agreement, the Company shall pay the Service Provider a fixed fee of NIS 22,000, or the equivalent of approximately $6,285
per month based on an exchange rate of $.286 for NIS1.0, plus VAT per month, and the Company shall reimburse DBN Finance Services
for reasonable and customary out of pocket expenses incurred by it or Mr. Ben Naim connection with the performance of the duties
under the Services Agreement. In addition, the Company shall maintain for the benefit of Mr. Ben Naim, a Directors and Officers
insurance policy, according to the Company&rsquo;s policy for other directors and officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
the Company and DBN Finance Services shall have the right to terminate the Agreement for any reason or without reason at any time
by furnishing the other party with a 30-day notice of termination. The Company shall further be entitled to terminate the Services
Agreement for &ldquo;cause&rdquo; without notice, in which case neither DBN Finance Services nor Mr. Ben Naim shall be entitled
to any compensation due to such early termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DBN
Finance Services and Mr. Ben Naim agreed to customary provisions regarding confidentiality and intellectual property ownership.
The Services Agreement also contains customary non-competition and non-solicitation provisions pursuant to which DBN Finance Services
and Mr. Ben Naim agree not to compete and solicit with the Company during the term of the Agreement and for a period of twelve
months following the termination of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eyal
Morag Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an employment agreement (the &ldquo;Morag Agreement&rdquo;), as of February 18, 2020, with Dr. Morag, to serve as
the Company&rsquo;s Chief Medical Officer, on an indefinite basis subject to the termination provisions described in the Morag
Agreement. Pursuant to the terms of the Morag Agreement, Dr. Morag shall receive a base salary of NIS64,000 per month plus Global
Overtime (as defined in the Morag Agreement) of NIS 16,000 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Morag shall also be entitled to receive a target annual cash bonus, based on certain milestones, of up to a maximum amount of
30% of his annual salary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Morag shall be further entitled to a monthly automobile allowance not to exceed NIS 4,800 per month plus expenses and applicable
taxes, and shall be granted options to purchase 25,000 shares of common stock of the Company based on vesting and other terms
set forth in the Morag Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Morag Agreement, the Company shall pay an amount equal to 8.33% of Dr. Morag&rsquo;s salary to be allocated for severance
pay, 6.5% of Dr. Morag&rsquo;s salary to be allocated for pension savings and 7.5% to be allocated to an educational fund. The
Company may have additional payment obligations for disability insurance as specified in the Morag Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the initial 24 months following the Commencement Date (&ldquo;Initial Period&rdquo;), either the Company or Dr. Morag may terminate
the Morag Agreement at its discretion at any time by providing the other party with a three months (or, following the Initial
Period, six months) prior written notice of termination (the &ldquo;Advance Notice Period&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Morag Agreement &ldquo;For Cause&rdquo; (as defined in the Morag Agreement) at any time by written notice
without the Advance Notice Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Company terminates Dr. Morag&rsquo;s employment during the Initial Period other than For Cause, Dr. Morag shall
be entitled to a one-time payment in an amount equal to his annual salary as of the date of termination of employment multiplied
by the balance time between the end of the Advance Notice Period and until the end of the Initial Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Morag Agreement contains customary non-competition and non-solicit provisions pursuant to which Dr. Morag agrees not to compete
and solicit with the Company. Dr. Morag also agreed to customary terms regarding confidentiality and ownership of intellectual
property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Hezi
Himelfarb Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an employment agreement (the &ldquo;Himelfarb Agreement&rdquo;) with Mr. Himelfarb on December 5, 2016, to serve
as our Chief Operating Office and General Manager, on an indefinite basis subject to the termination provisions described in the
Himelfarb Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of February 1, 2019, Mr. Himelfarb resigned from all positions with the Company and with Microbot Medical Ltd., a wholly-owned
subsidiary of the Company. Notwithstanding the foregoing, as a result of certain termination provisions of the Himelfarb Agreement,
Mr. Himelfarb was entitled to six months of compensation as a result of such resignation. As of December 2019, all the options
granted to Mr. Himelfarb were forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company generally enters into indemnification agreements with each of its directors and executive officers. Pursuant to the indemnification
agreements, the Company has agreed to indemnify and hold harmless these current and former directors and officers to the fullest
extent permitted by the Delaware General Corporation Law. The agreements generally cover expenses that a director or officer incurs
or amounts that a director or officer becomes obligated to pay because of any proceeding to which he is made or threatened to
be made a party or participant by reason of his service as a current or former director, officer, employee or agent of the Company,
provided that he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the
Company. The agreements also provide for the advancement of expenses to the directors and officers subject to specified conditions.
There are certain exceptions to the Company&rsquo;s obligation to indemnify the directors and officers, and, with certain exceptions,
with respect to proceedings that he initiates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limits
on Liability and Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide directors and officers insurance for our current directors and officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation eliminate the personal liability of our directors to the fullest extent permitted by law. The certificate
of incorporation further provide that the Company will indemnify its officers and directors to the fullest extent permitted by
law. We believe that this indemnification covers at least negligence on the part of the indemnified parties. Insofar as indemnification
for liabilities under the Securities Act may be permitted to our directors, officers, and controlling persons under the foregoing
provisions or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act of 1933 and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company adopted a compensation package for the non-management members of its Board, pursuant to which each such Board member would
receive for his services $12,000 per annum, $750 per duly called Board meeting and $250 per unanimous written consent. Furthermore,
each member of the Audit Committee of the Board receives an additional $10,000 per annum, and other committee members receive
an additional $5,000 per annum. Board members are also entitled to receive equity awards. Upon joining the Board, a member would
receive an initial grant of $40,000 of stock options (calculated as the product of the exercise price on the date of grant multiplied
by the number of shares underlying the stock option award required to equal $40,000), with an additional grant of stock options
each year thereafter, to purchase such number of shares of the Company&rsquo;s common stock equal to $20,000, subject to the member
of the Board having served on the Board for at least twelve continuous months, and having attended at least 80% of the Board meetings
over the prior year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes cash-based and equity compensation information for our outside directors, including annual Board and
committee retainer fees and meeting attendance fees, for the year ended December 31, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fees
    earned or paid in cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    Awards</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards (1)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-Equity
    Incentive Plan Compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonqualified
    Deferred Compensation Earnings</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
    Other Compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 33%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yoav
    Waizer (2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,250</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,469</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">61,719</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yoseph
    Bornstein</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,469</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">64,969</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Scott
    Burell</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,350</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,469</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">64,819</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martin
    Madden</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">43,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,469</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63,469</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prattipati
    Laxminarain</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,469</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,969</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    shown do not reflect cash compensation actually received by the director. Instead, the amounts shown are the non-cash aggregate
    grant date fair values of stock option awards made during the period presented as determined pursuant to ASC Topic 718 and
    excludes the effect of forfeiture assumptions. The assumptions used to calculate the fair value of stock option awards are
    set forth under Note 9 to the Consolidated Financial Statements of the Company included in the Company&rsquo;s Annual Report
    on Form 10-K for the fiscal year ended December 31, 2019.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Waizer resigned as a director of the Company effective as of June 30, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Gadot received compensation for his services to the Company as set forth under the summary compensation table above. The
above table does not include Ms. Stockburger or Mr. Wenderow, who were each appointed as a director subsequent
to December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Related
parties can include any of our directors or executive officers, certain of our stockholders and their immediate family members.
Each year, we prepare and require our directors and executive officers to complete Director and Officer Questionnaires identifying
any transactions with us in which the officer or director or their family members have an interest. This helps us identify potential
conflicts of interest. A conflict of interest occurs when an individual&rsquo;s private interest interferes, or appears to interfere,
in any way with the interests of the company as a whole. Our code of ethics requires all directors, officers and employees who
may have a potential or apparent conflict of interest to immediately notify our general counsel, who serves as our compliance
officer. In addition, the Corporate Governance Committee is responsible for considering and reporting to the Board any questions
of possible conflicts of interest of Board members. Our code of ethics further requires pre-clearance before any employee, officer
or director engages in any personal or business activity that may raise concerns about conflict, potential conflict or apparent
conflict of interest. Copies of our code of ethics and the Corporate Governance Committee charter are posted on the corporate
governance section of our website at <U>www.microbotmedical.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
have been no related party transactions or any other transactions or relationships required to be disclosed pursuant to Item 404
of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRINCIPAL
ACCOUNTANT FEES AND SERVICES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
and Tax Fees</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board, upon the recommendation of the Audit Committee, has selected the independent accounting firm of Brightman Almagor Zohar
&amp; Co., a Member of Deloitte Touche Tohmatsu Limited, to audit the accounts of the Company for the year ending December 31,
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee considered the tax compliance services provided by Brightman Almagor Zohar &amp; Co., concluded that provision
of such services is compatible with maintaining the independence of the independent accountants, and approved the provision by
Brightman Almagor Zohar &amp; Co. of tax compliance services with respect to the year ending December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Audit Committee received the following information concerning the fees of the independent accountants for the years ended December
31, 2019 and 2018, has considered whether the provision of these services is compatible with independence of the independent accountants,
and concluded that it is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12/31/19</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12/31/18</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit
    Fees (1)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit-Related
    Fees</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    Fees</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
    Other Fees (2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    fees represents fees for the integrated audit of our annual consolidated financial statements and reviews of the interim consolidated
    financial statements, and review of audit-related SEC filings.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    fees related to issuing comfort letter and consent(s).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
and tax fees include administrative overhead charges and reimbursement for out-of-pocket expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pre-Approval
Policies and Procedures</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Audit Committee has adopted policies and procedures for pre-approving all services (audit and non-audit) performed by our independent
auditors. In accordance with such policies and procedures, the Audit Committee is required to pre-approve all audit and non-audit
services to be performed by the independent auditors in order to assure that the provision of such services is in accordance with
the rules and regulations of the SEC and does not impair the auditors&rsquo; independence. Under the policy, pre-approval is generally
provided up to one year and any pre-approval is detailed as to the particular service or category of services and is subject to
a specific budget. In addition, the Audit Committee may pre-approve additional services on a case-by-case basis. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF THE AUDIT COMMITTEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversees our accounting and financial reporting processes and the audits of our financial statements on behalf
of the Board and selects an independent public accounting firm to perform these audits. Management has the primary responsibility
for establishing and maintaining adequate internal control over financial reporting, preparing the financial statements, and establishing
and maintaining adequate controls over public reporting. Our independent registered public accounting firm for fiscal 2019, Deloitte,
had responsibility for conducting an audit of our annual financial statements in accordance with the standards of the Public Company
Accounting Oversight Board (United States) and expressing an opinion on the conformity of those audited financial statements with
generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversaw the independent public accounting firm&rsquo;s qualifications and independence, as well as its performance.
The Audit Committee assisted the Board in overseeing the preparation of the Company&rsquo;s financial statements, the Company&rsquo;s
compliance with legal and regulatory requirements, and the performance of the Company&rsquo;s internal audit function. The Audit
Committee met with personnel of the Company and Deloitte to review the scope and the results of the annual audit, the amount of
audit fees, the Company&rsquo;s internal accounting controls, the Company&rsquo;s financial statements contained in the Company&rsquo;s
Annual Report to Shareholders and other related matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has reviewed and discussed with management the financial statements for fiscal year 2019 audited by Deloitte,
as well as management&rsquo;s report on internal control over financial reporting, using the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control &mdash; Integrated Framework. The Audit Committee
has discussed with Deloitte various matters related to the financial statements, including those matters required to be discussed
by SAS 114 (The Auditor&rsquo;s Communication with Those Charged with Governance). The Audit Committee has also discussed with
Deloitte its report on internal control over financial reporting, has received the written disclosures and the letter from Deloitte
required by Public Company Accounting Oversight Board (PCAOB) Ethics and Independence Rule 3526, <I>Communication with Audit Committees
Concerning Independence</I> (Rule 3526), and has discussed with Deloitte its independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon such review and discussions, the Audit Committee recommended to the Board of Directors, and the Board approved the recommendation,
that the audited financial statements be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ending
December 31, 2019 for filing with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    Burell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
    Madden</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoseph
    Bornstein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
foregoing Audit Committee Report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933
or the Securities Exchange Act of 1934, and shall not otherwise be deemed filed under these acts, except to the extent we specifically
incorporate by reference into such filings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
1: NOMINEES FOR ELECTION OF CLASS II DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of directors is currently fixed at seven, with there being one vacancy as a result of the resignation of Mr. Yoav Waizer
effective June 30, 2020, which is expected to be filled on August 1, 2020 with the appointment of Mr. Tal Wenderow. Both
our restated certificate of incorporation, as amended to date, and our amended and restated by-laws provide for the classification
of the Board into three classes (Class I, Class II and Class III), as nearly equal in number as possible, with the term of office
of one class expiring each year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise instructed, the enclosed proxy will be voted to elect the nominees named below, each of whom is now a Class II director,
as Class II directors for a term of three years expiring at the 2023 Annual Meeting of Shareholders and until their successors
are duly elected and qualified. Both Class II director nominees have been recommended by the Corporate Governance Committee because
of their past experience serving on the Company&rsquo;s Board, the breadth of their business expertise, sound judgment, and demonstrated
leadership, among other things. Proxies cannot be voted for a greater number of persons than the number of nominees named below.
It is expected that the nominees will be able to serve, but if any are unable to serve, the proxy will be voted for a substitute
nominee or nominees designated by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance Committee has recommended and the Board has nominated <B>Scott Burell and Aileen Stockburger </B>for election
as the Company&rsquo;s Class II directors to serve as Class II Directors until the 2023 Annual Meeting of Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THIS PROPOSAL 1 TO ELECT AS DIRECTORS THE TWO NOMINEES DESCRIBED
ABOVE</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
2: RATIFICATION OF INDEPENDENT REGISTERED ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is asking the stockholders to ratify the selection of Deloitte, or its U.S. affiliate, as the Company&rsquo;s independent
public accountants for the fiscal year ending December 31, 2020. The affirmative vote of the holders of a majority of the shares
represented and voting at the Annual Meeting will be required to ratify the selection of Deloitte or its U.S. affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the stockholders fail to ratify the appointment, the Audit Committee of the Board of Directors will consider it as a
recommendation to select other auditors for the subsequent year, which the Audit Committee would then take under advisement. Even
if the selection is ratified, the Audit Committee of the Board at its discretion could decide to terminate the engagement of Deloitte
or its U.S. affiliate and engage another firm at any time if the Audit Committee determines that such a change would be necessary
or desirable in the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of Deloitte is expected to attend the Annual Meeting telephonically and is not expected to make a statement, but
will be available to respond to appropriate questions and may make a statement if such representative desires to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THIS PROPOSAL 2 TO RATIFY THE SELECTION OF DELOITTE OR ITS U.S. AFFILIATE
AS THE COMPANY&rsquo;S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2020.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
3: APPROVAL OF A NON-BINDING ADVISORY RESOLUTION SUPPORTING THE COMPENSATION OF THE COMPANY&rsquo;S NAMED EXECUTIVE OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Say
on Pay&rdquo; Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 enables our shareholders to cast an advisory vote at the Annual
Meeting to approve the compensation of our named executive officers as disclosed in this Proxy Statement. The vote on this resolution
is not intended to address any specific element of compensation; rather the vote relates to the compensation of our named executive
officers generally, as described in this Proxy Statement. Shareholders are urged to read carefully the information in the &ldquo;Executive
Compensation&rdquo; section of this Proxy Statement before casting their vote. For purposes of this Proxy Statement, the following
Company executives are referred to collectively as the &ldquo;named executive officers&rdquo;: Harel Gadot, David Ben Naim and
Hezi Himelfarb. Mr. Himelfarb&rsquo;s employment with the Company was terminated in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has previously decided that it is a matter of good corporate governance to hold the advisory vote on compensation once every
three years until the next advisory vote on frequency occurs. An advisory vote on the frequency of stockholder votes to approve
executive compensation is required to be held at least once every six years. Accordingly, unless the Board modifies its policy
on the frequency of future votes, we expect to have our next advisory vote on compensation at our 2023 meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that this advisory vote is an important means of obtaining feedback from our shareholders about executive compensation,
which is set by the Compensation Committee and the independent directors and is designed to link pay with performance. Although
this vote is non-binding, our Board and Compensation Committee value the opinions of our shareholders and will consider the outcome
of this vote when making future compensation decisions affecting our executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Compensation Philosophy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive compensation program is designed to attract, reward and retain key employees, including our named executive officers,
who are critical to the Company&rsquo;s long-term success. Shareholders are urged to read the &ldquo;Executive Compensation&rdquo;
section of this Proxy Statement for greater detail about the Company&rsquo;s executive compensation programs, including information
about the fiscal year 2019 compensation of the named executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company is asking the shareholders to indicate their support for the compensation of the Company&rsquo;s named executive officers
as described in this Proxy Statement by voting in favor of the following resolution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESOLVED</B>,
that the Shareholders approve the compensation of the named executive officers of Microbot Medical Inc., as disclosed in the &ldquo;Executive
Compensation&rdquo; discussion, the Summary Compensation Table and the related compensation tables, notes and narrative in the
Proxy Statement for the Company&rsquo;s 2020 Annual Meeting of Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though this say-on-pay vote is advisory and therefore will not be binding on the Company, the Compensation Committee and the Board
of Directors value the opinions of the Company&rsquo;s shareholders. Accordingly, to the extent there is a significant vote against
the compensation of the named executive officers, the Board of Directors will consider shareholder concerns and the Compensation
Committee will evaluate what actions, if any, may be necessary or appropriate to address those concerns. You may vote &ldquo;for,&rdquo;
&ldquo;against,&rdquo; or &ldquo;abstain&rdquo; from the proposal to approve on an advisory basis the compensation of our named
executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS A VOTE &ldquo;FOR&rdquo; THE ADVISORY RESOLUTION TO APPROVE THE COMPENSATION OF THE COMPANY&rsquo;S
NAMED EXECUTIVE OFFICERS AS PRESENTED IN THIS PROXY STATEMENT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
4: APPROVAL OF THE MICROBOT MEDICAL INC. 2020 OMNIBUS PERFORMANCE AWARD PLAN.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2020, the Board adopted the Microbot Medical Inc. 2020 Omnibus Performance Award Plan (including a sub-plan for Israeli
residents), or the 2020 Plan, and unanimously recommends that the stockholders of the Company approve the 2020 Plan. As of July
30, 2020, no employees of the Company nor any other individuals have received awards under the 2020 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that our ability to offer our key employees, non-employee directors and certain consultants and advisers long-term,
equity-based compensation will help enable us to attract, motivate and retain experienced and highly qualified employees, directors
and other service providers who will contribute to our financial success. It is the judgment of the Board that approval of the
2020 Plan is in the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief description of the 2020 Plan. The full text of the 2020 Plan is attached as Exhibit A to this Proxy Statement,
and the following description is qualified in its entirety by reference to this Exhibit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purpose
and Effective Date</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to provide for the success and enhance the value of the Company by linking participants&rsquo; personal
interests with those of the Company&rsquo;s stockholders, and employees, by providing participants with an incentive for outstanding
performance, and to motivate, attract and retain the services of participants upon whom the success of the Company depends. The
Plan is flexible in that it provides for the grant of stock options (&ldquo;Options&rdquo;), stock appreciation rights (&ldquo;SARs&rdquo;),
shares of restricted stock (&ldquo;Restricted Stock&rdquo;), restricted stock units (&ldquo;RSUs&rdquo;), cash incentives, performance
shares and performance units (&ldquo;Performance Shares&rdquo; and &ldquo;Performance Units&rdquo;), singularly or in combination
as determined by the Compensation Committee of the Board of Directors. The Plan became effective, subject to stockholder approval
at the Meeting, as of July 17, 2020 (the &ldquo;Effective Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration
of the 2020 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Plan will be administered by the Compensation Committee of the Board of Directors of the Company (which will consist exclusively
of outside directors) and currently consists of Yoseph Bornstein and Martin Madden, or by such other committee consisting of not
less than two non-employee directors appointed by the Board of Directors (the &ldquo;Committee&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
Subject to the 2020 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Plan authorizes the grant of awards relating to 1,420,652 shares of the Company&rsquo;s Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any corporate transaction occurs which causes a change in the capitalization of the Company, the Committee is authorized to make
such adjustments to the number and class of shares of the Company&rsquo;s Common Stock delivered, and the number and class and/or
price of shares of the Company&rsquo;s Common Stock subject to outstanding awards granted under the 2020 Plan, as it deems appropriate
and equitable to prevent dilution or enlargement of participants&rsquo; rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility
and Participation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
eligible to participate in the 2020 Plan include management and key employees of the Company and its subsidiaries, as determined
by the Committee, including employees who are members of the Board. Directors who are not employees (&ldquo;Director Participants&rdquo;)
and Consultants to the Company also will be able to participate in the 2020 Plan. As of the Effective Date, it is anticipated
that the approximate number of individuals who will be eligible to participate under the 2020 Plan will be at least fifteen.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
and Termination of the 2020 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
no event may any award under the 2020 Plan be granted on or after the tenth anniversary of the 2020 Plan&rsquo;s Effective Date.
The Board may amend, modify or terminate the 2020 Plan at any time; provided that no amendment requiring stockholder approval
for the 2020 Plan to continue to comply with Sections 409A or 422 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;),
shall be effective unless approved by stockholders, and no amendment, termination or modification shall materially and adversely
affect any outstanding award without the consent of the participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sub-Plans
for Foreign Participants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to comply with the laws, rules, regulations and/or taxes in countries other than the United States in which the Company
operates or has employees, non-employee directors or consultants, or in order to comply with the requirements of any foreign securities
exchange, the Committee, in its sole discretion, shall have the power and authority to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    which affiliates shall be covered by the 2020 Plan;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    which individuals outside the United States are eligible to participate in the 2020 Plan;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">modify
    the terms and conditions of any award granted to individuals outside the United States to comply with applicable foreign laws
    or listing requirements of any such foreign securities exchange;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establish
    subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable;
    provided, however, that no such subplans and/or modifications shall increase the share limitations in the 2020 Plan; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">take
    any action, before or after an award is made, that it deems advisable to obtain approval or comply with any necessary local
    governmental regulatory exemptions or approvals or listing requirements of any such foreign securities exchange.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of adoption of the 2020 Plan, a sub-plan was adopted (subject to stockholder approval at the Company&rsquo;s Annual
Meeting of Stockholders) for Israeli residents eligible for awards under the 2020 Plan, which is attached as Appendix A to the
2020 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awards
Under the 2020 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
Options</U>. The Committee may grant incentive stock options (&ldquo;ISOs&rdquo;), non qualified stock options (&ldquo;non ISOs&rdquo;),
or a combination thereof under the 2020 Plan. As described below, there are certain tax advantages to employees who receive ISOs;
however, certain restrictions also apply to such grants. First, ISOs can be granted only to employees (not to non-employee directors
or consultants), and the Option exercise price for each such ISO shall be at least equal to 100% of the fair market value of a
share of the Company&rsquo;s Common Stock on the date the Option is granted (110% in the case of an individual who is a 10% owner
of the Company). Second, an ISO may not be exercised later than 10 years after the date of grant (5 years in the case of 10% owners
of the Company.) ISOs also may not be exercised later than 3 months (one year in the case of a termination of employment due to
disability) after the optionholder&rsquo;s termination of employment other than due to his or her death. Lastly, Common Stock
will be deemed to be acquired under an ISO only with respect to the first $100,000 worth of Common Stock (valued on the date of
grant) first exercisable in any one calendar year. In other words, if under an ISO, the participant vests in the right to acquire
more than $100,000 of shares of Common Stock in any one calendar year, the excess number of shares will not be deemed to have
been acquired under an ISO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
shall expire at such times as the Committee determines at the time of grant; provided, however, that no Option shall be exercisable
later than the tenth anniversary of its grant. Options granted under the 2020 Plan shall be exercisable at such times and subject
to such restrictions and conditions as the Committee shall approve. Except as may be provided in a grant award made to a particular
participant, in the event a participant&rsquo;s employment is terminated by reason of his voluntary termination without the Company&rsquo;s
consent, his involuntary termination for &ldquo;Cause&rdquo; or his voluntary termination in the absence of disability or &ldquo;Good
Reason&rdquo;, as defined under the 2020 Plan, all Options shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Option exercise price is payable in cash, in shares of the Company&rsquo;s Common Stock having a fair market value equal to the
exercise price, by share withholding or a combination of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISOs
may be transferred only under the laws of descent and distribution and, during his or her lifetime, shall be exercisable only
by the participant or his or her legal representative. Each stock option agreement shall specify the participant&rsquo;s (or his
or her beneficiary&rsquo;s) rights in the event of retirement, death or other termination of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Option to qualify for the exception to the restrictions imposed on non-qualified deferred compensation under Section 409A
of the Code, the exercise price (per share of Common Stock) of any Option must at all times be no less than the fair market value
of one share of the underlying Common Stock determined on the date the Option is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
may be subject to time and other vesting requirements, such as the attainment of individual or Company-related performance goals
and targets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
Appreciation Rights</U>. SARs granted under the 2020 Plan may be in the form of freestanding SARs, tandem SARs or a combination
thereof. The base value of a freestanding SAR shall be equal to the fair market value of a share of the Company&rsquo;s Common
Stock on the date of grant. The base value of a tandem SAR shall be equal to the exercise price of the related Option. The term
of any SAR granted under the 2020 Plan shall be determined by the Committee, provided that the term of any tandem SAR which is
linked to an ISO may not exceed ten (10) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freestanding
SARs may be exercised upon such terms and conditions as are imposed by the Committee and set forth under the SAR award agreement.
A tandem SAR may be exercised only with respect to the shares of Common Stock of the Company for which its related Option is exercisable.
Tandem SARs granted in connection with an Option shall expire no later than the expiration of the Option, and may be exercised
only when the fair market value of the shares subject to the Option exceeds the Option exercise price. Furthermore, the number
of shares of the Company&rsquo;s Common Stock that may be acquired under the related Option will be reduced, one for one, by the
number of shares with respect to which the tandem SAR is exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the exercise of an SAR, a participant will receive the difference between the fair market value of a share of the Company&rsquo;s
Common Stock on the date of exercise and the base value multiplied by the number of shares with respect to which the SAR is exercised.
Payment due upon exercise may be in cash, in shares of the Company&rsquo;s Common Stock having a fair market value equal to such
cash amount, or in a combination of cash and shares, as determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may only be transferred under the laws of descent and distribution and, during his or her lifetime, shall be exercisable only
by the participant or his or her legal representative. Each SAR award agreement shall specify the participant&rsquo;s (and his
or her beneficiary&rsquo;s) rights in the event of death or other termination of employment. Except as may be provided in a grant
award made to a particular participant, in the event a participant&rsquo;s employment is terminated by reason of his voluntary
termination without the Company&rsquo;s consent, his involuntary termination for &ldquo;Cause&rdquo; or his voluntary termination
in the absence of disability or &ldquo;Good Reason&rdquo;, as defined under the 2020 Plan, all SARs shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be subject to time and other vesting requirements, such as the attainment of individual or Company-related performance goals
and targets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock</U>. Restricted Stock are shares of Common Stock transferred to a participant which are subject to forfeiture back to the
Company in the event certain employment requirements or other vesting requirements are not met. The period during which such requirements
are in effect is hereinafter referred to as the &ldquo;restriction period.&rdquo; Restricted Stock may be granted in such amounts
and subject to such terms and conditions as determined by the Committee. The Committee shall impose such conditions and/or restrictions
on any shares of Restricted Stock as it deems advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
Stock may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated until the end of the applicable restriction
period or upon earlier satisfaction of such other conditions specified by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
holding Restricted Stock may not exercise full voting rights with respect to those shares during the restriction period and shall
not be credited with regular cash dividends paid with respect to such shares. Dividends or distributions credited during the restriction
period shall be subject to the same restrictions on transferability and forfeitability as the shares of Restricted Stock with
respect to which they were paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
rights with respect to Restricted Stock shall be available only during a participant&rsquo;s lifetime, and each Restricted Stock
award agreement shall specify the participant&rsquo;s (and his beneficiary&rsquo;s) rights in the event of death or other termination
of employment. Except as may be provided in a grant award made to a particular participant, in the event a participant&rsquo;s
employment is terminated by reason of his voluntary termination without the Company&rsquo;s consent, his involuntary termination
for &ldquo;Cause&rdquo; or his voluntary termination in the absence of disability or &ldquo;Good Reason&rdquo;, as defined under
the 2020 Plan, prior to the end of the restriction period, all shares of Restricted Stock granted to such participant shall be
forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Restricted Stock may be subject to time and other vesting requirements, such as the attainment of individual or Company-related
performance goals and targets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock Units</U>. Each RSU represents a promise by the Company to deliver to the participant one share of Common Stock at a predetermined
date in the future. RSUs are subject to forfeiture in the event certain employment requirements or other vesting requirements
are not met. The period during which such requirements are in effect is hereinafter referred to as the &ldquo;restriction period.&rdquo;
RSUs may be granted in such amounts and subject to such terms and conditions as determined by the Committee. The Committee shall
impose such conditions and/or restrictions on RSUs as it deems advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
rights with respect to RSUs shall be available only during a participant&rsquo;s lifetime, and each RSU award agreement shall
specify the participant&rsquo;s (and his beneficiary&rsquo;s) rights in the event of death or other termination of employment.
Except as may be provided in a grant award made to a particular participant, in the event a participant&rsquo;s employment is
terminated by reason of his voluntary termination without the Company&rsquo;s consent, his involuntary termination for &ldquo;Cause&rdquo;
or his voluntary termination in the absence of disability or &ldquo;Good Reason&rdquo;, as defined under the 2020 Plan, prior
to the end of the restriction period, all RSUs granted to such participant shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RSUs may be subject to time and other vesting requirements, such as the attainment of individual or Company-related performance
goals and targets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Performance
Shares and Performance Units</U>. Performance Shares and Performance Unit awards may be granted in the amounts and subject to
such terms and conditions as determined by the Committee. Performance Shares and Performance Units are, respectively, similar
to shares of Restricted Stock and RSUs except that certain individual, financial or other Company-related goals and targets must
be met in order for the Performance Shares and Units to become non-forfeitable. The Committee shall set performance goals which,
depending on the extent to which they are met during the performance periods established by the Committee, will determine the
number and/or value of Performance Shares/Units that will be paid to participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
shall receive payment of the value of Performance Shares or Performance Units earned in cash and/or shares of the Company&rsquo;s
Common Stock which have an aggregate fair market value equal to the value of the earned Performance Shares/Units after the end
of the applicable performance period, in such combination as the Committee determines. Such shares may be granted subject to any
restrictions deemed appropriate by the Committee. Prior to the beginning of each performance period, participants may elect to
defer receipt of payout on such terms as the Committee deems appropriate. Subject to the provisions of an applicable plan award,
participants may be entitled to have dividends declared with respect to Performance Shares earned in connection with Performance
Share/Unit grants earned but not yet distributed held in their performance accounts, subject to the same restrictions as are applicable
to dividends earned with respect to Restricted Stock, described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Performance Shares and Performance Units may also be subject to other vesting requirements, such as continued employment for specified
periods of time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as may be provided in a grant award made to a particular participant, in the event a participant&rsquo;s employment is terminated
by reason of his voluntary termination without the Company&rsquo;s consent, his involuntary termination for &ldquo;Cause&rdquo;
or his voluntary termination in the absence of disability or &ldquo;Good Reason&rdquo;, as defined under the 2020 Plan, prior
to the date such awards become vested all Performance Shares and Performance Units granted to such participant shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
Shares and Performance Units may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, other than
by will or by the laws of descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
Incentives</U>. Cash Incentives may be granted in the amounts and subject to such terms and conditions as determined by the Committee.
Under the terms of a Cash Incentive grant, certain individual, financial or other Company-related goals and targets must be met
in order for the Cash Incentives to become non-forfeitable and to determine the amount of the Cash Incentives to which the participant
is entitled. The Committee shall set performance goals which, depending on the extent to which they are met during the performance
periods established by the Committee, will determine the value of Cash Incentives that will be paid to participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
shall receive payment of the Cash Incentives at the end of the applicable performance period. To the extent permitted by the Committee,
prior to the beginning of each performance period, participants may elect to defer receipt of payout on such terms as the Committee
deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cash Incentives may be subject to time and other vesting requirements, such as the attainment of individual or Company-related
performance goals and targets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as may be provided in a grant award made to a particular participant, in the event a participant&rsquo;s employment is terminated
by reason of his voluntary termination without the Company&rsquo;s consent, his involuntary termination for &ldquo;Cause&rdquo;
or his voluntary termination in the absence of disability or &ldquo;Good Reason&rdquo;, as defined under the 2020 Plan, all unpaid
Cash Incentives granted to such participant shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
to Cash Incentives may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Merger,
Consolidation, Sale of Assets or Change in Control of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the effective date of a merger, consolidation, sale of generally all of the assets or the change in control of the Company
(and if the merger or consolidation agreement does not provide for the continuation of such awards or the substitution of new
awards or any other treatment) (1) any Option or SAR outstanding shall become immediately exercisable and (2) any restriction
periods and restrictions imposed on Restricted Stock shall be deemed to have expired. Performance Shares or Performance Units
payable after the date of such merger or consolidation shall be paid in cash as of the date they originally were to be paid unless,
subject to the limitations imposed by Code Section 409A, the Company or its successor determines to pay such amounts as of an
earlier date. Except as may be provided in a particular award, Performance Shares and Performance Units shall be pro-rated based
on the attainment of the applicable performance goals at the target level if, as a result of the merger or consolidation, the
value of such awards cannot be determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not possible at this time to determine awards that will be made pursuant to the 2020 Plan in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Federal
Income Tax Consequences of Awards Under the 2020 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been advised by its counsel that under currently applicable provisions of the Code, the following federal income tax
consequences may be expected by a participant (including a Director Participant) and by the Company in respect of the grant and
exercise of awards under the 2020 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Federal
Income Tax Consequences &ndash; Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consequences
to the Optionholder (Other than Director Participants or Consultants)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Grant</U>.
There are no federal income tax consequences to the optionholder solely by reason of the grant of ISOs and non ISOs under the
2020 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise</U>.
The exercise of an ISO is not a taxable event for regular federal income tax purposes if certain requirements are satisfied, including
the restriction mentioned above providing that the optionholder generally must exercise the Option no later than three months
following the termination of his employment. However, such exercise may give rise to an alternative minimum tax liability (see
&ldquo;Alternative Minimum Tax&rdquo; below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the exercise of a non ISO, the optionholder generally will recognize ordinary income in an amount equal to the excess of the fair
market value of the shares of the Company&rsquo;s Common Stock at the time of exercise over the amount paid as the exercise price.
The ordinary income recognized in connection with the exercise by an optionholder of a non ISO will be subject to both wage and
employment tax withholding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
optionholder&rsquo;s tax basis in the shares acquired pursuant to the exercise of an Option will be the amount paid upon exercise
plus, in the case of a non ISO, the amount of ordinary income recognized by the optionholder upon exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Qualifying
Disposition</U>. If an optionholder disposes of shares of the Company&rsquo;s Common Stock acquired upon the exercise of an ISO
in a taxable transaction, and such disposition occurs more than two years from the date on which the option is granted and more
than one more year after the date on which the shares are transferred to the optionholder pursuant to the exercise of the ISO,
the optionholder will recognize long term capital gain or loss equal to the difference between the amount realized upon such disposition
and the optionholder&rsquo;s adjusted basis in such shares (generally the Option exercise price).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disqualifying
Disposition</U>. If the optionholder disposes of shares of the Company&rsquo;s Common Stock acquired upon the exercise of an ISO
(other than in certain tax free transactions) within two years from the date on which the ISO is granted or within one year after
the transfer of the shares to the optionholder pursuant to the exercise of the ISO, then at the time of disposition the optionholder
generally will recognize ordinary income equal to the lesser of (i) the excess of such shares&rsquo; fair market value on the
date of exercise over the exercise price paid by the optionholder or (ii) the optionholder&rsquo;s actual gain (i.e., the excess,
if any, of the amount realized on the disposition over the exercise price paid by the optionholder). If the total amount realized
on a taxable disposition (including return of capital and capital gain) exceeds the fair market value on the date of exercise,
then the optionholder will recognize a capital gain in the amount of such excess. If the optionholder incurs a loss on the disposition
(i.e., if the total amount realized is less than the exercise price paid by the optionholder) then the loss will be a capital
loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
Dispositions</U>. If an optionholder disposes of shares of the Company&rsquo;s Common Stock acquired upon the exercise of a non
ISO in a taxable transaction, the optionholder will recognize capital gain or loss in an amount equal to the difference between
his basis (as discussed above) in the shares sold and the total amount realized upon the disposition. Any such capital gain or
loss (and any capital gain or loss recognized on a disqualifying disposition of shares of the Company&rsquo;s Common Stock acquired
upon the exercise of ISOs as discussed above) will be long term depending on whether the shares of the Company&rsquo;s Common
Stock were held for more than one year from the date such shares were transferred to the optionholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Alternative
Minimum Tax</U>. The alternative minimum tax (&ldquo;AMT&rdquo;) is imposed in addition to, but only to the extent it exceeds,
the optionholder&rsquo;s regular tax for the taxable year. As of January 1, 2018, AMT is computed at the rate of 26% on the excess
of a taxpayer&rsquo;s alternative minimum taxable income (&ldquo;AMTI&rdquo;) over the exemption amount, but only if such excess
amount does not exceed $191,500 ($95,700 in the case of married individuals filing separate returns). The AMT tax rate is 28%
of such excess amount over the $191,500 ($95,700 amount. For these purposes, the exemption amount is $109,400 for joint returns
or returns of surviving spouses ($70,300 for single taxpayers who is not a surviving spouse and $54,700 for married individuals
filing separate returns), reduced by 25% of the excess of AMTI over $1,000,000 for joint returns or returns of surviving spouses
($500,000 for single taxpayers who are not surviving spouses and $500,000 for married individuals filing separate returns). A
taxpayer&rsquo;s AMTI is essentially the taxpayer&rsquo;s taxable income adjusted pursuant to the AMT provisions and increased
by items of tax preference. For calendar years beginning on January 1, 2018 and ending on and before December 31, 2025 the dollar
amounts set forth above will be adjusted for inflation. Furthermore, special rules apply with regard to foreign tax credits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise of ISOs (but not non ISOs) will generally result in an upward adjustment to the optionholder&rsquo;s AMTI in the year
of exercise by an amount equal to the excess, if any, of the fair market value of the stock on the date of exercise over the exercise
price. The basis of the stock acquired, for AMT purposes, will equal the exercise price increased by the prior upward adjustment
of the taxpayer&rsquo;s AMTI due to the exercise of the option. Upon the disposition of the stock, the increased basis will result
in a smaller capital gains for AMTI than for ordinary income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consequences
to the Company (Other than Awards to Director Participants and Consultants)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no federal income tax consequences to the Company by reason of the grant of ISOs or non ISOs or the exercise of ISOs (other
than disqualifying dispositions).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the optionholder recognizes ordinary income from the exercise of a non ISO, the Company will be entitled to a federal
income tax deduction in the amount of the ordinary income so recognized (as described above), provided that the Company timely
satisfies its reporting and disclosure obligations described below. To the extent the optionholder recognizes ordinary income
by reason of a disqualifying disposition of the stock acquired upon exercise of ISOs, the Company will be entitled to a corresponding
deduction in the year in which the disposition occurs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will be required to report to the Internal Revenue Service any ordinary income recognized by an optionholder by reason
of the exercise of a non ISO or the disqualifying disposition of the Company&rsquo;s Common Stock acquired pursuant to an ISO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consequences
to Optionholder (Director Participants and Consultants)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Grant</U>.
There are no federal income tax consequences to the optionholder solely by reason of the grant of non qualified stock options
to a Director Participant or a Consultant under the 2020 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise</U>.
Upon the exercise of a non qualified stock option, the optionholder will generally recognize ordinary income in an amount equal
to the excess of the fair market value of the shares of Company Common Stock at the time of exercise over the amount paid as the
exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
optionholder&rsquo;s tax basis in the shares acquired pursuant to the exercise of a non qualified stock option will be the amount
paid upon exercise plus the amount of ordinary income recognized by the optionholder upon exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disposition</U>.
If an optionholder disposes of shares of Company Common Stock acquired upon exercise of a non qualified stock option in a taxable
transaction, the optionholder will recognize capital gain or loss in an amount equal to the difference between his basis (as discussed
above) in the shares sold and the amount realized upon disposition. Any such capital gain or loss will be long term or short term
depending on whether the shares of Company Common Stock were held for more than one year from the date such shares were transferred
to the optionholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consequences
to the Company (Grants to Director Participants and Consultants)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the optionholder recognizes ordinary income from the exercise of a non qualified stock option, the Company will be entitled
to a federal income tax deduction in the amount of the ordinary income so recognized (as described above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Federal
Income Tax Consequences - Other Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consequences
to the Employee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock</U>. An award payable in the form of the Company&rsquo;s Common Stock generally will be includable in the participant&rsquo;s
gross income as of the date the grant is made or, if later, the earlier of the date the Common Stock awarded to the participant
(i) is subsequently transferable by him or her or (ii) is not subject to a substantial risk of forfeiture. This determination
is made by reference to all of the facts and circumstances of such award, and, in particular, the nature of the restrictions imposed
with respect to the shares of Common Stock granted under the award. Nevertheless, so long as the sale of the Common Stock at a
profit could subject the recipient to suit under Section 16(b) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), the Common Stock is considered to be subject to a &ldquo;substantial risk of forfeiture&rdquo; (see the discussion
below, captioned &ldquo;Restrictions on Resale&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time as the substantial risk of forfeiture terminates, the participant will recognize ordinary income to the extent of the
excess of the fair market value of the Common Stock on the date the risk of forfeiture terminates over the participant&rsquo;s
cost (if any) of such Common Stock. Under certain circumstances, however, the participant may make a so-called &ldquo;Section
83(b) election&rdquo; to have such excess amount determined and includible in his or her gross income at the time of grant, regardless
of any restrictions on subsequent transferability or substantial risks of forfeiture. As the value of the Common Stock for federal
income tax purposes is determined as of the date it is included in the participant&rsquo;s gross income, such an election may
be worthwhile if significant appreciation is expected between the date of grant and the date the restrictions expire or are eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock Units</U>. An award payable in the form of RSUs generally will be includable in the participant&rsquo;s gross income as
of the date the underlying shares of Common Stock are transferred to the participant or, if later, the earlier of the date the
underlying Common Stock awarded to the participant (i) is subsequently transferable by him or her or (ii) is not subject to a
substantial risk of forfeiture. This determination is made by reference to all of the facts and circumstances of such award, and,
in particular, the nature of the restrictions imposed with respect to the shares of Common Stock granted under the award. Nevertheless,
so long as the sale of the Common Stock at a profit could subject the recipient to suit under Section 16(b) of the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), the Common Stock is considered to be subject to a &ldquo;substantial
risk of forfeiture&rdquo; (see the discussion below, captioned &ldquo;Restrictions on Resale&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time as the substantial risk of forfeiture terminates, the participant will recognize ordinary income to the extent of the
excess of the fair market value of the Common Stock on the date of delivery to the participant (or, if later, the date the risk
of forfeiture terminates) over the participant&rsquo;s cost (if any) of such Common Stock. Under certain circumstances, however,
the participant may make a so-called &ldquo;Section 83(b) election&rdquo; at the time of delivery of otherwise restricted shares
of Common Stock to have such excess amount determined and includible in his or her gross income at the time of delivery, regardless
of any restrictions on subsequent transferability or substantial risks of forfeiture. As the value of the Common Stock for federal
income tax purposes is determined as of the date it is included in the participant&rsquo;s gross income, such an election may
be worthwhile if significant appreciation is expected between the date of grant and the date the restrictions expire or are eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Performance
Shares and Performance Units</U>. A participant who receives Performance Shares or Performance Units will not recognize any income
for federal income tax purposes on the date of the grant of the award. He will recognize ordinary income for federal income tax
purposes at the time of the receipt of the cash and/or Common Stock with respect to the Award in an amount equal to the sum of
(i) the amount of cash received, plus (ii) the excess, if any, of the fair market value of the Common Stock on the date received
over the participant&rsquo;s cost of such Award, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disposition
of Common Stock</U>. If a participant disposes of shares of the Company&rsquo;s Common Stock received under an award in a taxable
transaction, the participant will recognize capital gain or loss in an amount equal to the difference between his basis (generally,
the amount included as ordinary income pursuant to the award and the amount, if any, paid for such Common Stock) in the shares
sold and the total amount realized upon the disposition. Any such capital gain or loss will be long term so long as the shares
of the Company&rsquo;s Common Stock were held for more than one year from the date such shares were granted to the participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
Incentives</U>. Cash Incentives generally are included in the gross income of the participant at the time paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consequences
to the Company</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the participant recognizes ordinary income upon the receipt of an award under the 2020 Plan, the Company generally will
be entitled to a federal income tax deduction in the amount of the ordinary income so recognized (as described above), provided
that the Company timely reports to the Internal Revenue Service the ordinary income recognized by the participant pursuant to
the award. Any dividends paid on restricted stock (prior to the earlier of (i) the date the restrictions lapse or (ii) the date
a Section 83(b) election is made) will be deductible by the Company as a compensation expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Tax Consequences</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing discussion is not a complete description of the federal income tax aspects of awards made under the 2020 Plan. In addition,
administrative and judicial interpretations of the application of the federal income tax laws are subject to change. Furthermore,
the foregoing discussion does not address state or local tax consequences, nor does it address the rules applicable to &ldquo;non-qualified
deferred compensation&rdquo; as defined under Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Israeli
Tax Treatment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the Israeli income tax consequences of certain transactions under the 2020 Plan with regard to the granting
of wards to Israeli participants. It is general and does not purport to be comprehensive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the 2020 Plan provides for the granting of awards to employees, directors and consultants under either Section 102 or Section
3(i) of the ITO. The awards granted under the 2020 Plan to employees and office holders, who are not controlling shareholders
(as defined in the ITO) are subject to the &ldquo;capital gains tax route&rdquo; under Section 102 of the ITO (the &ldquo;Capital
Gains Tax Route&rdquo;), and the awards granted to participants in the 2020 Plan who do not qualify to receive awards under the
Capital Gains Tax Route, including consultants, service providers and controlling shareholders, are subject to Section 3(i) of
the ITO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Capital Gains Tax Route generally provides for a reduced tax rate of 25% on gains realized upon the sale of the Award&rsquo;s
underlying shares, subject to the fulfillment of certain procedures and conditions including the deposit of such Awards (or shares
issued upon their exercise or shares in case that a restricted stock was granted) for a requisite period of time with a trustee
approved by the Israeli Tax Authority (currently, 24 months from the date of grant).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, in any event where the exercise price of the underlying shares subject to the Awards is less than the fair market value
of the underlying shares at the time of grant of the Awards (calculated as the average value of a company&rsquo;s shares on the
30 trading days preceding the date of grant), such amount will be deemed ordinary income of the Award holder, taxed at the applicable
marginal tax rate (up to 50% in 2020) together with health insurance and social security insurance payments, on the earlier of:
(i) date of sale of the underlying shares; or (ii) the date of the release of such underlying shares from trust (whether to the
Award holder or to a third party).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the requirements of Section 102 of the ITO for the allocation of Awards according to the Capital Gains Tax Route are
not met, the benefit attributed to the Award holder as a result of the grant of such Awards will be taxed as ordinary work income
at applicable marginal income tax rates (together with health insurance and social security insurance payments). For as long as
the Award holder is not the record owner of the restricted stock or the shares issued upon exercise of Awards, such Award holder
shall have none of the rights of a stockholder with respect to such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Capital Gains Tax Route, a company, or its Israeli subsidiary, as the case may be, is generally not entitled to recognize
a deduction for Israeli tax purposes on the gain recognized by the Award holder upon sale of the shares underlying the Awards
(except for such amount that will be deemed ordinary income of the Award holder as explained above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Israeli subsidiary of the Company will be required to withhold applicable tax (and social security and national health insurance
charges, if applicable) at source on behalf of the Award holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Restrictions
on Resale</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to officers or directors of the Company, neither the grant of an Option, nor the acquisition of shares of Common Stock
upon the &ldquo;in-the-money&rdquo; or &ldquo;at-the-money&rdquo; exercise of an Option will be considered a &ldquo;purchase&rdquo;
under the Section 16 of the Exchange Act and will not be matched with sales of shares of Common Stock occurring within six months
of the grant of the Option so long as the Option was granted by the full Board of Directors of the Company or by a committee composed
solely of two or more &ldquo;Non-Employee&rdquo; directors. In the case of an individual who is the direct or indirect beneficial
owner of more than 10% of the Common Stock, the grant will not be matched with a sale only if the shares of Common Stock acquired
by the exercise of the Option are not sold within 6 months of the date the Option is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the of the stock having voting power present in person or represented by proxy
shall be sufficient for the approval of the 2020 Plan and for the approval of the performance-based criteria that will permit
us to maximize our opportunities to pay tax-deductible compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THIS PROPOSAL 4 TO APPROVE THE MICROBOT MEDICAL INC. 2020 OMNIBUS
PERFORMANCE AWARD PLAN</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Proposals</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who wish to present proposals for inclusion in the Company&rsquo;s proxy materials for the 2021 Annual Meeting of Shareholders
may do so by following the procedures prescribed in Rule 14a-8 under the Exchange Act. To be eligible, the Shareholder proposals
must be received by our corporate secretary on or before April 5, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who wish to make a proposal at the 2021 Annual Meeting of Shareholders, other than one that will be included in our proxy materials,
must notify us no later than June 19, 2021 (see Rule 14a-4 under the Exchange Act). If a Shareholder who wishes to present
a proposal at the 2021 Annual Meeting of Shareholders fails to notify us by June 19, 2021, the proxies that management
solicits for the meeting will confer discretionary authority to vote on the Shareholder&rsquo;s proposal if it is properly brought
before the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Nominations of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shareholder entitled to vote for the election of directors at a meeting may nominate persons for election as directors by giving
timely notice thereof in proper written form to the secretary accompanied by a petition signed by at least 100 record holders
of capital stock of the Company which shows the class and number of shares held by each person and which represent in the aggregate
1% or more of the outstanding shares entitled to vote in the election of directors. The submission must be in writing and delivered
to Microbot Medical Inc., Attn: Secretary, Board of Directors, 25 Recreation Park Drive, Unit 108, Hingham, MA 02043, in accordance
with the advance notice procedures and other requirements set forth in Section 3.2 of our bylaws for nominees to be considered
for nomination at the 2021 annual meeting. These requirements are separate from, and in addition to, the requirements discussed
above to have the shareholder nomination or other proposals included in our proxy statement and form of proxy/voting instruction
card pursuant to the SEC&rsquo;s rules. Submissions must include the name, address and number of shares of common stock beneficially
owned by each participant in the Nominating Shareholder group, a representation that the Nominating Shareholder meets the requirements
described in the Board policy and will continue to meet them through the date of the annual meeting, a description of all arrangements
or understandings between or among the Nominating Shareholder group (or any participant in the Nominating Shareholder group) and
the candidate or any other person or entity regarding the candidate, all information regarding the candidate that the Company
would be required to disclose in a proxy statement under SEC rules, including whether the candidate is independent or, if not,
a description of the reasons why not, the consent of the candidate to serve as a director, and representations by the candidate
regarding his or her performance of the duties of a director. Full details may be obtained from the secretary of the Board at
the address above or on our website at www.microbotmedical.com. The Corporate Governance Committee will consider and evaluate
up to two candidates recommended in accordance with this policy in connection with any annual meeting. The Corporate Governance
Committee will consider and evaluate candidates recommended by Shareholders on the same basis as candidates recommended by other
sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company&rsquo;s by-laws provide that a Shareholder entitled to vote for the election of directors at a meeting may
nominate persons for election as directors by giving timely notice thereof in proper written form to the Secretary accompanied
by a petition signed by at least 100 record holders of capital stock of the Company representing in the aggregate 1% or more of
the outstanding shares entitled to vote in the election of directors, which petition must show the class and number of shares
held by each person. To be timely, such notice and petition must be received at the principal executive offices of the Company
not less than 60 days nor more than 90 days prior to the meeting, except if less than 70 days notice of the date of the meeting
is given to Shareholders, in which case the notice and petition must be received not later than the close of business on the tenth
day following the day on which notice of the date of the meeting was mailed or public disclosure of such date was made. The requesting
Shareholder is required to provide information with respect to the nominee(s) for director similar to that described above, as
more fully set forth in the Company&rsquo;s by-laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as filed with the SEC, is available without
charge upon request by writing to Microbot Medical Inc. at 25 Recreation Park Drive, Unit 108, Hingham, MA 02043, Attention: Investor
Relations. A copy of this report is also available through our website at www.microbotmedical.com or, alternatively, at <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Householding&rdquo;
of Proxy Materials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
banks, brokers and other nominee record holders may be participating in the practice of &ldquo;householding&rdquo; proxy statements
and annual reports. This means that only one copy of our proxy statement and annual report to shareholders may have been sent
to multiple shareholders in your household. The Company will promptly deliver a separate copy of either document to you if you
contact the Secretary at the following address or telephone number: Microbot Medical Inc., 25 Recreation Park Drive, Unit 108,
Hingham, MA 02043; telephone: (781) 875-3605. In addition, copies of both documents may be obtained from our website (www.microbotmedical.com,
click on the button &ldquo;Investors&rdquo; and then &ldquo;Presentation + Resources&rdquo;). You may also request information
from Morrow Sodali LLC, our proxy solicitor, at the following address and telephone number: Morrow Sodali LLC, 470 West Avenue,
Stamford, CT 06902; Stockholders Call Toll Free: 800-662-5200; Microbot-info@morrowsodali.com. If you want to receive separate
copies of the proxy statement or the annual report to shareholders in the future, or if you are receiving multiple copies and
would like to receive only one copy per household, you should contact your bank, broker or other nominee record holder, or you
may contact the Company at the above address or telephone number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board knows of no business that will come before the meeting for action except as described in the accompanying Notice of Meeting.
However, as to any such business, the persons designated as proxies will have authority to act in their discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    order of the Board of Directors</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    President, and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: White"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: White"><B>2020
OMNIBUS PERFORMANCE AWARD PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effective
as of July 17, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
Omnibus Performance Award Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTRODUCTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical Inc., a Delaware corporation (hereinafter referred to as the &ldquo;Corporation&rdquo;), hereby establishes an incentive
compensation plan to be known as the <B>&ldquo;Microbot Medical Inc. 2020 Omnibus Performance Award Plan&rdquo;</B> (hereinafter
referred to as the &ldquo;Plan&rdquo;), as set forth in this document. The Plan permits the grant of Cash Incentives, Non-Qualified
Stock Options, Incentive Stock Options, Stock Appreciation Rights, shares of Restricted Stock, Restricted Stock Units, Performance
Units and Performance Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall become effective on July 17, 2020. However, it shall be rendered null and void and have no effect, and all Plan Awards
granted hereunder shall be canceled, if the Plan is not approved by a majority vote of the Corporation&rsquo;s stockholders within
12 months of the date the Plan is adopted by the Corporation&rsquo;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to promote the success and enhance the value of the Corporation by linking the personal interests of Participants
to those of the Corporation&rsquo;s stockholders by providing Participants with an incentive for outstanding performance. The
Plan is further intended to assist the Corporation in its ability to motivate, and retain the services of, Participants upon whose
judgment, interest and special effort the successful conduct of its and its subsidiaries&rsquo; operations is largely dependent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan also provides pay systems that support the Corporation&rsquo;s business strategy and emphasizes pay-for-performance by tying
reward opportunities to carefully determined and articulated performance goals at corporate, operating unit, business unit and/or
individual levels.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the Plan, the following terms shall be defined as follows unless the context clearly indicates otherwise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Affiliate</U>&rdquo; <FONT STYLE="background-color: white">shall mean, as it relates to any limitations or requirements
with respect to Incentive Stock Options, any Subsidiary or Parent of the Corporation. Affiliate otherwise means any entity that
is part of a controlled group of corporations or limited liability entities or is under common control with the Corporation within
the meaning of Code Sections 1563(a), 414(b) or 414(c), except that, in making any such determination, 50% shall be substituted
for 80% under such Code Sections and the related regulations.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="background-color: white">&ldquo;<U>Applicable Law</U>&rdquo; shall mean the applicable provisions of the Code, the
Securities Act, the Exchange Act and any other federal, state or foreign corporate, securities or tax or other laws, rules, requirements
or regulations, the rules of any national securities exchange or automated quotation system on which the shares of Common Stock
are listed, quoted or traded and any other applicable law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<U>Award Agreement</U>&rdquo; shall mean the written agreement, executed by an appropriate officer of the Corporation and
a Participant, pursuant to which a Plan Award is granted and containing the terms and conditions of the Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<U>Board of Directors</U>&rdquo; or &ldquo;<U>Board</U>&rdquo; shall mean the Board of Directors of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<U>Cash Incentives</U>&rdquo; shall mean a Plan Award granting to the Participant the right to receive a certain amount
of cash in the future subject to the satisfaction of certain time-vesting requirements and/or the attainment of one or more annual
or multi-year performance goals and targets, all as described in Article IX, below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<U>Cause</U>&rdquo; shall, with respect to a Participant (i) have the same meaning as &ldquo;cause&rdquo; or &ldquo;for
cause&rdquo; set forth in an employment, consulting, advisory or similar contract entered into by and between the Participant
and the Corporation or any Affiliate or, in the absence of any such contract or defined terms, (ii) mean (A) the Participant&rsquo;s
willful or gross misconduct or willful or gross negligence in the performance of his duties for the Corporation or for any Affiliate,
(B) the Participant&rsquo;s intentional or habitual neglect of his duties for the Corporation or for any Affiliate, (C) the Participant&rsquo;s
(1) theft or misappropriation of funds or other property of the Corporation or of any Affiliate, (2) fraud, (3) criminal misconduct,
(4) breach of fiduciary duty or dishonesty in the performance of his duties on behalf of the Corporation or any Affiliate, (5)
commission of a felony, or crime of moral turpitude or (6) any other conduct reflecting adversely upon the Corporation or any
Affiliate, (D) the Participant&rsquo;s violation of any covenant not to compete, not to disclose confidential information or similar
restriction with respect to the Corporation or any Affiliate or (E) the direct or indirect breach by the Participant of the terms
of any employment, consulting, advisory or similar contract with the Corporation or any Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<U>Change in Control of the Corporation</U>&rdquo; As used herein, a &ldquo;Change in Control of the Corporation&rdquo;
shall be deemed to have occurred if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any person (including any individual, firm, partnership or other entity) together with all Affiliates and Associates (as defined
under Rule 12b-2 of the General Rules and Regulations promulgated under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;)) of such person, <U>but excluding</U> (A) a trustee or other fiduciary holding securities under an employee benefit
plan of the Corporation or any subsidiary of the Corporation, (B) a corporation owned, directly or indirectly, by the equity holders
of the Corporation in substantially the same proportions as their ownership of the Corporation, (C) the Corporation or any subsidiary
of the Corporation, (D) any person who is an equity holder of the Corporation on the Effective Date of the Plan, (E) the spouse,
children, brother, sisters, nephews, nieces or estate (or a trust or trusts benefiting any one or more of such persons) of any
person who is an equity holder of the Corporation on the Effective Date of the Plan, (F) a Participant or (G) the spouse, children
or estate (or a trust or trusts benefiting any one or more of such persons) of a Participant, first becomes the Beneficial Owner
(as defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Corporation representing
more than 50% of the combined voting power of the Corporation&rsquo;s then outstanding securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the consummation of a merger or consolidation of the Corporation with any other corporation, <U>other</U> than a merger or consolidation
that would result in the voting securities of the Corporation outstanding immediately prior thereto continuing to represent (either
by remaining outstanding or by being converted into voting securities of the surviving entity) 50% or more of the combined voting
power of the voting securities of the Corporation or such surviving entity outstanding immediately after such merger or consolidation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the consummation of a plan of complete liquidation of the Corporation or an agreement for the sale or disposition by the Corporation
of all or substantially all of the Corporation&rsquo;s assets to a person or persons totally unrelated to any Participant or any
equity holder of the Corporation (or to any Affiliates and Associates of any such Participant or equity holder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
a majority of the members of the Corporation&rsquo;s Board of Directors is replaced, during any 12-month period, by directors
whose appointment or election is not endorsed by a majority of the members of the Board of Directors before the date of such appointment
or election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, with respect to Plan Awards constituting &ldquo;non-qualified deferred compensation&rdquo; pursuant to the provisions
of Code Section 409A and the regulations promulgated thereunder, the term &ldquo;Change in Control of the Corporation&rdquo; shall
be limited, if necessary, to satisfy the requirements set forth under forth Treas. Reg. &sect;1.409A-3(i)(5). In no instance shall
an Initial or Secondary Public Offering of the Corporation&rsquo;s Common Stock be deemed to constitute a Change in Control of
the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<U>Code</U>&rdquo; shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<U>Committee</U>&rdquo; shall, subject to the provisions of Section II(a) hereof, mean <FONT STYLE="background-color: white">the
Compensation Committee of the Board or such other Committee as the Board may appoint from time to time to administer the Plan,
or the Board itself if no Compensation Committee or other appointed Committee exists.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<U>Common Stock</U>&rdquo; shall mean the common stock of the Corporation, $0.01 par value per share, as authorized from
time to time. At all times, the Common Stock made available for grants hereunder shall be &ldquo;<U>Service Recipient Stock</U>&rdquo;
as defined in Treas. Reg. &sect;1.409A-1(b)(5)(iii)(A) and the terms of the Plan and of any Award Agreement shall be deemed to
be modified to the degree necessary to comply with this requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<U>Consultant</U>&rdquo; shall mean an individual who is in a Consulting Relationship with the Corporation or any Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<U>Consulting Relationship</U>&rdquo; shall mean the relationship that exists between an individual and the Corporation
(or any Affiliate) if (i) such individual or (ii) any entity of which such individual is an executive officer or owns a substantial
equity interest has entered into a written consulting contract with the Corporation or any Affiliate and if, pursuant to such
written consulting agreement, such individual or entity qualifies as a consultant under the applicable rules of the Securities
and Exchange Commission for registration of shares on a Form S-8 Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<U>Corporation</U>&rdquo; shall mean Microbot Medical Inc., a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<U>Disability</U>&rdquo; or &ldquo;<U>Disabled</U>&rdquo; shall have the same meaning as the term &ldquo;permanent and
total disability&rdquo; under Section 22(e)(3) of the Code or, with respect to Plan Awards constituting &ldquo;non-qualified deferred
compensation&rdquo; pursuant to the provisions of Code Section 409A and the regulations promulgated thereunder, shall have the
meaning set forth in Treas. Reg. &sect;1.409A-3(i)(4)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<U>DRO</U>&rdquo; shall mean a domestic relations order as defined by the Code or Title I of the Employee Retirement Income
Security Act of 1974, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<U>Employee</U>&rdquo; shall mean an employee (as determined in accordance with Section 3401(c) of the Code and the regulations
promulgated thereunder) of the Corporation or of any Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<U>Exchange Act</U>&rdquo; shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<U>Fair Market Value</U>&rdquo; shall mean:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
In the event the Corporation&rsquo;s Common Stock is publicly traded, the Fair Market Value of such Common Stock on a Trading
Day shall mean the closing price of the Common Stock on such Trading Day as reported by the national securities exchange on which
the Common Stock then has its primary listing or by the quotation system on which the Common Stock is primarily quoted; provided,
however, that, if no sale of shares of Common Stock shall have been reported on such Trading Day, then the immediately preceding
Trading Day on which a sale of shares of Common Stock has been so reported shall be used. For purposes of this definition, a &ldquo;Trading
Day&rdquo; shall mean, if the Common Stock is listed on any national securities exchange, a business day during which such exchange
was open for trading and at least one trade of Common Stock was effected on such exchange on such business day, or, if the Common
Stock is not listed on any national securities exchange but is traded in the over-the-counter market, a business day during which
the over-the-counter market was open for trading and at least one &ldquo;eligible dealer&rdquo; quoted both a bid and asked price
for the Common Stock. An &ldquo;eligible dealer&rdquo; for any day shall include any broker-dealer who quoted both a bid and asked
price for such day but shall not include any broker-dealer who quoted only a bid or only an asked price for such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
In the event the Corporation&rsquo;s Common Stock is not publicly traded, the Fair Market Value of such Common Stock shall be
determined by the Committee in good faith pursuant to the requirements of Treas. Reg. &sect;1.409A-1(b)(5)(iv)(B). The Committee
shall determine the Fair Market Value of such Common Stock by reference to the most recent valuation performed by an appraisal
or valuation firm selected by the Corporation. If the most recent valuation performed by an appraisal or valuation firm selected
by the Corporation is more than 12) months old, then the Committee shall select an appraisal or valuation firm to perform an updated
valuation. The appraisal or valuation firm shall be independent of the Corporation and the Participant (or selling stockholder
as the case may be). The selection of the appraisal or valuation firm by the Committee shall be final and binding on all persons.
The Corporation shall pay the fees and expenses of the appraisal or valuation firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<U>Freestanding SAR</U>&rdquo; or &ldquo;<U>Freestanding Stock Appreciation Right</U>&rdquo; shall mean an SAR that is
granted independently of any Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&ldquo;<U>Good Reason</U>&rdquo; shall, with respect to a Participant (i) have the same meaning as &ldquo;good reason&rdquo; or
similar term set forth in an employment, consulting, advisory or similar contract entered into by and between the Participant
and the Corporation or any Affiliate (but only to the extent such meaning or meanings satisfy the requirements for &ldquo;good
reason&rdquo; as set forth under Treas. Reg. &sect;1.409A-1(n)(2)(ii)) or, (ii) in the absence of any such contract or defined
term, have the &ldquo;safe-harbor&rdquo; meaning set forth in such regulation section, and, in the case of both clauses (i) and
(ii), a termination of employment or other services shall be deemed to have occurred for Good Reason only if the procedural and
time limitation provisions of Treas. Reg. &sect;&sect;1.409A-1(n)(2)(ii)(A), (B) and (C) are satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<U>Incentive Stock Option</U>&rdquo; shall mean a stock option satisfying the requirements for tax-favored treatment under
Section 422 of the Code and which is intended by the Committee to be treated as an incentive stock option under Code Section 422.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<U>Initial or Secondary Public Offering</U>&rdquo; shall mean the completion of the sale of shares of the Corporation&rsquo;s
equity securities pursuant to an effective registration statement described under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<U>Non-Employee Director</U>&rdquo; shall mean a member of the Board of Directors of the Corporation who is not an Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<U>Non-Qualified Option</U>&rdquo; shall mean a stock option which does not satisfy the requirements for, or which is not
intended to be eligible for, tax-favored treatment under Section 422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<U>Option</U>&rdquo; shall mean a right to purchase shares of Common Stock at a specified exercise price that is granted
under Article V. An Option shall be either a Non-Qualified Option or an Incentive Stock Option; provided, however, that Options
granted to Non-Employee Directors and Consultants shall only be Non-Qualified Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<U>Optionee</U>&rdquo; shall mean a Participant who is granted an Option under the terms of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<U>Parent</U>&rdquo; shall mean a parent corporation of the Corporation within the meaning of Section 424(e) of the Code.
However, a corporation that otherwise qualifies as a Parent will not be so defined if the Plan Award it grants with Common Stock
will render the Common Stock not to be Service Recipient Stock (as defined in Section I(j) hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<U>Participant</U>&rdquo; shall mean any Employee, Consultant, member of the Board of Directors or other person identified
in Section IV(a), hereof, who is granted a Plan Award under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<U>Performance Share</U>&rdquo; shall mean a Plan Award granted pursuant to the provisions of Article VII hereof, which
is similar to Restricted Stock, but which Award is based upon any performance factor established by the Committee on or prior
to the date of grant of such Plan Award, pursuant to the provisions of such Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<U>Performance Unit</U>&rdquo; shall mean a Plan Award granted pursuant to the provisions of Article VIII hereof, which
is similar to a Restricted Stock Unit, but which Award is based upon any performance factor established by the Committee pursuant
to the provisions of such Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&ldquo;<U>Permitted Transferee</U>&rdquo; shall mean, with respect to a Participant, any &ldquo;family member&rdquo; (as defined
under the instructions related to the Form S-8 Registration Statement under the Securities Act) of the Participant who has acquired
a Plan Award from such Participant through a gift or pursuant to a DRO, or any other transferee specifically approved by the Committee
after taking into account Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&ldquo;<U>Plan Award</U>&rdquo; shall mean an Option, Performance Share, Performance Unit, share of Restricted Stock, Restricted
Stock Unit, Cash Incentive or Stock Appreciation Right granted pursuant to the terms of the Plan (including any sub-plan).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
&ldquo;<U>Restricted Stock</U>&rdquo; shall mean a grant of one or more shares of Common Stock subject to certain restrictions
as provided under Article VII hereof and the related Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<U>Restricted Stock Unit</U>&rdquo; shall mean a right to receive one share of Common Stock at a date, and subject to any
and all restrictions, set forth in the related Award Agreement, as provided in Article VIII, hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&ldquo;<U>Securities Act</U>&rdquo; shall mean the Securities Act of 1933, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&ldquo;<U>Service</U>&rdquo; shall mean personal service performed for the Corporation or an Affiliate as an Employee, member
of the Board or as a Consultant, as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
&ldquo;<U>Stock Appreciation Right</U>&rdquo; or &ldquo;<U>SAR</U>&rdquo; shall mean a right, granted alone or in connection with
a related Option, designated as an SAR, to receive a payment on the day the right is exercised, pursuant to the terms of Article
VI hereof. Each SAR shall be denominated in terms of one share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&ldquo;<U>Substitute Award</U>&rdquo; shall mean a Plan Award granted under the Plan upon the assumption of, or in substitution
for, outstanding equity awards previously granted by a company or other entity in connection with a corporate transaction, such
as a merger, combination, consolidation or acquisition of property or stock; provided, however, that in no event shall the term
&ldquo;Substitute Award&rdquo; be construed to refer to an award made in connection with the cancellation and repricing of an
Option or Stock Appreciation Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
&ldquo;<U>Subsidiary</U>&rdquo; shall mean a subsidiary corporation of the Corporation within the meaning of Section 424(f) of
the Code. However, a corporation that otherwise qualifies as a Subsidiary will not be so defined if the Plan Award it grants with
Common Stock will render the Common Stock not to be Service Recipient Stock (as defined in Section I(j) hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
&ldquo;<U>Tandem SAR</U>&rdquo; or &ldquo;<U>Tandem Stock Appreciation Right</U>&rdquo; shall mean an SAR that is granted in connection
with a related Option, the exercise of which shall require forfeiture of the right to purchase a share of Common Stock under the
related Option (and when a share of Common Stock is purchased under such Option, the Tandem SAR being similarly canceled).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
&ldquo;<U>Termination of Consulting Relationship</U>&rdquo; shall mean the cessation, abridgment or termination of a Consultant&rsquo;s
Consulting Relationship with the Corporation or any Affiliate as a result of (i) the Consultant&rsquo;s death, Disability or resignation,
(ii) the cancellation, annulment, expiration, termination or breach of the written consulting contract between the Corporation
(or any Affiliate) and the Consultant (or any other entity) giving rise to the Consulting Relationship or (iii) if the written
consulting contract is not directly between the Corporation (or any Affiliate) and the Consultant, the Consultant&rsquo;s termination
of service with, or sale of all or substantially all of his equity interest in, the entity which has entered into the written
consulting contract with the Corporation or Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
&ldquo;<U>Termination of Service</U>&rdquo; shall mean the termination of a person&rsquo;s active and full-time Service as a member
of the Board, as an Employee or, in the case of a Consultant, his Termination of Consulting Relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADMINISTRATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="background-color: white"><U>Committee</U>. The Committee (or another committee or a subcommittee of the Board assuming
the functions of the Committee under the Plan) shall administer the Plan (except as otherwise provided herein) and, unless otherwise
determined by the Board, shall consist solely of two or more Non-Employee Directors appointed by and holding office at the pleasure
of the Board, each of whom is intended to qualify as (i) a &ldquo;non-employee director&rdquo; as defined by Rule 16b-3 of the
Exchange Act or any successor rule and (ii) an &ldquo;independent director&rdquo; under the rules of any national securities exchange
or automated quotation system on which the shares of Common Stock are listed, quoted or traded; provided that any action taken
by the Committee shall be valid and effective, whether or not members of the Committee at the time of such action are later determined
not to have satisfied the requirements for membership set forth above in this Section II(a) or otherwise provided in any charter
of the Committee. Except as may otherwise be provided in any charter of the Committee, appointment of Committee members shall
be effective upon acceptance of appointment. Committee members may resign at any time by delivering written or electronic notice
to the Board. Vacancies in the Committee may only be filled by the Board. Notwithstanding the foregoing, (i) the full Board, acting
by a majority of its members in office, shall conduct the general administration of the Plan with respect to Plan Awards granted
to Non-Employee Directors (and, if the Committee does not consist solely of two or more Non-Employee Directors, Plan Awards granted
to individuals subject to the provisions of Section 16 of the Exchange Act) and, with respect to such Plan Awards, the term &ldquo;Committee&rdquo;
as used in the Plan shall be deemed to refer to the Board and (ii) the Board or Committee may delegate its authority hereunder
to the extent permitted by Section II(f).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="background-color: white"><U>Duties and Powers of Committee</U>. It shall be the duty of the Committee to conduct
the general administration of the Plan in accordance with its provisions. The Committee shall have the power to interpret the
Plan and the Award Agreements, and to adopt such rules for the administration, interpretation and application of the Plan as are
not inconsistent therewith, to interpret, amend or revoke any such rules and to amend any Award Agreement; provided that the rights,
or obligations, of the Participant that are provided under any such Award Agreement are not adversely affected by such amendment,
unless the consent of the Participant is obtained or such amendment is otherwise explicitly permitted under the Plan. Any such
Plan Award made under the Plan need not be the same with respect to each Participant. Any such interpretations and rules with
respect to Incentive Stock Options shall be consistent with the provisions of Section 422 of the Code. In its sole discretion,
the Board may at any time and from time to time exercise any and all rights and duties of the Committee under the Plan except
with respect to matters which under Rule 16b-3 under the Exchange Act or any successor rule or the rules of any national securities
exchange or automated quotation system on which the shares of Common Stock are listed, quoted or traded are required to be determined
in the sole discretion of the Committee.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="background-color: white"><U>Action by the Committee</U>. Unless otherwise established by the Board or in any charter
of the Committee, a majority of the Committee shall constitute a quorum and the acts of a majority of the members present at any
meeting at which a quorum is present, and acts approved in writing by all members of the Committee in lieu of a meeting, shall
be deemed the acts of the Committee. Each member of the Committee is entitled, in good faith, to rely or act upon any report or
other information furnished to that member by any officer or other employee of the Corporation or any Affiliate, the Corporation&rsquo;s
independent registered public accountants, or any executive compensation consultant or other professional retained by the Committee
to assist in the design or administration of the Plan.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<FONT STYLE="background-color: white"><U>Authority of Committee</U>. Subject to the Corporation&rsquo;s bylaws, the Committee&rsquo;s
charter and any provision set forth hereunder, the Committee has the exclusive power, authority and sole discretion to:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<FONT STYLE="background-color: white">Designate the Participants who will receive Plan Awards;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<FONT STYLE="background-color: white">Determine the type or types of Plan Awards to be granted to Plan Participants;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<FONT STYLE="background-color: white">Determine the number of Plan Awards to be granted and the number of shares of Common Stock
to which a Plan Award will relate;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<FONT STYLE="background-color: white">Determine the terms and conditions of any Plan Award granted pursuant to the Plan, including,
but not limited to, the exercise price, grant price, or purchase price, any performance criteria, any restrictions or limitations
on the Plan Award, any schedule for vesting, lapse of forfeiture restrictions or restrictions on the exercisability of a Plan
Award, and accelerations or waivers thereof, and any provisions related to non-competition and recapture of gain on a Plan Award,
based in each case on such considerations as the Committee in its sole discretion determines;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<FONT STYLE="background-color: white">Determine whether, to what extent, and pursuant to what circumstances a Plan Award may be
settled in, or the exercise price of a Plan Award may be paid in cash, of shares of Common Stock, other Plan Awards, or other
property, or a Plan Award may be canceled, forfeited, or surrendered;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<FONT STYLE="background-color: white">Adjust performance factors to take into account changes in law and accounting or tax rules
as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events or circumstances
to avoid windfalls or hardships;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<FONT STYLE="background-color: white">Prescribe the form of each Award Agreement, which need not be identical for each Participant;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
<FONT STYLE="background-color: white">Determine the Fair Market Value of Common Stock in good faith, if necessary;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
<FONT STYLE="background-color: white">Grant waivers of Plan or Plan Award conditions;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<FONT STYLE="background-color: white">Correct any defect, supply any omission or reconcile any inconsistency in the Plan, any
Plan Award or any Award Agreement;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
<FONT STYLE="background-color: white">Determine whether a Plan Award has been earned;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
<FONT STYLE="background-color: white">Decide all other matters that must be determined in connection with a Plan Award;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
<FONT STYLE="background-color: white">Establish, adopt, or revise any rules and regulations as it may deem necessary or advisable
to administer the Plan;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
<FONT STYLE="background-color: white">Interpret the terms of, and any matter arising pursuant to, the Plan or any Award Agreement;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)
<FONT STYLE="background-color: white">Make all other decisions and determinations that may be required pursuant to the Plan or
as the Committee deems necessary or advisable to administer the Plan;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)
<FONT STYLE="background-color: white">Accelerate wholly or partially the vesting or lapse of restrictions of any Plan Award or
portion thereof at any time after the grant of a Plan Award, subject to the terms and conditions set forth under Article X; and</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)
<FONT STYLE="background-color: white">Establish, adopt or revise any rules and regulations, including adopting sub-plans to the
Plan, for the purposes of facilitating compliance with foreign laws, easing the administration of the Plan and/or taking advantage
of tax-favorable treatment for Awards granted to Participants outside the U.S., in each case as it may deem necessary or advisable;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<FONT STYLE="background-color: white"><U>Decisions Binding</U>. The Committee&rsquo;s interpretation of the Plan, any Plan Awards
granted pursuant to the Plan and any Award Agreement and all decisions and determinations by the Committee with respect to the
Plan are final, binding, and conclusive on all persons. Any dispute regarding the interpretation of the Plan or any Award Agreement
shall be submitted by the Participant or Corporation to the Committee for review. Subject to the provisions of Section XI(m) and
Article XVII, the resolution of such a dispute by the Committee shall be final, binding and conclusive on the Corporation and
the Participant.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<FONT STYLE="background-color: white"><U>Delegation of Authority</U>. To the extent permitted by Applicable Law, the Board or
Committee may from time to time delegate to a committee of one or more members of the Board or to one or more officers of the
Corporation or any Affiliate the authority to grant and/or amend Plan Awards and/or to take other administrative actions pursuant
to this Article II; provided, however, that in no event shall an officer of the Corporation or any Affiliate be delegated the
authority to grant awards to, or amend awards held by, the following individuals: (i) individuals who are subject to Section 16
of the Exchange Act or (ii) officers of the Corporation (or directors) to whom authority to grant or amend Plan Awards has been
delegated hereunder; provided, further, that any delegation of administrative authority shall only be permitted to the extent
it does not violate the provisions of Applicable Law. Any delegation hereunder shall be subject to the restrictions and limits
that the Board or Committee specifies at the time of such delegation, and the Board or Committee, as the case may be, may, at
any time, rescind the authority so delegated or appoint a new delegatee. At all times, the delegatee appointed under this Section
II(f) shall serve in such capacity at the pleasure of the Board and the Committee.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<FONT STYLE="background-color: white"><U>Section 16 of the Exchange Act</U>. Awards granted to Participants who are subject to
Section 16 of the Exchange Act must be approved by two or more &ldquo;<U>non-employee directors</U>&rdquo; (as defined in the
rules and regulations promulgated under Section 16 of the Exchange Act).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<FONT STYLE="background-color: white"><U>Indemnification of the Committee</U>. The Corporation shall bear all expenses of administering
the Plan. The Corporation shall indemnify and hold harmless each person who is or shall have been a member of the Committee acting
as administrator of the Plan, or any agent or person appointed or delegated by the Committee to perform any of its duties, against
and from any cost, liability, loss or expense that may be imposed upon or reasonably incurred by such person in connection with
or resulting from any action, claim, suit or proceeding to which such person may be a party or in which such person may be involved
by reason of any action taken or not taken in good faith under the Plan and against and from any and all amounts paid by such
person in settlement thereof, with the Corporation&rsquo;s approval, or paid by such person in satisfaction of any judgment in
any such action, suit or proceeding against such person, provided he or she shall give the Corporation an opportunity, at its
own expense, to handle and defend the same before he undertakes to handle and defend it on his own behalf. Notwithstanding the
foregoing, the Corporation shall not indemnify and hold harmless any such person if Applicable Law or the Corporation&rsquo;s
Certificate of Incorporation or bylaws prohibit such indemnification. The foregoing right of indemnification shall not be exclusive
of any other rights of indemnification to which such persons may be entitled under the Corporation&rsquo;s Certificate of Incorporation,
bylaws or any agreement, as a matter of law or otherwise, or under any other power that the Corporation may have to indemnify
or hold harmless such person. The provisions of the foregoing indemnity shall survive indefinitely the term of the Plan.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARES
AVAILABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Number of Shares of Common Stock</U>. Subject to the adjustments provided in Article X of the Plan, the aggregate number of
shares of the Common Stock which may be granted for all purposes under the Plan (including, but not limited to, Incentive Stock
Options) shall be 1,420,652 shares of Common Stock. Shares of Common Stock underlying Plan Awards and shares of Common Stock directly
awarded hereunder (whether or not on a restricted basis) shall be counted against the limitation set forth in the immediately
preceding sentence and may be reused to the extent that the related Plan Award to any individual is settled in cash, expires,
is terminated unexercised, or is forfeited. To the extent that a Stock Appreciation Right related to an Option is exercised, such
Option shall be deemed to have been exercised and vice versa. Common Stock granted to satisfy Plan Awards under the Plan may be
authorized and unissued shares of the Common Stock, issued shares of such Common Stock held in the Corporation&rsquo;s treasury
or shares of Common Stock acquired on the open market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Substitute Awards</U>. To the extent permitted by Applicable Law, Substitute Awards shall not reduce the number of shares of
Common Stock authorized for grant under the Plan. Additionally, in the event that an entity acquired by the Corporation or any
Affiliate or with which the Corporation or any Affiliate combines has shares available under a pre-existing plan approved by stockholders
or equity holders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant
to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or
valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common
stock of the entities party to such acquisition or combination) may be used for Plan Awards under the Plan and shall not reduce
the number of shares of Common Stock authorized for grant under the Plan; provided that Plan Awards using such available shares
shall not be made after the date awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition
or combination, and shall only be made to individuals who were not employed by or providing services to the Corporation or its
Affiliates immediately prior to such acquisition or combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELIGIBILITY,
ETC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="background-color: white"><U>Eligible Individuals</U>. Any Employee of the Corporation or an Affiliate (including
an entity that becomes an Affiliate after the adoption of the Plan), a member of the Board or the board of directors of an Affiliate
(including an entity that becomes an Affiliate after the adoption of the Plan) (whether or not such Board or board of directors
member is an Employee), any Consultant to the Corporation or an Affiliate (including an entity that becomes an Affiliate after
the adoption of the Plan) and any entity which is a wholly-owned alter ego of such Employee, member of the Board or board of directors
of an Affiliate or Consultant is eligible to participate in the Plan if the Committee, in its sole discretion, determines that
such person or entity has contributed significantly or can be expected to contribute significantly to the profits or growth of
the Corporation or any Affiliate or if it is otherwise in the best interest of the Corporation or any Affiliate for such person
or entity to participate in the Plan. With respect to any Board member who is (i) designated or nominated to serve as a Board
member by a stockholder of the Corporation and (ii) an employee of such stockholder of the Corporation, then, at the irrevocable
election of the employing stockholder, the person or entity who shall be eligible to participate in the Plan on behalf of the
service of the respective Board member shall be the employing stockholder (or one of its Affiliates). To the extent such election
is made, the respective Board member shall have no rights hereunder as a Participant with respect to such Board member&rsquo;s
participation in the Plan. A Plan Award may be granted to a person or entity who has been offered employment or service by the
Corporation or an Affiliate and who would otherwise qualify as eligible to receive the Plan Award to the extent that person or
entity commences employment or service with the Corporation or an Affiliate, provided that such person or entity may not receive
any payment or exercise any right relating to the Plan Award, and the grant of the Plan Award will be contingent, until such person
or entity has commenced employment or service with the Corporation or an Affiliate.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Limitations Applicable to Section 16 Persons</U>. Notwithstanding any other provision of the Plan to the contrary, any Plan
Award granted or awarded to any individual who is then subject to Section 16 of the Exchange Act shall be subject to any additional
limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including Rule 16b-3 of the Exchange
Act and any amendments thereto) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable
Law and the Plan, Plan Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to such
applicable exemptive rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Foreign Participant</U>. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws, rules,
regulations and/or taxes in countries other than the United States in which the Corporation and its Affiliates operate or have
Employees, Non-Employee Directors or Consultants, or in order to comply with the requirements of any foreign securities exchange,
the Committee, in its sole discretion, shall have the power and authority to: (i) determine which Affiliates shall be covered
by the Plan; (ii) determine which individuals outside the United States are eligible to participate in the Plan; (iii) modify
the terms and conditions of any Plan Award granted to individuals outside the United States to comply with applicable foreign
laws or listing requirements of any such foreign securities exchange; (iv) establish subplans and modify exercise procedures and
other terms and procedures, to the extent such actions may be necessary or advisable (any such subplans and/or modifications to
be attached to the Plan as appendices); provided, however, that no such subplans and/or modifications shall increase the share
limitations contained in Article III; and (v) take any action, before or after a Plan Award is made, that it deems advisable to
obtain approval or comply with any necessary local governmental regulatory exemptions or approvals or listing requirements of
any such foreign securities exchange. Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no
Plan Awards shall be granted, that would violate Applicable Law. For purposes of the Plan, all references to foreign laws, rules,
regulations or taxes shall be references to the laws, rules, regulations and taxes of any applicable jurisdiction other than the
United States or a political subdivision thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Non-Employee Director Awards</U>. The Committee may, in its sole discretion, provide that Plan Awards granted to Non-Employee
Directors shall be granted pursuant to a written formula established by the Committee (the &ldquo;<U>Non-Employee Director Compensation
Policy</U>&rdquo;), subject to the limitations of the Plan. The Non-Employee Director Compensation Policy shall set forth the
type of Plan Award(s) to be granted to Non-Employee Directors, the number of shares of Common Stock to be subject to Non-Employee
Director Plan Awards, the conditions on which such Plan Awards shall be granted, become exercisable and/or payable and expire,
and such other terms and conditions as the Committee shall determine in its sole discretion. The Non-Employee Director Compensation
Policy may be modified by the Committee from time to time in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>V</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCK
OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall have the authority, in its sole discretion, to grant Incentive Stock Options or to grant Non-Qualified Stock Options
or to grant both types of Options. Notwithstanding anything contained herein to the contrary, an Incentive Stock Option may be
granted only to common law employees of the Corporation or of any Affiliate now existing or hereafter formed or acquired, and
not to any director or officer who is not also such a common law employee. The terms and conditions of the Options shall be determined
from time to time by the Committee; <U>provided</U>, <U>however</U>, that the Options granted under the Plan shall be subject
to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise Price</U>. The Committee shall establish the exercise price at the time any Option is granted at such amount as the
Committee shall determine; <U>provided</U>, <U>however</U>, that the exercise price for each share of Common Stock purchasable
under (i) any Incentive Stock Option granted hereunder or (ii) any Option intended to satisfy the requirements of Treas. Reg.
&sect;1.409A-1(b)(5)(i)(A) shall at all times be not less than such amount as the Committee shall, in its best judgment, determine
to be 100% of the Fair Market Value per share of Common Stock at the date the Option is granted; and <U>provided, further</U>,
that in the case of an Incentive Stock Option granted to a person who, at the time such Incentive Stock Option is granted, owns
(or, pursuant to Section 422(b)(6) of the Code and the regulations promulgated thereunder, is deemed to own) shares of stock of
the Corporation or of any Affiliate which possess more than 10% of the total combined voting power of all classes of shares of
stock of the Corporation or of any Affiliate, the exercise price for each share of Common Stock shall be such amount as the Committee,
in its best judgment, shall determine to be not less than 110% of the Fair Market Value per share of Common Stock at the date
the Option is granted. The exercise price of any Option will be subject to adjustment in accordance with the provisions of Section
X of the Plan. Notwithstanding the foregoing, the Committee shall have sole discretion, with respect to Non-Qualified Stock Options,
to establish an exercise price at less than the Fair Market Value per share of Common Stock on the date the Option is granted,
but only if any such Option is designed to comply with the requirements of Section 409A of the Code by including one of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Award Agreement related to any such Option must provide that, under all circumstances, the Common Stock (or cash or other
property) to be received by the Participant (or other person) upon the exercise or settlement of the Option must be so received
no later than the 15<SUP>th</SUP> day of the third month of the year immediately following the year during which the Option vests;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Award Agreement related to any such Option must provide that the Option may be exercised only during a specific year specified
in the Award Agreement or upon a payment event permitted under Section 409A of the Code and the regulations promulgated thereunder
(with such year(s) and payment events being set forth in the related Award Agreement); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Award Agreement related to any such Option must provide that Common Stock (or cash or other property) deliverable to a Participant
(or other person) pursuant to an exercise or settlement of the Option may not be so delivered until a specified date or payment
event permitted under Section 409A of the Code and the regulations promulgated thereunder (with such date(s) and payment events
being set forth in the related Award Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Payment of Exercise Price</U>. The exercise price per share of Common Stock with respect to each Option shall be payable at
the time the Option is exercised. Such price shall be payable in cash or pursuant to any of the other methods set forth in Section
V(g) hereof, as determined by the Committee. Shares of Common Stock delivered to the Corporation in payment of the exercise price
shall be valued at the Fair Market Value of the Common Stock on the date preceding the date of the exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exercisability of Options</U>. Except as provided in Section V(e) hereof, each Option shall be exercisable in whole or in installments,
and at such time(s), and subject to the fulfillment of any conditions on, and to any limitations on, exercisability as may be
determined by the Committee at the time of the grant of such Option. The right to purchase shares of Common Stock shall be cumulative
so that when the right to purchase any shares of Common Stock has accrued such shares of Common Stock or any part thereof may
be purchased at any time thereafter until the expiration or termination of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Expiration of Options</U>. No Incentive Stock Option by its terms shall be exercisable after the 10 years from the date of
grant of such Option; <U>provided</U>, <U>however</U>, in the case of an Incentive Stock Option granted to a person who, at the
time such Option is granted, owns (or, pursuant to Section 422(b)(6) of the Code and the regulations promulgated thereunder, is
deemed to own) shares of stock of the Corporation or of any Affiliate possessing more than 10% of the total combined voting power
of all classes of shares of stock of the Corporation or of any Affiliate, such Option shall not be exercisable after the expiration
of five years from the date of grant of such Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Exercise Upon Optionee&rsquo;s Termination of Service</U>. If the Service of an Optionee is terminated by the Optionee, the
Corporation or any Affiliate for any reason other than death, any Incentive Stock Option granted to such Optionee may not be exercised
later than three months (one year in the case of Termination of Service due to Disability) after the date of such Termination
of Service. For purposes of determining whether any Optionee has incurred a Termination of Service, an Optionee who is both an
Employee (or a Consultant) and a member of the Board shall (with respect to any Non-Qualified Option that may have been granted
to him) be considered to have incurred a Termination of Service only upon his Termination of Service both as an employee (or as
a Consultant) and as a member of the Board. Furthermore, except as otherwise may be provided in, and only with respect to, a particular
Plan Award, if an Optionee engages in an act or omission that would give rise to his Termination of Service by the Corporation
or by any Affiliate for Cause, then the Optionee shall, at the time of such Termination of Service, automatically forfeit his
rights to exercise any and all of the outstanding Option(s) theretofore granted to him.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Maximum Amount of Incentive Stock Options</U>. Each Plan Award under which Incentive Stock Options are granted shall provide
that to the extent the sum of (i) the Fair Market Value of the shares of Common Stock (determined as of the date of the grant
of the Option) subject to such Incentive Stock Option plus (ii) the Fair Market Values (determined as of the date(s) of grant
of the option(s)) of all other shares of Common Stock subject to Incentive Stock Options granted to an Optionee by the Corporation
or any Affiliate, which are exercisable for the first time by any person during any calendar year, exceed(s) $100,000, such excess
shares of Common Stock shall not be deemed to be purchasable pursuant to Incentive Stock Options. The terms of the immediately
preceding sentence shall be applied by taking all options, whether or not granted under the Plan, into account in the order in
which they are granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Procedures for Exercise of Option</U>. The Committee may, in its sole discretion, establish procedures for an Optionee (i)
to exercise an Option by payment of cash, (ii) to have withheld from the total number of shares of Common Stock to be acquired
upon the exercise of an Option that number of shares having a Fair Market Value, which, together with such cash as shall be paid
in respect of fractional shares, shall equal the Option exercise price of the total number of shares of Common Stock to be acquired,
(iii) to exercise all or a portion of an Option by delivering that number of shares of Common Stock already owned by the Optionee
having a Fair Market Value which shall equal the Option exercise price for the portion exercised and, in cases where an Option
is not exercised in its entirety, and subject to the requirements of the Code, to permit the Optionee to deliver the shares of
Common Stock thus acquired by him in payment of shares of Common Stock to be received pursuant to the exercise of additional portions
of such Option, the effect of which shall be that an Optionee can in sequence utilize such newly acquired shares of Common Stock
in payment of the exercise price of the entire Option, together with such cash as shall be paid in respect of fractional shares,
(iv) delivery of a written or electronic notice that the Participant has placed a market sell order with a broker with respect
to shares of Common Stock then issuable upon exercise of an Option, and that the broker has been directed to pay a sufficient
portion of the net proceeds of the sale to the Corporation in satisfaction of the aggregate payments required; provided that payment
of such proceeds is then made to the Corporation upon settlement of such sale, (v) other form of legal consideration acceptable
to the Committee, or (vi) any combination of the foregoing. The Committee shall also determine the methods by which shares of
Common Stock shall be delivered or deemed to be delivered to Participants. Notwithstanding any other provision of the Plan to
the contrary, no Participant who is a member of the Board or an &ldquo;executive officer&rdquo; of the Corporation within the
meaning of Section 13(k) of the Exchange Act shall be permitted to make payment with respect to any Options granted under the
Plan, or continue any extension of credit with respect to such payment, with a loan from the Corporation or a loan arranged by
the Corporation in violation of Section 13(k) of the Exchange Act, to the extent applicable. The Committee may, in its sole discretion,
require that an exercise described under any one or more of the methods described under clause (iii) of the immediately preceding
sentence (to the extent such exercise is, or is deemed to constitute, an exercise effected by the tendering of Common Stock) be
consummated with Common Stock (i) held by the Optionee for at least six months or (ii) acquired by the Optionee other than under
the Plan or a similar program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Substitute Awards</U>. Notwithstanding the foregoing provisions of this Article V to the contrary, but subject to the requirements
of Sections 409A and 424 of the Code, in the case of an Option that is a Substitute Award, the exercise price per share of the
shares of Common Stock subject to such Option may be less than the Fair Market Value per share on the date of grant of the Substitute
Award; provided that the excess of: (i) the aggregate Fair Market Value (as of the date such Substitute Award is granted) of the
shares of Common Stock subject to the Substitute Award, over (ii) the aggregate exercise price thereof does not exceed the excess
of: (x) the aggregate Fair Market Value (as of the time immediately preceding the transaction giving rise to the Substitute Award,
such Fair Market Value to be determined by the Committee) of the shares of the predecessor entity that were subject to the grant
assumed or substituted for by the Corporation, over (y) the aggregate exercise price of such shares pursuant to the option of
the acquired company or other entity for which the Substitute Award substitutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCK
APPRECIATION RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Tandem Stock Appreciation Rights</U>. The Committee shall have the authority to grant Tandem Stock Appreciation Rights in tandem
with an Option at the time of the grant of the Option. Each such Tandem Stock Appreciation Right shall be subject to the same
terms and conditions as the related Option, if any, and shall be exercisable only at such times and to such extent as the related
Option is exercisable; <U>provided</U>, <U>however</U>, that a Tandem Stock Appreciation Right may be exercised only when the
Fair Market Value of the Common Stock exceeds the exercise price of the related Option. A Tandem Stock Appreciation Right shall
entitle the Optionee to surrender to the Corporation unexercised the related Option, or any portion thereof, and, except as provided
below, to receive from the Corporation in exchange therefor that number of shares of Common Stock equal in value to the excess
of the Fair Market Value of one share of the Common Stock of the Corporation on the Trading Day preceding the surrender of such
Option over the exercise price per share of Common Stock multiplied by the number of shares of Common Stock provided for under
the Option, or portion thereof, which is surrendered; <U>provided</U>, <U>however</U>, that no fractional shares of Common Stock
shall be issued by reason thereof (cash being delivered to the Participant in lieu of such fractional shares). The number of shares
of Common Stock which may be received pursuant to the exercise of a Tandem Stock Appreciation Right may not exceed the number
of shares of Common Stock provided for under the Option, or portion thereof, which is surrendered. The Committee shall have the
right, in its sole discretion, to require a Participant to receive cash in whole or in part in settlement of a Tandem Stock Appreciation
Right. Within 30 days following the receipt by the Committee of a request by the Participant to receive cash in whole or in part
in settlement of a Tandem Stock Appreciation Right, the Committee shall, in its sole discretion, either consent to or disapprove,
in whole or in part, such a request. A request to receive cash in whole or in part in settlement of a Tandem Stock Appreciation
Right may provide that, to the extent that the Committee shall disapprove such request, such request shall be deemed to be an
exercise of such Tandem Stock Appreciation Right for shares of Common Stock. Each Tandem SAR shall comply with the requirements
of Treas. Reg. &sect;1.409A-1(b)(5)(i)(B); provided, however, that the Committee shall have sole discretion, with respect to Stock
Appreciation Rights, to establish an exercise price at less than the Fair Market Value per share of Common Stock on the date the
Stock Appreciation Right is granted, but only if any such Stock Appreciation Right is designed to comply with the requirements
of Section 409A of the Code by including one or more of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Award Agreement related to any such Stock Appreciation Right must provide that, under all circumstances, the Common Stock
(or cash or other property) to be received by the Participant (or other person) upon the exercise or settlement of the Stock Appreciation
Right must be so received no later than the 15th day of the third month of the year immediately following the year during which
the Stock Appreciation Right vests;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Award Agreement related to any such Stock Appreciation Right must provide that the Stock Appreciation Right may be exercised
only during a specific year specified in the Award Agreement or upon a payment event permitted under Section 409A of the Code
and the regulations promulgated thereunder (with such year(s) and payment events being set forth in the related Award Agreement);
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Award Agreement related to any such Stock Appreciation Right must provide that Common Stock (or cash or other property) deliverable
to a Participant (or other person) pursuant to an exercise or settlement of the Stock Appreciation Right may not be so delivered
until a specified date or payment event permitted under Section 409A of the Code and the regulations promulgated thereunder (with
such date(s) and payment events being set forth in the related Award Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Freestanding Stock Appreciation Rights</U>. The Committee also shall have the authority to grant Stock Appreciation Rights
unrelated to any Option that may be granted hereunder. Each such Freestanding Stock Appreciation Right shall be subject to such
terms and conditions as determined by the Committee. Freestanding Stock Appreciation Rights shall entitle the Participant to surrender
to the Corporation a portion or all of such rights and, except as provided below, to receive from the Corporation in exchange
therefor that number of shares of Common Stock (or cash, as provided below) equal in value to the excess of the Fair Market Value
of one share of the Common Stock of the Corporation on the Trading Day preceding the surrender of such Freestanding Stock Appreciation
Rights over the Fair Market Value per share of Common Stock (determined as of the date the Stock Appreciation Right was granted)
multiplied by the number of Freestanding Stock Appreciation Rights which are surrendered; <U>provided</U>, <U>however</U>, that
no fractional shares of Common Stock shall be issued by reason thereof (cash being delivered to the Participant in lieu of such
fractional shares). The Committee shall have the right, in its sole discretion, to require a Participant to receive cash in whole
or in part in settlement of a Stock Appreciation Right. Within 30 days following the receipt by the Committee of a request by
the Participant to receive cash in whole or in part in settlement of a Stock Appreciation Right, the Committee shall, in its sole
discretion, either consent to or disapprove, in whole or in part, such a request. A request to receive cash in whole or in part
in settlement of a Stock Appreciation Right may provide that, to the extent that the Committee shall disapprove such request,
such request shall be deemed to be an exercise of such Stock Appreciation Right for shares of Common Stock. Each Freestanding
Stock Appreciation Right shall comply with the requirements of Treas. Reg. &sect;1.409A-1(b)(5)(i)(B); provided, however, that
the Committee shall have sole discretion, with respect to Stock Appreciation Rights, to establish an exercise price at less than
the Fair Market Value per share of Common Stock on the date the Stock Appreciation Right is granted, but only if any such Stock
Appreciation Right is designed to comply with the requirements of Section 409A of the Code by including one or more of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Award Agreement related to any such Stock Appreciation Right must provide that, under all circumstances, the Common Stock
(or cash or other property) to be received by the Participant (or other person) upon the exercise or settlement of the Stock Appreciation
Right must be so received no later than the 15th day of the third month of the year immediately following the year during which
the Stock Appreciation Right vests;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Award Agreement related to any such Stock Appreciation Right must provide that the Stock Appreciation Right may be exercised
only during a specific year specified in the Award Agreement or upon a payment event permitted under Section 409A of the Code
and the regulations promulgated thereunder (with such year(s) and payment events being set forth in the related Award Agreement);
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Award Agreement related to any such Stock Appreciation Right must provide that Common Stock (or cash or other property) deliverable
to a Participant (or other person) pursuant to an exercise or settlement of the Stock Appreciation Right may not be so delivered
until a specified date or payment event permitted under Section 409A of the Code and the regulations promulgated thereunder (with
such date(s) and payment events being set forth in the related Award Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exercise of Stock Appreciation Rights. </U>The exercisability of a Plan Award granted under this Article VI shall be determined
as set forth in any agreement executed by the Corporation and such Participant hereunder. For purposes of determining whether
a Participant has incurred a Termination of Service (in the context of determining the non-forfeitability of his Stock Appreciation
Rights), a Participant who is both an Employee (or a Consultant) and a member of the Board shall be considered to have incurred
a Termination of Service only upon his Termination of Service both as an Employee (or as a Consultant) and as a member of the
Board. Except as otherwise may be provided in, and only with respect to, a particular Plan Award, if the Participant engages in
any act or omission that would give rise to his involuntary Termination of Service for Cause, then the Participant shall, at the
time of such Termination of Service, forfeit his rights to exercise any and all of the outstanding Plan Awards granted under this
Article VI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTED
STOCK AND PERFORMANCE SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall have the authority to grant shares of Restricted Stock and/or Performance Shares. The terms and conditions of
Performance Shares and shares of Restricted Stock shall be determined from time to time by the Committee, without limitation,
except as otherwise provided in the Plan. Furthermore:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Services Rendered</U>. Each such Award of Restricted Stock and Performance Shares shall be granted for Services rendered or
to be rendered; <U>provided</U>, <U>however</U>, that, with regard to Common Stock-based Plan Awards, the value of the Services
performed must equal or exceed the par value of such shares of Common Stock to be granted to the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Duration of Performance or Restricted Period; Satisfaction of Conditions</U>. The duration of the performance or restricted
period and the condition or conditions upon which (i) such restrictions will lapse (and upon which the restricted period will
end), (ii) the performance goals will be deemed to have been satisfied and (iii) such Plan Awards will be paid or distributed
shall, except as otherwise provided herein, be determined by the Committee at the time each such grant is made and will be set
forth under the subject Award Agreement. More than one grant may be outstanding at any one time, and performance or restricted
periods may be of different lengths.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Restricted Stock</U>. Shares of Common Stock granted in the form of Restricted Stock shall be registered in the name of the
Participant and, together with a stock power endorsed by the Participant in blank, deposited with the Corporation at the time
the Plan Award is granted. With respect to such Restricted Stock, the Participant shall generally have the rights and privileges
of a stockholder of the Corporation as to such shares except that the following restrictions shall apply: (i) the Participant
shall not be entitled to delivery of a certificate until the expiration or termination of the restricted period; (ii) none of
the shares of Restricted Stock may be sold, transferred, assigned, pledged, or otherwise encumbered or disposed of during the
restricted period; and (iii) all of the shares of Restricted Stock shall be forfeited by the Participant without further obligation
on the part of the Corporation as set forth in this Section VII(c) hereof. Cash and stock dividends and distributions with respect
to the Restricted Stock will be withheld by the Corporation for the Participant&rsquo;s account, and interest may be paid on the
amount of cash dividends withheld at a rate and subject to such terms as may be determined by the Committee. All cash or stock
dividends and distributions so withheld by the Corporation shall initially be subject to forfeiture, but shall become non-forfeitable
and payable at the same times, and at the same rate, as determined with respect to the lapse of restrictions on the underlying
Restricted Stock. Upon the forfeiture of any shares of Restricted Stock, such forfeited shares of Common Stock (and any dividends
and distributions set aside thereon) shall be transferred to the Corporation without further action by the Participant. Upon the
expiration or termination of the restricted period, the restrictions imposed on the appropriate shares of Restricted Stock shall
lapse and a stock certificate for the number of shares of Restricted Stock with respect to which the restrictions have lapsed
shall be delivered, free of all such restrictions, except any that may be imposed by Applicable Law or by any applicable agreement,
to the Participant. A Participant who files an election with the Internal Revenue Service to include the Fair Market Value of
any Restricted Stock in gross income while they are still subject to restrictions shall promptly furnish the Corporation with
a copy of such election together with the amount of any federal, state, local or other taxes that may be required to be withheld
to enable the Corporation to claim an income tax deduction with respect to such election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Performance Shares</U>. For purposes of this Article VII, Performance Shares shall be substantially identical to shares of
Restricted Stock except that the vesting of such Performance Shares will be based solely upon the attainment of one or more performance
targets, as further described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Performance Targets</U>. At the time of each grant, the Committee shall establish specific performance targets (to be satisfied
during the performance period) and/or periods of service to which the vesting of Performance Shares and shares of Restricted Stock
shall be subject. The Committee may also establish a relationship between performance targets and the number of Performance Shares
and shares of Restricted Stock which shall become vested. Furthermore, the Committee also may establish a relationship between
performance results other than the targets and the number of Performance Shares and shares of Restricted Stock which shall become
vested. The Committee shall determine the measures of performance to be used in determining the extent to which restrictions on
shares of Restricted Stock and Performance Shares shall lapse. Performance measures and targets may vary among grants and the
Committee may, in its sole discretion, make such adjustments as it may deem necessary or advisable in the event of material changes
in the criteria used for establishing performance targets which would result in the dilution or enlargement of a Participant&rsquo;s
award outside the goals intended by the Committee at the time of the grant of the Plan Award. The performance targets must be
established in writing (i) at the time of the grant of the Plan Award or (ii) if the performance period is 12 months or longer
and the Participant performs Services on a continuous basis from the beginning of the performance period or, if later, from the
date the performance targets are determined, no later than six months before the end of the performance period. Notwithstanding
the foregoing, the performance targets must be established in writing while the attainment of such targets remains uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Termination of Service</U>. The vesting of a Plan Award granted under this Article VII shall be determined as set forth in
any agreement executed by the Corporation and such Participant hereunder. For these purposes, any Participant who is both an Employee
(or a Consultant) and a member of the Board will be considered to have incurred a Termination of Service only upon his Termination
of Service both as an Employee (or as a Consultant) and as a member of the Board. Except as otherwise may be provided in, and
only with respect to, a particular Plan Award, if the Participant engages in any act or omission that would give rise to his Termination
of Service for Cause, all Plan Awards granted under this Section VII and subject to restrictions shall be immediately forfeited.
In such case, the Corporation shall have the right to complete the blank stock power with respect to shares of Restricted Stock
and Performance Shares and transfer the same to the Corporation&rsquo;s treasury.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VIII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESTRICTED
STOCK UNITS AND PERFORMANCE UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall have the authority to grant Restricted Stock Units and/or Performance Units either separately or in combination
with other Plan Awards. The terms and conditions of Restricted Stock Units and Performance Units shall be determined from time
to time by the Committee, without limitation, except as otherwise provided in the Plan. Furthermore:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Services Rendered</U>. Each such Plan Award shall be granted for Services rendered or to be rendered; <U>provided</U>, <U>however</U>,
that, with regard to Common Stock-based Plan Awards, the value of the Services performed must equal or exceed the par value of
such shares of Common Stock to be granted to the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Duration of Performance or Restricted Period; Satisfaction of Conditions</U>. The duration of the performance or restricted
period and the condition or conditions upon which (i) such restrictions will lapse (and upon which the restricted period will
end), (ii) the performance goals will be deemed to have been satisfied and (iii) such Plan Awards will be paid or distributed
shall, except as otherwise provided herein, be determined by the Committee at the time each such grant is made and will be set
forth under the subject Award Agreement. More than one grant may be outstanding at any one time, and performance or restricted
periods may be of different lengths.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Restricted Stock Units</U>. The Committee may grant one or more Restricted Stock Units to a Participant. Such Restricted Stock
Units shall vest pursuant to the vesting schedule set forth in the related Award Agreement and the shares of Common Stock underlying
vested Restricted Stock Units will be distributed to the Participant on the date(s), or upon the event(s), set forth in the related
Award Agreement in the amount of one share of Common Stock for each vested Restricted Stock Unit. At the time of distribution,
a stock certificate for such number of shares of Common Stock shall be delivered to the Participant free of all restrictions (except
any restrictions that may be imposed (i) under the Award Agreement, (ii) by Applicable Law, or (iii) by any applicable agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Performance Units</U>. For purposes of this Article VIII, Performance Units shall be substantially identical to shares of Restricted
Stock Units except that the vesting of such Performance Units will be based solely upon the attainment of one or more performance
targets, as further described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Performance Targets</U>. At the time of each grant, the Committee shall establish specific performance targets (to be satisfied
during the performance period) and/or periods of service to which the vesting of Performance Units and Restricted Stock Units
shall be conditioned. The Committee may also establish a relationship between performance targets and the number of Performance
Units and Restricted Stock Units which shall be earned. Furthermore, the Committee also may establish a relationship between performance
results other than the targets and the number of Restricted Stock Units and the number or value of Performance Units which shall
be earned. The Committee shall determine the measures of performance to be used in determining the extent to which restrictions
on Restricted Stock Units or Performance Units shall lapse. Performance measures and targets may vary among grants and the Committee
may, in its sole discretion, make such adjustments as it may deem necessary or advisable in the event of material changes in the
criteria used for establishing performance targets which would result in the dilution or enlargement of a Participant&rsquo;s
award outside the goals intended by the Committee at the time of the grant of the Plan Award. The performance targets must be
established in writing (i) at the time of the grant of the Plan Award or (ii) if the performance period is 12 months or longer
and the Participant performs Services on a continuous basis from the beginning of the performance period or, if later, from the
date the performance targets are determined, no later than six months before the end of the performance period. Notwithstanding
the foregoing, the performance targets must be established in writing while the attainment of such targets remains uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Dividend or Interest Equivalents for Restricted Stock Units and Performance Units</U>. The Committee may provide that amounts
equivalent to dividends, distributions or interest shall be payable with respect to Restricted Stock Units or Performance Units
held in the Participant&rsquo;s performance account. Such amounts shall be credited to the performance account, and shall be payable
to the Participant in cash or in Common Stock, as set forth under the terms of the subject Plan Award, at such time as the Restricted
Stock Units or Performance Units are earned. The Committee further may provide that amounts equivalent to interest, dividends
or distributions held in the performance accounts shall be credited to such accounts on a periodic or other basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Termination of Service</U>. The vesting of a Plan Award granted under this Article VIII shall be determined as set forth in
any agreement executed by the Corporation and such Participant hereunder. For these purposes, any Participant who is both an Employee
(or a Consultant) and a member of the Board will be considered to have incurred a Termination of Service only upon his Termination
of Service both as an Employee (or as a Consultant) and as a member of the Board. Except as otherwise may be provided in, and
only with respect to, a particular Plan Award, if the Participant engages in any act or omission that would give rise to his Termination
of Service for Cause, all Plan Awards granted under this Section VIII and subject to restrictions shall be immediately forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CASH
INCENTIVES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall have the authority to grant Cash Incentives either separately or in combination with other Plan Awards. The terms
and conditions of Cash Incentives shall be determined from time to time by the Committee, without limitation, except as otherwise
provided in the Plan. Furthermore:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Services Rendered</U>. Each such Plan Award shall be granted for Services rendered or to be rendered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Duration of Performance or Restricted Period; Satisfaction of Conditions</U>. The duration of the performance or restricted
period and the condition or conditions upon which (i) such restrictions will lapse (and upon which the restricted period will
end), upon which (ii) the performance goals will be deemed to have been satisfied and (iii) such Plan Awards will be paid or distributed
shall, except as otherwise provided herein, be determined by the Committee at the time each such grant is made and will be set
forth under the subject Award Agreement. More than one grant may be outstanding at any one time, and performance or restricted
periods may be of different lengths.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cash Incentives</U>. The Committee may grant Cash Incentive awards to one or more Participants, which provide that the recipients
will receive cash payments (of either a fixed dollar amount or an amount determined by formula) at a specified time in the future
based upon the attainment of certain vesting requirements one or more annual or multi-year performance goals, as further described
below. Except as may be provided in an Award Agreement with respect to a particular Participant, any Cash Incentives earned during
a performance period shall be paid in cash within 2&frac12; months after the end of the performance period to which such Plan
Award relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Performance Targets</U>. At the time of each grant, the Committee shall establish specific performance targets (to be satisfied
during the performance period) and/or periods of service to which the vesting of Cash Incentives shall be conditioned. The Committee
may also establish a relationship between performance targets and the amount of Cash Incentives which shall be earned. Furthermore,
the Committee also may establish a relationship between performance results other than the targets and the amount of Cash Incentives
which shall be earned. The Committee shall determine the measures of performance to be used in determining the extent to which
Cash Incentives are earned. Performance measures and targets may vary among grants and the Committee may, in its sole discretion,
make such adjustments as it may deem necessary or advisable in the event of material changes in the criteria used for establishing
performance targets which would result in the dilution or enlargement of a Participant&rsquo;s award outside the goals intended
by the Committee at the time of the grant of the Plan Award. The performance targets must be established in writing (i) at the
time of the grant of the Plan Award or (ii) if the performance period is 12 months or longer and the Participant performs Services
on a continuous basis from the beginning of the performance period or, if later, from the date the performance targets are determined,
no later than six months before the end of the performance period. Notwithstanding the foregoing, the performance targets must
be established in writing while the attainment of such targets remains uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Termination of Service</U>. The vesting of a Plan Award granted under this Article IX shall be determined as set forth in any
agreement executed by the Corporation and such Participant hereunder. For these purposes, any Participant who is both an Employee
(or a Consultant) and a member of the Board will be considered to have incurred a Termination of Service only upon his Termination
of Service both as an Employee (or as a Consultant) and as a member of the Board. Except as otherwise may be provided in, and
only with respect to, a particular Plan Award, if the Participant engages in any act or omission that would give rise to his Termination
of Service for Cause, all Plan Awards granted under this Section IX and subject to restrictions shall be immediately forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>X</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADJUSTMENT
OF SHARES; MERGER OR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATION,
ETC. OF THE CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Recapitalization, Etc</U>. In the event there is any change in the number of the outstanding shares of Common Stock of the
Corporation by reason of any reorganization, recapitalization, reincorporation, stock split, reverse stock split, stock dividend,
combination of shares or otherwise, or in the case of the payment of an extraordinary dividend as defined in Section 1059(c) of
the Code, there shall be automatically substituted for or added to each share of Common Stock theretofore appropriated or thereafter
subject, or which may become subject, to the Plan and any Option, Stock Appreciation Right, grant of Restricted Stock, Restricted
Stock Unit, Performance Share or Performance Unit award, the number and kind of shares of stock or other securities into which
each outstanding share of Common Stock shall be so changed or for which each such share shall be exchanged, or to which each such
share shall be entitled, as the case may be, and the per share price thereof also shall be appropriately adjusted. Notwithstanding
the foregoing, (i) each such adjustment shall comply with the requirements of Treas. Reg. &sect;1.409A-1(b)(5)(v), (ii) each such
adjustment with respect to an Incentive Stock Option shall comply with the rules of Section 424(a) of the Code and (iii) in no
event shall any adjustment be made which would render any Incentive Stock Option granted hereunder to be other than an incentive
stock option for purposes of Section 422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Merger, Consolidation, Change in Control of the Corporation or Sale of Assets</U>. Upon:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the merger or consolidation of the Corporation with or into another corporation (pursuant to which the stockholders of the Corporation
immediately prior to such merger or consolidation will not, as of the date of such merger or consolidation, own a beneficial interest
in shares of voting securities of the corporation surviving such merger or consolidation having at least a majority of the combined
voting power of such corporation&rsquo;s then outstanding securities), if the agreement of merger or consolidation does not provide
for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the continuance of the Options, Stock Appreciation Rights, Restricted Stock Units, Performance Units, shares of Restricted Stock,
Performance Shares and/or Cash Incentives granted hereunder, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
the substitution of new cash incentives, options, stock appreciation rights, restricted stock units, performance units, shares
of restricted stock and/or performance shares for Cash Incentives, Options, Stock Appreciation Rights, Restricted Stock Units,
Performance Units, shares of Restricted Stock or Performance Shares granted hereunder, or for the assumption of the same by the
surviving corporation,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the dissolution or liquidation of the Corporation, or a sale of all or substantially all the assets of the Corporation to a person
who is (A) not an &ldquo;Affiliate&rdquo; or &ldquo;Associate&rdquo; (as defined under Section 12b-2 of the General Rules and
Regulations promulgated under the Exchange Act) of the Corporation or to (B) a direct or indirect owner of a majority of the voting
power of the Corporation&rsquo;s then outstanding voting securities (such sale of assets being referred to as an &ldquo;Asset
Sale&rdquo;), or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Change in Control of the Corporation, if after such Change in Control of the Corporation the Plan (or another plan of the
Corporation or of a successor to the Corporation) does not provide for (1) the continuance of the Cash Incentives, Options, Stock
Appreciation Rights, Restricted Stock Units, Performance Units, shares of Restricted Stock and/or Performance Shares granted hereunder
or (2) the substitution of new cash incentives, options, stock appreciation rights, restricted stock units, shares of restricted
stock, performance units or performance shares for Cash Incentives, Options, Stock Appreciation Rights, Restricted Stock Units,
shares of Restricted Stock, Performance Shares or Performance Units granted hereunder, or for the assumption of the same by the
surviving corporation,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Then,
(A) with respect to such Options and Stock Appreciation Rights, the holder of any such Option or Stock Appreciation Right theretofore
granted and still outstanding (and not otherwise expired) shall have the right immediately prior to the effective date of such
merger, consolidation, dissolution, liquidation, Asset Sale or Change in Control of the Corporation to exercise such Option(s)
or Stock Appreciation Right(s) in whole or in part without regard to any installment provision that may have been made part of
the terms and conditions of such Option(s) or Stock Appreciation Right(s), (B) all restrictions regarding transferability and
forfeiture on shares of Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units shall be removed immediately
prior to the effective date of such merger, consolidation, dissolution, liquidation, Asset Sale or Change in Control of the Corporation
(and the shares of Common Stock underlying any such Restricted Stock Units and Performance Units shall be immediately distributed
to the applicable Participants) and (C) the outstanding amount of Cash Incentives, to the extent vested and earned, shall immediately
be paid to the Participant; provided that all conditions precedent to (x) the exercise of such Option(s) or Stock Appreciation
Right(s), (y) the transferability of such shares of Restricted Stock or Performance Shares and the vesting of Restricted Stock
Units and Performance Units and (z) the payment of such Cash Incentives, other than the passage of time, have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation, to the extent practicable, shall give advance notice to affected Optionees and holders of Stock Appreciation Rights
of any such merger, consolidation, dissolution, liquidation, Asset Sale or Change in Control of the Corporation. Unless otherwise
provided in the subject Award Agreement or merger, consolidation or Asset Sale agreement, all such Options and Stock Appreciation
Rights which are not so exercised shall be forfeited as of the effective time of such merger, consolidation, dissolution, liquidation
or Asset Sale (but not in the case of a Change in Control of the Corporation). In the event the Corporation becomes a subsidiary
of another corporation (the &ldquo;New Parent Corporation&rdquo;) with respect to which the stockholders of the Corporation (as
determined immediately before such transaction) own, immediately after such transaction, a beneficial interest in shares of voting
securities of the New Parent Corporation having at least a majority of the combined voting power of such New Parent Corporation&rsquo;s
then outstanding securities, then, notwithstanding the provisions of the immediately preceding paragraph, there shall be substituted
for Cash Incentives, Options, Stock Appreciation Rights, Restricted Stock Units, shares of Restricted Stock, Performance Shares
and Performance Units granted hereunder, (i) cash incentives and (ii) options to purchase, stock appreciation rights issued with
respect to, restricted stock units (and performance units) related to shares of the New Parent Corporation and restricted shares
of common stock (and performance shares) of the New Parent Corporation. The substitution described in the immediately preceding
sentence shall be effected in a manner such that any option granted by the New Parent Corporation (i) shall comply with Treas.
Reg. &sect;1.409A-1(b)(5)(v) and (ii) which is intended to replace an Incentive Stock Option granted hereunder shall satisfy the
requirements of Section 422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Effect of Merger or Consolidation on Performance-Based Plan Awards, Etc.</U> Notwithstanding the above, as of the effective
date of any merger, consolidation, dissolution, liquidation or Asset Sale described in Section X(b), above, no Participant shall
earn any additional performance-based Plan Award or dividend or interest equivalent under the Plan. Furthermore, if the value
of any such Plan Award cannot be determined as of such date because such Plan Award is conditioned upon the future financial performance
of the Corporation, such Plan Award (including any applicable dividend or interest equivalents) shall, unless otherwise provided
in the subject Award Agreement, be prorated based upon the assumption that such performance criteria have been satisfied at the
target level. Except as provided in Section X(b), any Plan Award payable after the date of the merger, consolidation, dissolution,
liquidation or Asset Sale shall be paid in cash (unless the appropriate merger, consolidation or Asset Sale agreement provides
otherwise) as of the date such Plan Award originally was to have been paid, or as of such earlier date as may be determined by
the Corporation or its successor but subject to the provisions of Section 409A of the Code and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS
PROVISIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Administrative Procedures</U>. The Committee may establish any procedures determined by it to be appropriate in discharging
its responsibilities under the Plan. All actions and decisions of the Committee shall be final.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Assignment or Transfer</U>. Except as provided in Article XII, no grant or award of any Plan Award or any rights or interests
therein shall be assignable or transferable by a Participant. During the lifetime of a Participant, Incentive Stock Options granted
hereunder to such Participant shall be exercisable only by the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Investment Representation</U>. In the case of Plan Awards paid in shares of Common Stock or other securities, or, with respect
to shares of Common Stock received pursuant to the exercise of an Option or a Stock Appreciation Right, or upon the payment upon
any Plan Award, the Committee may require, as a condition of receiving such securities, that the Participant furnish to the Corporation
such written representations and information as the Committee deems appropriate to permit the Corporation, in light of the existence
or nonexistence of an effective registration statement under the Securities Act, to deliver such securities in compliance with
the provisions of the Securities Act or other Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Withholding Taxes</U>. The Corporation (or the appropriate Affiliate) shall have the right to deduct and withhold from all
payments hereunder the statutorily required federal, state, local or foreign taxes due to be withheld with respect to such payments.
In the case of the issuance or distribution of Common Stock or other securities hereunder, either directly or upon the exercise
of or payment upon any Plan Award, the Corporation, as a condition of such issuance or distribution, may require the payment (through
withholding from the Participant&rsquo;s salary, reduction of the number of shares of Common Stock or other securities to be issued,
or otherwise) of any such taxes. Each Participant may satisfy the withholding obligations by paying to the Corporation (or the
appropriate Affiliate) a cash amount equal to the amount required to be withheld or, subject to the Committee&rsquo;s consent
thereto, by tendering to the Corporation (or to the appropriate Affiliate) a number of shares of Common Stock having a Fair Market
Value equivalent to such cash amount, or by use of the following procedure if approved in writing by the Committee: A procedure
whereby a number of shares of Common Stock or other securities may be withheld from the total number of shares of Common Stock
or other securities to be issued upon exercise, vesting or payment upon an Option, Stock Appreciation Right or other grant of
Plan Awards, as applicable. The Committee may, in its sole discretion, require that if any such withholding is effected by the
tendering of Common Stock, such withholding shall be consummated with Common Stock (i) held by the Optionee for at least six months
or (ii) acquired by the Optionee other than under the Plan or a similar program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Costs and Expenses</U>. The costs and expenses of administering the Plan shall be borne by the Corporation and shall not be
charged against any award nor to any person receiving a Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Funding of Plan</U>. The Plan shall be unfunded. The Corporation (and the appropriate Affiliates) shall not be required to
segregate any of their assets to assure the payment of any Plan Award under the Plan. Neither the Participants nor any other persons
shall have any interest in any fund or in any specific asset or assets of the Corporation or any other entity by reason of any
Plan Award, except to the extent expressly provided hereunder. The interests of each Participant and former Participant hereunder
are unsecured and shall be subject to the claims of the general creditors of the Corporation and of the Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Other Incentive Plans</U>. The adoption of the Plan does not preclude the utilization of existing, or adoption by appropriate
means of any other, incentive, performance or other plan for Employees, Non-Employee Directors or other service providers or any
other person eligible to be granted a Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Severability</U>. In case any provision of the Plan shall be held illegal or void, such illegality or invalidity shall not
affect the remaining provisions of the Plan, but shall be fully severable, and the Plan shall be construed and enforced as if
said illegal or invalid provisions had never been inserted herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Payments Due Missing Persons</U>. The Corporation shall make a reasonable effort to locate all persons entitled to benefits
under the Plan (the &ldquo;Benefits&rdquo;). However, notwithstanding any provisions of the Plan to the contrary, if, after a
period of one (1) year from the date such Benefits shall be due, any such persons entitled to Benefits have not been located,
their rights under the Plan with respect to such Benefits shall stand suspended. Before this provision becomes operative, the
Corporation shall send a certified letter to all such persons at their last known addresses advising them that their rights under
the Plan shall be suspended. Subject to all applicable state laws, any such suspended Benefits shall be held by the Corporation
for a period of one (1) additional year and thereafter such Benefits shall be forfeited and thereafter remain the property of
the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Liability and Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Neither the Corporation nor any Affiliate shall be responsible in any way for any action or omission of the Committee, or any
other fiduciaries in the performance of their duties and obligations as set forth in the Plan. Furthermore, neither the Corporation
nor any Affiliate shall be responsible for any act or omission of any of their agents, or with respect to reliance upon advice
of their counsel, provided that the Corporation and/or the appropriate Affiliate relied in good faith upon the action of such
agent or the advice of such counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Neither the Corporation, nor any Affiliate, the Committee, nor any agents, employees, officers, directors or stockholders of any
of them, nor any other person shall have any liability or responsibility with respect to the Plan, except as expressly provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Incapacity</U>. If the Committee shall receive evidence satisfactory to it that a person entitled to receive payment of, or
exercise, any Plan Award is, at the time when such benefit becomes payable or exercisable, a minor, or is physically or mentally
incompetent to receive or exercise such Plan Award and to give a valid release thereof, and that another person or an institution
is then maintaining or has custody of such person and that no guardian, committee or other representative of the estate of such
person shall have been duly appointed, the Committee may make payment of such Plan Award otherwise payable to such person to (or
permit such Plan Award to be exercised by) such other person or institution, including a custodian under the Uniform Gifts to
Minors Act or corresponding legislation (who shall be an adult, a guardian of the minor or a trust company), and the release by
such other person or institution shall be a valid and complete discharge for the payment or exercise of such Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Cooperation of Parties</U>. The Corporation, each Participant and any person claiming any interest hereunder agree to perform
any and all acts and execute any and all documents and papers which are necessary or desirable for carrying out the Plan or any
of its provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Governing Law</U>. All questions pertaining to the validity, construction and administration of the Plan shall be determined
in accordance with the laws of the State of Delaware without regard to its principles of conflicts of law. Subject to the provisions
of Article XVII hereof, and to any provision contained in an Award Agreement or any appendix or exhibit thereto to the contrary,
in the event that any person is compelled to bring a claim related to the Plan, to interpret or enforce the provisions of the
Plan, to recover damages as a result of a breach of the terms of the Plan, or from any other cause (a &ldquo;<U>Claim</U>&rdquo;),
such Claim must be processed in the manner set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<B>THE SOLE AND EXCLUSIVE METHOD TO RESOLVE ANY CLAIM IS BINDING ARBITRATION, AND THE CORPORATION AND EACH PARTICIPANT (INCLUDING
FORMER PARTICIPANTS, BENEFICIARIES OF PARTICIPANTS OR OF FORMER PARTICIPANTS OR PERSONS ACTING FOR OR ON BEHALF THEREOF) WAIVE
THE RIGHT TO A JURY TRIAL OR COURT TRIAL.</B> No Participant shall initiate or prosecute any lawsuit in any way related to any
Claim covered by the terms of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The arbitration shall be binding and conducted before a single arbitrator in accordance with the then-current rules of the American
Arbitration Association (the &ldquo;<U>AAA</U>&rdquo;), as modified by the terms and conditions of this paragraph. Venue for any
arbitration pursuant to this Plan will lie in Boston, Massachusetts. The arbitrator will be selected by mutual agreement of the
parties to the arbitration proceeding (the &ldquo;<U>Parties</U>&rdquo;) or, if the Parties cannot agree, then by striking from
a list of arbitrators supplied by the AAA. Each Party shall pay its own arbitrator&rsquo;s fees and arbitration costs. Upon the
conclusion of the arbitration hearing, the arbitrator shall issue a written opinion revealing, however briefly, the essential
findings and conclusions upon which the arbitrator&rsquo;s award is based. The award of the arbitrator shall be final and binding.
Upon the conclusion of an arbitration the losing Party shall reimburse the prevailing Party for any reasonable legal fees and
expenses incurred by the prevailing Party. As used herein, that the prevailing Party of an arbitration shall be determined by
the arbitrator or, if applicable, by the following procedure. At any time up until ten days following the delivery of the initial
&ldquo;complaint&rdquo; of the Party commencing arbitration to the other party, either Party may make one or more written settlement
offers to the other Party (the &ldquo;<U>Final Settlement Date</U>&rdquo;). Each such offer must state that it is binding and
enforceable against the offeror if accepted in writing by the offeree on or before the date that is five days following the Final
Settlement Date, unless first withdrawn or superseded by another offer from such Party prior to written acceptance. A copy of
such settlement offers will be sent either to an escrow agent agreed to by the Parties or to the AAA, but shall <B><U>NOT</U></B>
be shown to the arbitrator or arbitrators until after he, she or they have rendered their decision in all respects, except with
respect of determining the prevailing Party and determined the amount of recoverable legal fees. After such time, the arbitrator
or arbitrators shall review the settlement offers and the Party whose settlement offer is deemed by the arbitrator or arbitrators
to be the closest to the arbitrator&rsquo;s decision or award shall be deemed to be the prevailing Party. Judgment upon any award
may be entered in any court having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Nonguarantee of Employment or Consulting Relationship</U>. Nothing contained in the Plan shall be construed as a contract of
employment (or as a consulting, advisory or similar contract) between the Corporation (or any Affiliate), and any Employee, Consultant
or Participant, as a right of any Employee, Consultant or Participant to be continued in the employ of <B>(</B>or in a Consulting
Relationship with) the Corporation (or any Affiliate), or as a limitation on the right of the Corporation or any Affiliate to
discharge any of its Employees (or Consultants), at any time, with or without cause (but subject to the terms of any applicable
employment, consulting, advisory or similar agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Notices</U>. Each notice relating to this Plan shall be in writing and delivered in person, by E-Mail, by recognized overnight
courier, Unites States Postal Service (&ldquo;USPS&rdquo;) Express Mail or by USPS Certified Mail, return receipt requested to
the proper address set forth below. All notices to the Corporation or the Committee shall be addressed to them at 25 Recreation
Park Drive, Unit 108, Hingham, MA 02043; Attn: Chairman. All notices to Participants, former Participants, estates of Participants
or other persons acting for or on behalf of such persons shall be addressed to such person at the last address for such person
maintained in the Committee&rsquo;s records. All notices to any individual or entity (i) delivered in person shall be considered
to be received on delivery, (ii) sent by E-Mail shall be deemed to have been received 12 hours after posting, (iii) sent by recognized
overnight courier or USPS Express Mail shall be deemed to have been received at the close of business on the second business day
after posting and (iv) sent by USPS Certified Mail return receipt requested shall be deemed to have been received at the close
of business on the third business day after posting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Written Agreements</U>. Each Plan Award shall be evidenced by a signed written Award Agreement between the Corporation and
the Participant containing the terms and conditions of the Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Section 409A of the Code</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
This Plan and the related Award Agreements (collectively, for purposes of this Section XI(q), the &ldquo;Plan&rdquo;) are intended
to comply with the requirements of Section 409A of the Code (&ldquo;Section 409A&rdquo;). Deferrals of compensation subject to
the restrictions set forth under Section 409A and the regulations promulgated thereunder (hereinafter, &ldquo;Non-Qualified Deferred
Compensation&rdquo;) may only be made under this Plan to a Participant subject to the provisions of Section 409A upon an event
and in a manner permitted by Section 409A. Any amounts payable solely on account of an involuntary separation from service of
the Participant within the meaning of Section 409A shall be excludible from the requirements of Section 409A, either as involuntary
separation pay (exempt from the provisions of Section 409A under Treas. Reg. &sect;1.409A-1(b)(9)) or as short-term deferral amounts
(as described in Treas. Reg. &sect;1.409A-1(b)(4)), to the maximum possible extent. For purposes of Section 409A, the right to
a series of installment payments under this Plan shall be treated as a right to a series of separate payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To the extent required by Section 409A, and notwithstanding any other provision of the Plan to the contrary, no payment of Non-Qualified
Deferred Compensation will be provided to, or with respect to, a Participant on account of his separation from service until the
first to occur of (i) the date of the Participant&rsquo;s death or (ii) the date which is one day after the six month anniversary
of his separation from service, <B>but in either case only if he is a &ldquo;specified employee&rdquo;</B> (as defined under Section
409A(a)(2)(B)(i) of the Code and the regulations promulgated thereunder) in the year of his separation from service. Any payment
that is delayed pursuant to the provisions of the immediately preceding sentence shall instead be paid in a lump sum within 10
days following the first to occur of the two dates specified in such immediately preceding sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Any payment of Non-Qualified Deferred Compensation made pursuant to a voluntary or involuntary Termination of Service shall be
withheld until the Participant (who is subject to the provisions of Section 409A) incurs both (i) a Termination of Service and
(ii) a &ldquo;separation from service&rdquo; with the Corporation and all of the Affiliates, as such term is defined in Treas.
Reg. &sect;1.409A-1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<FONT STYLE="background-color: white">If a Participant subject to the provisions of Section 409A is permitted to elect to defer
a Plan Award or any payment under a Plan Award, such election shall be made in accordance with the requirements of Code Section
409A. Each initial deferral election (an &ldquo;Initial Deferral Election&rdquo;) must be received by the Committee prior to the
following dates or will have no effect whatsoever:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<FONT STYLE="background-color: white">Except as otherwise provided below or in Treas. Reg. &sect;1.409A-2, the December 31<SUP>st
</SUP>immediately preceding the year in which the compensation is earned;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<FONT STYLE="background-color: white">With respect to the first year of participation in the Plan, within 30 days of the beginning
of such year;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="background-color: white">With respect to any annual or long-term incentive pay which qualifies as &ldquo;performance-based
compensation&rdquo; within the meaning of Code Section 409A, by the date six months prior to the end of the performance measurement
period applicable to such incentive pay provided such additional requirements set forth in Code Section 409A are met;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<FONT STYLE="background-color: white">With respect to &ldquo;fiscal year compensation&rdquo; as defined under Code Section 409A,
by the last day of the Corporation&rsquo;s fiscal year immediately preceding the year in which the fiscal year compensation is
earned; or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<FONT STYLE="background-color: white">With respect to mid-year Plan Awards or other legally binding rights to a payment of compensation
in a subsequent year that is subject to a forfeiture condition requiring the Participant&rsquo;s continued service for a period
of at least 12 months, on or before the 30<SUP>th</SUP> day following the grant of such Plan Award (or the date such legally binding
right to a payment of compensation arises), provided that the election is made at least 12 months in advance of the earliest date
at which the forfeiture condition could lapse.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
If the Plan so permits, the Committee may, in its sole discretion, permit Participants to submit additional deferral elections
in order to delay, but not to accelerate, a payment, or to change the form of payment of an amount of deferred compensation (a
&ldquo;Subsequent Deferral Election&rdquo;), if, and only if, the following conditions are satisfied: (i) the Subsequent Deferral
Election must not take effect until 12 months after the date on which it is made, (ii) in the case of a payment other than a payment
attributable to the Participant&rsquo;s death, disability or an unforeseeable emergency (all within the meaning of Section 409A
of the Code) the Subsequent Deferral Election further defers the payment for a period of not less than five years from the date
such payment would otherwise have been made and (iii) the Subsequent Deferral Election is received by the Committee at least 12
months prior to the date the payment would otherwise have been made. In addition, such Participants may be further permitted to
revise the form of payment they have elected, or the number of installments elected, provided that such revisions comply with
the requirements of a Subsequent Deferral Election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
To the extent the Plan provides that Non-Qualified Deferred Compensation can be paid or commenced during a certain period following
a permissible payment or commencement event or trigger, (i) the period must begin and end within one taxable year of the Participant
or (ii) the period will not exceed 90 days and if the payment or commencement period spans two taxable years of the Participant,
then such Non-Qualified Deferred Compensation shall be paid and/or commenced during the second of such taxable years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
The preceding provisions of this Section XI(q) shall not be construed as a guarantee by the Corporation or by any Affiliate of
any particular tax effect to the Participants under the Plan. The Corporation and its Affiliates shall not be liable to the Participants
for any additional tax, penalty or interest imposed under Section 409A nor for reporting in good faith any payment made under
the Plan as an amount includible in gross income under Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Listing, Registration, Etc</U>. All shares of Common Stock issued pursuant to the terms of the Plan will be subject to the
requirement that if at any time the Board determines, in its sole discretion, that it is necessary or desirable to list, register
or qualify upon any national securities exchange or under any state or federal securities or other law or regulation, such shares
of Common Stock, or that it is necessary or desirable to obtain the consent or approval of any governmental regulatory body, as
a condition to or in connection with the issuance hereunder of Common Stock, the Common Stock may not be issued unless or until
the listing, registration, qualification, consent or approval has been effected or obtained free of any conditions not acceptable
to the Board. The recipient of any shares of Common Stock must supply the Corporation with any certificates, representations and
information as the Corporation reasonably requests, and must otherwise cooperate with the Corporation in obtaining or effecting
any listing, registration, qualification, consent or approval the Board deems necessary or desirable. If the Corporation, as part
of an offering of securities or otherwise, finds it desirable because of federal or state regulatory requirements to reduce the
period during which any Plan Award vests (including a reduction that may result in a penalty being imposed on any Participant
(or on any other person) pursuant to Section 409A of the Code), the Board may, in its sole discretion and without the holders&rsquo;
consent, reduce that period on not less than 10 days&rsquo; written notice to the holders affected. Nothing contained herein will
obligate the Corporation to list, register or qualify any shares of Common Stock or other securities upon any national securities
exchange or otherwise or under any federal or state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Golden Parachute Restrictions</U>. <FONT STYLE="background-color: white">Notwithstanding any other provisions of the Plan to
the contrary, if the receipt of any payments or benefits under the Plan (along with any other payments receivable by the Participant
other than under the Plan) would subject a Participant to tax under Code Section 4999, the Committee may determine whether some
amount of such payments or benefits would meet the definition of a &ldquo;Reduced Amount.&rdquo; If the Committee determines that
there is a Reduced Amount, the total payments or benefits to the Participant under all Plan Awards (and all other such potential
payments) must be reduced to such Reduced Amount, but not below zero. It is the intention of the Corporation and any such Participant
to reduce the payments under the Plan (and other than under the Plan) only if the aggregate &ldquo;Net After Tax Receipts&rdquo;
to such Participant would thereby be increased. If the Committee determines that the benefits and payments must be reduced to
the Reduced Amount, the Corporation must promptly notify such Participant of that determination, with a copy of the detailed calculations
by the Committee. All determinations of the Committee under this Section XI(s) shall be final, conclusive and binding upon the
Corporation and any such Participant. As result of the uncertainty in the application of Code Section 4999 at the time of the
initial determination by the Committee under this XI(s), however, it is possible that amounts will have been paid under the Plan
(and other than under the Plan) to or for the benefit of a Participant which should not have been so paid (&ldquo;Overpayment&rdquo;)
or that additional amounts which will not have been paid under the Plan (or other than under the Plan) to or for the benefit of
a Participant could have been so paid (&ldquo;Underpayment&rdquo;), in each case consistent with the calculation of the Reduced
Amount. If the Committee, based either upon the assertion of a deficiency by the Internal Revenue Service against the Corporation
or a Participant, which the Committee believes has a high probability of success, or controlling precedent or other substantial
authority, determines that an Overpayment has been made, any such Overpayment must be treated for all purposes as a loan, to the
extent permitted by Applicable Law, which such Participant must repay to the Corporation together with interest at the applicable
federal rate under Code Section 7872(f)(2); provided, however, that no such loan may be deemed to have been made and no amount
shall be payable by a Participant to the Corporation if and to the extent such deemed loan and payment would not either reduce
the amount on which the Participant is subject to tax under Code Sections 1, 3101 or 4999 or generate a refund of such taxes.
If the Committee, based upon controlling precedent or other substantial authority, determines that an Underpayment has occurred,
the Committee must promptly notify the Corporation of the amount of the Underpayment, which then shall be paid promptly to the
Participant but no later than the end of the Participant&rsquo;s taxable year next following the Participant&rsquo;s taxable year
in which the determination is made that the Underpayment has occurred. For purposes of this Section XI(s), (i) &ldquo;Net After
Tax Receipts&rdquo; means the Present Value of a payment under the Plan (and other than under the Plan) net of all taxes imposed
on Participant with respect thereto under Code Sections 1, 3101 and 4999, determined by applying the highest marginal rate under
Code Section 1 which applies to the Participant&rsquo;s taxable income for the applicable taxable year; (ii) &ldquo;Present Value&rdquo;
means the value determined in accordance with Code Section 280G(d)(4); and (iii) &ldquo;Reduced Amount&rdquo; means the smallest
aggregate amount of all payments and benefits under the Plan (and other than under the Plan) which (x) is less than the sum of
all payments and benefits under the Plan (and other than under the Plan) and (y) results in aggregate Net After Tax Receipts which
are equal to or greater than the Net After Tax Receipts which would result if the aggregate payments and benefits under the Plan
(and other than under the Plan) were any other amount less than the sum of all payments and benefits to be made under the Plan
(and other than under the Plan). Except as may be provided in any other agreement entered into by and between the Participant
and the Corporation, if any payment or benefit is reduced under this Section XI(s), such reduction shall be made, in pro rata
amounts from benefits provided under the Plan and payments which may be made other than under the Plan, in the following order:
</FONT>(i) first, any future cash payments (if any) shall be reduced (if necessary, to zero); (ii) second, any current cash payments
shall be reduced (if necessary, to zero); (iii) third, all non-cash payments (other than equity or equity derivative related payments)
shall be reduced (if necessary, to zero); and (iv) fourth, all equity or equity derivative payments shall be reduced. Any necessary
reduction in each subcategory shall first be applied to the latest scheduled payment in such subcategory and shall continue to
the extent necessary until the most current payment is reduced or eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Clawback of Payments</U>. Notwithstanding any provision of the Plan to the contrary, each Participant&rsquo;s benefits awarded
or paid hereunder (including, but not limited to, payments of cash, equity underlying grants, and equity released from restrictions)
may be subject to recoupment by the Corporation to the extent (i) required under the applicable requirements of Section 304 of
the Sarbanes-Oxley Act of 2002 and/or Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (each
as in effect from time to time, any applicable rules and regulations with respect thereto that are promulgated thereunder by the
Securities and Exchange Commission and the exchange(s) and/or other trading facility(ies) on which any class of securities of
the Corporation is traded), (ii) required by any other policy or rule adopted by the Board or the Corporation&rsquo;s stockholders
pursuant to a duly authorized vote or (iii) as may be provided in a particular Award Agreement. To the extent these recoupment
rules apply to any Participant, but without in any way limiting the generality of the foregoing, the Participant&rsquo;s Plan
Awards shall be subject to recoupment under the Corporation&rsquo;s clawback policy, as in effect from time to time (the &ldquo;Clawback
Policy&rdquo;), to the extent provided therein. The Corporation intends, but the Corporation does not and cannot guarantee, that
to the extent any payment under the Plan qualifies as non-qualified deferred compensation (as defined under Section 409A of the
Code and the regulations promulgated thereunder) any recoupment required under this Section XI(t) shall either be exempt from
Section 409A of the Code or comply with the applicable requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Lock-up Agreement</U>. Each recipient of a Plan Award hereunder agrees, in connection with any registration with the Securities
and Exchange Commission under the Securities Act of the public sale of the Corporation&rsquo;s Common Stock, not to sell, make
any short sale of, loan, grant any option for the purchase of or otherwise dispose of any securities of the Corporation, including
any Plan Awards, (other than those included in the registration) without the prior written consent of the Corporation or the underwriters
of such public offer or sale, as the case may be, for such period of time from the effective date of such registration as the
Corporation or the underwriters, as the case may be, shall specify. Each such recipient agrees that the Corporation may instruct
its transfer agent to place stop-transfer notations in its records to enforce this Section XI(u). Each such recipient agrees to
execute such form of agreement reflecting the foregoing restrictions and such other restrictions as requested by the underwriters
managing such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Certain Rules of Construction</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The headings and subheadings set forth in the Plan are inserted for the convenience of reference only and are to be ignored in
any construction of the terms set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Wherever applicable, the neuter, feminine or masculine pronoun as used herein shall also include the neuter, masculine or feminine,
as the case may be, and the plural shall refer to the singular and vice versa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The words &ldquo;hereof,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereunder&rdquo; and similar words refer to the Plan as a whole and
not to any particular provision of the Plan; and any references to any subsection, Section, Schedule, Appendix or Exhibit to the
Plan references are to the Plan unless otherwise specified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
The term &ldquo;including&rdquo; is not limiting and means &ldquo;including without limitation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
References in the Plan to any statute or statutory provisions include a reference to such statute or statutory provisions as from
time to time amended, modified, reenacted, extended, consolidated or replaced (whether before or after the date of the Plan),
to any subordinate legislation made from time to time under such statute or statutory provision and to any and all rules, regulations
and other documents of general application promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
References to the Plan or to any other document include a reference to the Plan or to such other document as varied, amended,
modified, novated or supplemented from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
References to &ldquo;writing&rdquo; or &ldquo;written&rdquo; include any non-transient means of representing or copying words
legibly, including by facsimile or electronic mail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
References to &ldquo;$&rdquo; are to United States Dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
References to &ldquo;%&rdquo; are to percent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>No Stockholder&rsquo;s Rights</U>. Except as otherwise provided herein, a Participant shall have none of the rights of a stockholder
with respect to shares of Common Stock covered by any Plan Award until the Participant becomes the record owner of such shares
of Common Stock. Without limiting the generality of the foregoing, no Participant will have any of the rights of a stockholder
with respect to any shares of Common Stock until the shares of Common Stock are issued to the Participant. Subject to the other
provisions of the Plan to the contrary, after shares of Common Stock are issued to the Participant, the Participant will be a
stockholder and have all the rights of a stockholder with respect to such shares of Common Stock, including the right to vote
and receive all dividends or other distributions made or paid with respect to such shares of Common Stock; provided, that if such
shares of Common Stock are Restricted Stock or Performance Shares, then any new, additional or different securities a Participant
may become entitled to receive with respect to such shares of Common Stock by virtue of a stock dividend, stock split or any other
change in the corporate or capital structure of the Corporation will be subject to the same restrictions as the Restricted Stock
or Performance Shares; and further provided that such Participant will have no right to retain such stock dividends or stock distributions
with respect to shares of Common Stock that are forfeited or repurchased by the Corporation pursuant to the Plan or the Award
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Paperless Administration; Consent to Electronic Communications</U>. In the event that the Corporation establishes or maintains,
for itself or using the services of a third party, an automated system for the documentation, granting or exercise of Plan Awards,
such as a system using an internet website or interactive voice response, then the paperless documentation, granting or exercise
of Plan Awards by a Participant may be permitted through the use of such an automated system. Each Participant, by way of his
acceptance of any Plan Award, agrees and consents to the Corporation communicating with such Participant (and any beneficiary
or representative of, or any successor to, such Participant) via any electronic medium (including via email or website access)
and agrees and consents to the Corporation providing to such Participant (and any beneficiary or representative of, or any successor
to, such Participant) via any electronic medium any disclosure, report or other document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Compliance with Laws</U>. The Plan, the granting and vesting of Plan Awards under the Plan and the issuance and delivery of
shares of Common Stock and the payment of money under the Plan or under Plan Awards granted or awarded hereunder are subject to
compliance with all Applicable Laws (including but not limited to margin requirements), and to such approvals by any listing,
regulatory, self-regulatory or governmental authority as may, in the opinion of counsel for the Corporation, be necessary or advisable
in connection therewith. Any securities delivered under the Plan shall be subject to such restrictions, and the person acquiring
such securities shall, if requested by the Corporation, provide such assurances and representations to the Corporation as the
Corporation may deem necessary or desirable to assure compliance with all Applicable Laws. To the extent permitted by Applicable
Law, the Plan and Plan Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to Applicable
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Securities Law and Other Regulator/Compliance</U>. In no way limiting the application of the provisions contained in Section
XI(y), above, a Plan Award will not be effective unless such Plan Award is in compliance with all applicable federal, state and
foreign securities laws, rules and regulations of any governmental body, and the requirements of any national stock exchange or
automated quotation system upon which the shares of Common Stock granted under such Plan Award may then be listed or quoted, as
they are in effect on the date of grant of the Plan Award on the date of exercise or other issuance or any other date while the
Plan Award is outstanding. Notwithstanding any other provision in the Plan to the contrary, the Corporation will have no obligation
to issue or deliver certificates for shares of Common Stock under the Plan prior to: (i) obtaining any approvals from governmental
agencies that the Corporation determines are necessary or advisable; and/or (ii) completion of any registration or other qualification
of such shares of Common Stock under any state, federal or foreign law or ruling of any governmental body that the Corporation
determines to be necessary or advisable. The Corporation will be under no obligation to register the shares of Common Stock with
the Securities and Exchange Commission (if such shares of Common Stock are not otherwise so registered) or to effect compliance
with the registration, qualification or listing requirements of any state securities laws, national stock exchange or automated
quotation system, and the Corporation will have no liability for any inability or failure to do so. As a condition to the grant
of any Plan Award, the Corporation may require each Participant to satisfy any qualifications that may be necessary or appropriate
to evidence compliance with any Applicable Law and to make any representation or warranty with respect thereto as may be requested
by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(aa) <FONT STYLE="font-size: 10pt"><U>Awards
Not Includable for Benefit Purposes</U></FONT>. Payments received by a Participant pursuant to the provisions of the Plan
shall not be included in the determination of benefits under any pension, group insurance, or other benefit plan applicable
to the Participant that is maintained by the Corporation, except as may be provided under the terms of those plans or as
determined by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRANSFERABILITY
OF AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>In General</U>. Except as otherwise provided in Section XII(b):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
No Plan Award may be sold, pledged, encumbered, assigned or transferred in any manner other than by will or the laws of descent
and distribution or, subject to the consent of the Committee, pursuant to a DRO, unless and until such Plan Award has been exercised,
or the shares of Common Stock underlying such Plan Award have been issued, and all restrictions, including without limitation
risks of forfeiture, applicable to such shares of Common Stock have lapsed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
No Plan Award or interest or right therein shall be liable for or may be applied to pay, satisfy or settle the debts, contracts
or engagements of a Participant or his or her successors in interest nor shall be subject to disposition by transfer, alienation,
anticipation, pledge, hypothecation, encumbrance, assignment or any other means, whether such disposition be voluntary or involuntary,
or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy
or insolvency), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such
disposition is permitted by Section XII(a)(i); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
During the lifetime of a Participant, only such Participant may exercise a Plan Award (or any portion thereof) granted to him
under the Plan, unless (other than in the case of an Incentive Stock Option) it has been disposed of pursuant to a DRO, and after
the death of a Participant any exercisable portion of a Plan Award may, prior to the time when such portion becomes unexercisable
under the Plan or the applicable Award Agreement, be exercised by such Participant&rsquo;s personal representative or by any person
empowered to do so under the deceased Participant&rsquo;s will or under the then applicable laws of descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Permitted Transferees</U>. Notwithstanding Section XII(a) hereof, the Committee may, in its sole discretion, permit a Participant
to transfer a Plan Award other than an Incentive Stock Option to any one or more Permitted Transferees, subject to the following
terms and conditions: except as may be provided in a Stock Restriction Agreement that is an Exhibit to any Plan Award (or as may
be provided in any applicable stockholders&rsquo; agreement) (i) a Plan Award transferred to a Permitted Transferee shall not
be assignable or transferable by the Permitted Transferee other than by will or the laws of descent and distribution; (ii) a Plan
Award transferred to a Permitted Transferee shall continue to be subject to all the terms and conditions of the Plan Award as
applicable to the original Participant (other than the ability to further transfer the Plan Award); (iii) any transfer of a Plan
Award to a Permitted Transferee shall be without consideration; and (iv) the Participant and the Permitted Transferee shall execute
any and all documents requested by the Committee or the Corporation, including, without limitation documents to (A) confirm the
status of the transferee as a Permitted Transferee, (B) satisfy any requirements for an exemption for the transfer under Applicable
Law and (C) evidence the transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Beneficiaries</U>. Notwithstanding Section XII(a) hereof, a Participant may, in the manner determined by the Committee, designate
a beneficiary to exercise the rights of such Participant and to receive any distribution that may be made with respect to any
Plan Award upon the Participant&rsquo;s death. A beneficiary, legal guardian, legal representative, or other person claiming any
rights pursuant to the Plan is subject to all terms and conditions of the Plan and any Award Agreement applicable to the Participant,
except to the extent the Plan and the Award Agreement otherwise provide, and to any additional restrictions deemed necessary or
appropriate by the Committee. If a Participant is married or a domestic partner in a domestic partnership qualified under Applicable
Law and resides in a community property state, a designation of a person other than the Participant&rsquo;s spouse or domestic
partner, as applicable, as his or her beneficiary with respect to more than 50% of the Participant&rsquo;s interest in the Plan
Award shall not be effective without the prior written or electronic consent in form and substance satisfactory to the Committee
or the Corporation of such Participant&rsquo;s spouse or domestic partner. If no beneficiary has been designated or survives the
Participant, payment shall be made to the person entitled thereto pursuant to the Participant&rsquo;s will or the laws of descent
and distribution. Subject to the foregoing and Applicable Law, a beneficiary designation may be changed or revoked by a Participant
at any time provided that the change or revocation is filed with the Committee prior to the Participant&rsquo;s death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XIII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
TO ISSUANCE OF SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Delivery of Certificates</U>. Notwithstanding anything herein to the contrary, the Corporation shall not be required to issue
or deliver any certificates or make any book entries evidencing shares of Common Stock pursuant to the exercise, vesting or settlement
of any Plan Award, unless and until the Board or the Committee has determined, with advice of counsel, that the issuance of such
shares of Common Stock is in compliance with Applicable Law and the shares of Common Stock are covered by an effective registration
statement under the Securities Act or applicable exemption under the Securities Act from registration. In addition to the terms
and conditions provided herein, the Board or the Committee may require that a Participant make such reasonable covenants, agreements,
and representations as the Board or the Committee, in its sole discretion, deems advisable in order to comply with Applicable
Law as a condition to the issuance or exercise of any Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Stop-Transfer Orders</U>. All stock certificates delivered pursuant to the Plan and all shares of Common Stock issued pursuant
to book entry procedures are subject to any stop-transfer orders and other restrictions as the Committee deems necessary or advisable
to comply with Applicable Law. The Committee may place legends on any stock certificate or book entry to reference restrictions
applicable to the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Settlement of Plan Award</U>. The Committee shall have the right to require any Participant to comply with any timing or other
restrictions with respect to the settlement, distribution or exercise of any Plan Award, including a window-period limitation,
as may be imposed in the sole discretion of the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Fractional Shares</U>. No fractional shares of Common Stock shall be issued and the Committee shall determine, in its sole
discretion, whether cash shall be given in lieu of fractional shares of Common Stock or whether such fractional shares of Common
Stock shall be eliminated by rounding down to the nearest whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Book Entry Stock</U>. Notwithstanding any other provision of the Plan, unless otherwise determined by the Committee or required
by Applicable Law or the bylaws of the Corporation, the Corporation shall not deliver to any Participant certificates evidencing
shares of Common Stock issued in connection with any Plan Award and instead such shares of Common Stock shall be recorded in the
books of the Corporation (or, as applicable, its transfer agent or stock plan administrator).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XIV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
OR TERMINATION OF PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of the Corporation shall have the right to amend, suspend or terminate the Plan at any time, provided that
no amendment shall be made which shall increase the total number of shares of the Common Stock of the Corporation which may be
issued and sold pursuant to Incentive Stock Options, reduce the minimum exercise price in the case of an Incentive Stock Option
or modify the provisions of the Plan relating to eligibility with respect to Incentive Stock Options unless such amendment is
made by or with the approval of the stockholders of the Corporation within 12 months of the effective date of such amendment,
but only if such approval is required by Applicable Law. Furthermore, any amendment or termination of the Plan shall be subject
to all other Applicable Law. The Board of Directors of the Corporation shall also be authorized to amend the Plan and the Options
granted thereunder to maintain qualification as Incentive Stock Options, if applicable. Except as otherwise provided herein, no
amendment, suspension or termination of the Plan shall alter or impair any Plan Award previously granted under the Plan without
the consent of the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCKHOLDER
APPROVAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>General Rule</U>. Notwithstanding any provision of the Plan or any Award Agreement to the contrary, but only to the extent
necessary to satisfy Applicable Law, no Plan Award may be granted (or settled) in the absence of the timely approval of the Plan
and/or the Plan Awards by that number of the owners of the Corporation&rsquo;s outstanding shares of Common Stock required by
Applicable Law to approve the Plan and/or such Plan Awards. Such approval must be obtained by a separate vote of the Corporation&rsquo;s
stockholders or by any other method allowed under the Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Delegation of Voting Power</U>. Furthermore, to the extent permitted by Applicable Law, any one or more of the Corporation&rsquo;s
stockholders may delegate to any agent, proxy or other person the power to so vote such stockholder&rsquo;s or stockholders&rsquo;
shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XVI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERM
OF PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall automatically terminate on the day immediately preceding the tenth (10<SUP>th</SUP>) anniversary of the date the Plan
was adopted by the Board of Directors of the Corporation, unless sooner terminated by such Board of Directors. No Plan Awards
may be granted under the Plan subsequent to the date of the termination of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XVII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLAIMS
PROCEDURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Denial of Claims</U>. If a Participant is denied any portion of the amounts to which he reasonably believes is due to be paid
to him under the Plan, and only if the Plan (or the applicable portion thereof), in conjunction with the applicable Plan Award,
is deemed to constitute an &ldquo;employee benefit plan&rdquo; within the meaning of Section 3(1) of the Employee Retirement Income
Security Act of 1974, as amended (&ldquo;<U>ERISA</U>&rdquo;), such Participant must so notify the Committee and the Committee
shall advise the Participant in writing of the specific reasons for such denial. The Committee shall also furnish the Participant
at that time with a written notice containing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A specific reference to the pertinent provisions of the Plan and/or Plan Award;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A description of any additional material or information necessary for the Participant to perfect his claim, if possible, and an
explanation of why such material or information is needed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
An explanation of the Plan&rsquo;s claim review procedure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Right to Reconsideration</U>. Within 180 days of receipt of the information stated in Section XVII(a), above, the Participant
shall, if he desires further review, file a written request for reconsideration with the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Review of Documents</U>. As long as the Participant&rsquo;s request for review is pending (including the 180-day period in
Section XVII(b), above), the Participant or his duly authorized representative may review pertinent Plan documents and may submit
issues and comments in writing to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Decision by Committee</U>. A final decision, which shall be binding upon the Participant, shall be made by the Committee within
60 days of the filing by the Participant of his request for reconsideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Notice by Committee</U>. The Committee&rsquo;s decision shall be conveyed to the Participant in writing and shall include specific
reasons for the decision, written in a manner calculated to be understood by the Participant, with specific references to the
pertinent Plan provisions on which the decision is based.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Arbitration</U>. No Participant may avail himself of the arbitration provisions of Section XI(m), hereof, unless he or she
complies with the foregoing provisions of this Article XVII.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Plan Administrator</U>. For purposes of application of this Article XVII, the Committee shall serve as the plan administrator
of the Plan, as required by, and defined under, ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>XVIII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FOREIGN
AWARDS AND RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Notwithstanding
any provision of the Plan to the contrary, in order to comply with the laws in countries and other jurisdictions in which the
Company and its Subsidiaries have Eligible Individuals, the Committee, in its sole discretion, shall have the power and authority
to (i) modify the terms and conditions of any Plan Award granted to Eligible Individuals to comply with Applicable Laws of jurisdictions
where Eligible Individuals reside; (ii) establish sub-plans and determine the Exercise Price, exercise procedures and other terms
and procedures and rules, to the extent such actions may be necessary or advisable, including adoption of rules, procedures or
sub-plans applicable to particular Subsidiaries or Participants residing in particular locations; provided, however, that no such
sub-plans and/or modifications shall increase the share limits contained in Section 2 or otherwise require stockholder approval;
and (iii) take any action, before or after a Plan Award is made, that it deems advisable to obtain approval or comply with any
necessary local governmental regulatory exemptions or approvals. Without limiting the generality of the foregoing, the Committee
is specifically authorized to adopt rules, procedures and sub-plans with provisions that limit or modify rights on eligibility
to receive a Plan Award under the Plan or on Termination of Service, available methods of exercise or settlement of a Plan Award,
payment of Tax-Related Items, the shifting of employer tax liability to a Participant, the withholding procedures and handling
of any Share certificates or other indicia of ownership which may vary with local requirements. The Committee may also adopt sub-plans
to the Plan intended to allow the Company to grant tax-qualified Plan Awards in a particular jurisdiction and, as part of such
sub-plan, may restrict the sale of Shares and/or modify the Change in Control and adjustments provisions of the Plan to the extent
necessary to comply the tax requirements of the jurisdiction. Notwithstanding the foregoing, the Committee may not take any actions
hereunder, and no Plan Awards shall be granted, that would violate the Securities Act, Exchange Act, the Code, or any securities
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
furtherance of the foregoing, Appendix A of the Plan shall set forth the sub-plan for Participants who are taxpayers in the State
of Israel as of the effective date of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>APPENDIX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>2020
OMNIBUS PERFORMANCE AWARD PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>SUB-PLAN
&mdash; ISRAELI TAXPAYERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B>SPECIAL PROVISIONS FOR ISRAELI TAXPAYERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
This Sub-Plan for Israeli Taxpayers (the &ldquo;<B>Sub-Plan</B>&rdquo;) to the Microbot Medical Inc. 2020 Omnibus Performance
Award Plan (the &ldquo;<B>Plan</B>&rdquo;) is made in accordance with Section II(d)(xvii) and Article XVIII of the Plan. This
Sub-Plan was approved by the Committee on July 17, 2020, subject to stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
The provisions specified hereunder apply only to persons who are deemed to be residents of the State of Israel for tax purposes,
or are otherwise subject to taxation in Israel with respect to Plan Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
This Sub-Plan applies with respect to Plan Awards granted under the Plan. The purpose of this Sub-Plan is to establish certain
rules and limitations applicable to Plan Awards that may be granted or issued under the Plan from time to time, in compliance
with the tax, securities and other applicable laws currently in force in the State of Israel. Except as otherwise provided by
this Sub-Plan, all grants made pursuant to this Sub-Plan shall be governed by the terms of the Plan. This Sub-Plan is applicable
only to grants made after the date of its adoption. This Sub-Plan complies with, and is subject to the ITO and Section 102. An
Option granted under this Sub-Plan will be deemed a Non-Qualified Stock Option for the purposes of U.S. taxation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
The Plan and this Sub-Plan shall be read together. In any case of contradiction, whether explicit or implied, between the provisions
of this Sub-Plan and the Plan, the provisions of this Sub-Plan shall govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms not otherwise defined herein shall have the meaning assigned to them in the Plan. The following additional definitions will
apply to grants made pursuant to this Sub-Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>3(i)
Award</B>&rdquo; means a Plan Award, which is subject to taxation pursuant to Section 3(i) of the ITO, which has been granted
to any person who is not an Eligible 102 Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>102
Capital Gains Track</B>&rdquo; means the tax alternative set forth in Section 102(b)(2) of the ITO pursuant to which all or a
part of the income resulting from the sale of Shares is taxable as a capital gain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>102
Capital Gains Track Grant</B>&rdquo; means a 102 Trustee Grant qualifying for the special tax treatment under the 102 Capital
Gains Track.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>102
Ordinary Income Track</B>&rdquo; means the tax alternative set forth in Section 102(b)(1) of the ITO pursuant to which income
resulting from the sale of Shares derived from Plan Awards is taxed as ordinary income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>102
Ordinary Income Track Grant</B>&rdquo; means a 102 Trustee Grant qualifying for the ordinary income tax treatment under the 102
Ordinary Income Track.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>102
Trustee Grant</B>&rdquo; means a Plan Award of an Option, Performance Share, Performance Unit, share of Restricted Stock or Restricted
Stock Unit, granted pursuant to Section 102(b) of the ITO and held in trust by a Trustee for the benefit of the Eligible 102 Participant,
and includes both 102 Capital Gains Track Grants and 102 Ordinary Income Track Grants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
for the purpose of grants made under this Sub-Plan, means any Affiliate, as defined in the Plan, that is an &ldquo;employing company&rdquo;
within the meaning of Section 102(a) of the ITO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Controlling
Shareholder</B>&rdquo; as defined in Section 32(9) of the ITO, currently defined as an individual who prior to the grant or as
a result of the grant or exercise of any Plan Award, holds or would hold, directly or indirectly, in his name or with a relative
(as defined in the ITO) (i) 10% of the outstanding share capital of the Company or 10% of the voting power of the Company, (ii)
the right to hold or purchase 10% of the outstanding equity or voting power, (iii) the right to obtain 10% of the &ldquo;profit&rdquo;
of the Company (as defined in the ITO), or (iv) the right to appoint a director of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Deposit
Requirements</B>&rdquo; shall mean with respect a 102 Trustee Grant, the requirement to evidence deposit of a Plan Award with
the Trustee, in accordance with Section 102, in order to qualify as a 102 Trustee Grant. As of the time of approval of this Sub-Plan,
the ITA guidelines regarding Deposit Requirements for 102 Capital Gains Track Grants require that the Trustee be provided with
(a) the resolutions approving Plan Awards intended to qualify as 102 Capital Gains Track Grants within 45 days of the date of
Committee&rsquo;s approval of such Plan Award, including full details of the terms of the Plan Awards, and (b) a copy of the Award
Agreement executed by the Eligible 102 Participant and/or Eligible 102 Participant&rsquo;s consent to the requirements of the
102 Capital Gains Track Grant within 90 days of the Committee&rsquo;s approval of such Plan Award, and (c) with respect to Plan
Awards of Restricted Stock, either a share certificate and copy of the Company&rsquo;s share register evidencing issuance of the
Shares underlying such Plan Award in the name of the Trustee for the benefit of the Eligible 102 Participant, or deposit of the
Shares with a financial institution in an account administered in the name of the Trustee, as applicable, in each case, within
90 days of the date of the Committee&rsquo;s approval of such Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Election</B>&rdquo;
means the Company&rsquo;s choice of the type of 102 Trustee Grants it will make under the Plan (as between capital gains track
or ordinary income track), as filed with the ITA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Eligible
102 Participant</B>&rdquo; means a Participant who is a person employed by the Company or its Affiliates, including an individual
who is serving as an office holder (as defined in the ITO), who is not a Controlling Shareholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Israeli
Fair Market Value</B>&rdquo; shall mean with respect to 102 Capital Gains Track Grants only, for the sole purpose of determining
tax liability pursuant to Section 102(b)(3) of the ITO, if at the date of grant the Company&rsquo;s shares are listed on any established
stock exchange or a national market system or if the Company&rsquo;s shares will be registered for trading within ninety (90)
days following the date of grant, the fair market value of the Shares at the date of grant shall be determined in accordance with
the average value of the Company&rsquo;s shares on the thirty (30) trading days preceding the date of grant or on the thirty (30)
trading days following the date of registration for trading, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ITA</B>&rdquo;
means the Israeli Tax Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>ITO</B>&rdquo;
means the Israeli Income Tax Ordinance (New Version), 1961, and the rules, regulations, orders or procedures promulgated thereunder
and any amendments thereto, including specifically the Rules, all as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Non-Trustee
Grant</B>&rdquo; means a Plan Award granted to an Eligible 102 Participant pursuant to Section 102(c) of the ITO and not held
in trust by a Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Required
Holding Period</B>&rdquo; means the requisite period prescribed by the ITO and the Rules, or such other period as may be required
by the ITA, with respect to 102 Trustee Grants, during which Plan Awards granted by the Company must be held by the Trustee for
the benefit of the person to whom it was granted. As of the date of the adoption of this Sub-Plan, the Required Holding Period
for 102 Capital Gains Track Grants is 24 months from the date of grant of the Plan Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Rules</B>&rdquo;
means the Income Tax Rules (Tax Benefits in Share Issuance to Employees), 2003.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Section
102</B>&rdquo; shall mean the provisions of Section 102 of the ITO, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shares</B>&rdquo;
shall mean shares of Common Stock, as defined in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trustee</B>&rdquo;
means a person or entity designated by the Committee to serve as a trustee for the purposes of this Sub-Plan and approved by the
ITA in accordance with the provisions of Section 102(a) of the ITO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B>TYPES OF PLAN AWARDS AND SECTION 102 ELECTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
Plan Awards made as 102 Trustee Grants shall be made pursuant to either (a) Section 102(b)(2) of the ITO as 102 Capital Gains
Track Grants or (b) Section 102(b)(1) of the ITO as 102 Ordinary Income Track Grants. The Company&rsquo;s Election regarding the
type of 102 Trustee Grant it chooses to make shall be filed with the ITA. Once the Company (or its Affiliate) has filed such Election,
it may change the type of 102 Trustee Grant that it chooses to make only after the passage of at least 12 months from the end
of the calendar year in which the first grant was made in accordance with the previous Election, in accordance with Section 102.
For the avoidance of doubt, such Election shall not prevent the Company from granting Non-Trustee Grants to Eligible 102 Participants
at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
Eligible 102 Participants may receive only 102 Trustee Grants or Non-Trustee Grants under this Sub-Plan. Participants who are
not Eligible 102 Participants may be granted only 3(i) Awards under this Sub-Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
No 102 Trustee Grants may be made effective pursuant to this Sub-Plan until 30 days after the date the requisite filings required
by the ITO and the Rules, including the filing of the Plan and Sub-Plan, have been made with the ITA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
The Award Agreement shall indicate whether the grant is a 102 Trustee Grant, a Non-Trustee Grant or a 3(i) Award; and, if the
grant is a 102 Trustee Grant, whether it is a 102 Capital Gains Track Grant or a 102 Ordinary Income Track Grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B>TERMS AND CONDITIONS OF 102 TRUSTEE GRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
Unless determined otherwise by the Committee, each 102 Trustee Grant will be deemed granted on the date approved by the Committee
and stated in a written or electronic notice by the Company, provided that the Company and the Trustee have complied with any
applicable requirements set forth by the ITA with regard to such grants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
Each 102 Trustee Grant granted to an Eligible 102 Participant and each certificate for Shares acquired pursuant to a 102 Trustee
Grant shall be deposited with a Trustee in compliance with the Deposit Requirements and held in trust by the Trustee (or be subject
to a supervisory trustee arrangement if approved by the ITA). After termination of the Required Holding Period, upon request of
the Participant, the Trustee may release such Plan Awards and any Shares issued with respect to such Plan Award, provided that
(i) the Trustee has received an acknowledgment from the ITA that the Eligible 102 Participant has paid any applicable tax due
pursuant to the ITO or (ii) the Trustee and/or the Company or its Affiliate withholds any applicable tax due pursuant to the ITO.
The Trustee shall not release any 102 Trustee Grants or shares issued with respect to the 102 Trustee Grants prior to the full
payment of the Eligible 102 Participant&rsquo;s tax liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
Each 102 Trustee Grant shall be subject to the relevant terms of Section 102 and the ITO, which shall be deemed an integral part
of the 102 Trustee Grant and shall prevail over any term contained in the Plan, this Sub-Plan or Award Agreement that is not consistent
therewith. Any provision of the ITO and any approvals of the ITA not expressly specified in this Sub-Plan or any document evidencing
a Plan Award that are necessary to receive or maintain any tax benefit pursuant to the Section 102 shall be binding on the Eligible
102 Participant. The Trustee and the Eligible 102 Participant granted a 102 Trustee Grant shall comply with the ITO, and the terms
and conditions of the Trust Agreement entered into between the Company and the Trustee. For avoidance of doubt, it is reiterated
that compliance with the ITO specifically includes compliance with the Rules. Further, the Eligible 102 Participant agrees to
execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with
the provision of any applicable law, and, particularly, Section 102. With respect to 102 Capital Gain Track Grants, to the extent
that the Shares are listed on any established stock exchange or a national market system, the provisions of Section 102(b)(3)
of the ITO will apply with respect to the Israeli tax rate applicable to such Plan Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
During the Required Holding Period, the Eligible 102 Participant shall not require the Trustee to release or sell the Plan Awards
and Shares received subsequently following any realization of rights derived from Plan Awards or Shares (including stock dividends)
to the Eligible 102 Participant or to a third party, unless permitted to do so by applicable law. Notwithstanding the foregoing,
the Trustee may, pursuant to a written request and subject to applicable law, release and transfer such Shares to a designated
third party, provided that both of the following conditions have been fulfilled prior to such transfer: (i) all taxes required
to be paid upon the release and transfer of the shares have been withheld for transfer to the tax authorities and (ii) the Trustee
has received written confirmation from the Company that all requirements for such release and transfer have been fulfilled according
to the terms of the Company&rsquo;s corporate documents, the Plan, any applicable Award Agreement and applicable law. To avoid
doubt, such sale or release during the Required Holding Period will result in different tax ramifications to the Eligible 102
Participant under Section 102 of the ITO and the Rules and/or any other regulations or orders or procedures promulgated thereunder,
which shall apply to and shall be borne solely by such Eligible 102 Participant (including tax and mandatory payments otherwise
payable by the Company or its Affiliates, which would not apply absent a sale or release during the Required Holding Period).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
In the event a stock dividend is declared and/or additional rights are granted with respect to Shares which derive from Plan Awards
granted as 102 Trustee Grants, such dividend and/or rights shall also be subject to the provisions of this Section 4 and the Required
Holding Period for such dividend shares and/or rights shall be measured from the commencement of the Required Holding Period for
the Plan Award with respect to which the dividend was declared and/or rights granted. In the event of a cash dividend on Shares,
the Trustee shall transfer the dividend proceeds to the Eligible 102 Participant in accordance with the Plan after deduction of
taxes and mandatory payments in compliance with applicable withholding requirements, and subject to any other requirements imposed
by the ITA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
If a Plan Award granted as a 102 Trustee Grant is exercised during the Required Holding Period, the Shares issued upon such exercise
shall be issued in the name of the Trustee for the benefit of the Eligible 102 Participant (or be subject to a supervisory trustee
arrangement if approved by the ITA). If such a Plan Award is exercised or settled after the Required Holding Period ends, the
Shares issued upon such exercise or settlement shall, at the election of the Eligible 102 Participant, either (i) be issued in
the name of the Trustee (or be subject to a supervisory trustee arrangement if approved by the ITA), or (ii) be transferred to
the Eligible 102 Participant directly, provided that the Eligible 102 Participant first complies with all applicable provisions
of the Plan and this Sub-Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
To avoid doubt: (i) notwithstanding anything to the contrary in the Plan, payment upon exercise or purchase of Plan Awards granted
as a 102 Trustee Grant, may only be paid by cash or check, and not by surrender or withholding of Shares, or by reduction of shares
pursuant to a cashless exercise, net exercise or similar arrangement, or other forms of payment, unless and to the extent permitted
under Section 102 or as expressly authorized by the ITA; (ii) notwithstanding anything to the contrary in the Plan, certain adjustments
and amendments to the terms of Plan Awards granted under the 102 Capital Gains Track, including an exchange program, recapitalization
events, dividend and so forth, may disqualify the Options from benefitting from the tax benefits under the 102 Capital Gains Track,
unless the prior approval of the ITA is obtained; (iii) notwithstanding anything to the contrary in the Plan, repurchase rights
with regard to Plan Awards made as 102 Capital Gains Track Grants shall be subject to compliance with Section 102 requirements
and/or the express approval of the ITA; (iv) Stock Appreciation Rights may not be granted under the 102 Capital Gains Track unless
and to the extent expressly authorized by the ITA; (v) grants of Restricted Stock Units under the 102 Capital Gains Track may
require the prior approval of the ITA; (vi) notwithstanding anything to the contrary in the Plan, amounts equivalent to dividends,
distributions or interest may not be settled in shares with respect to Plan Awards granted under 102 Capital Gains Track Awards
without the prior approval of the ITA; (vii) Performance Shares may require the approval of the ITA in order to qualify under
the 102 Capital Gains Track; (viii) notwithstanding anything to the contrary in the Plan, Plan Awards granted under the 102 Capital
Gains Track may only be settled in Shares and not in cash, and Cash Incentives will not qualify under the 102 Capital Gains Track
and (ix) notwithstanding anything to the contrary in the Plan, the continuance or substitution of 102 Capital Gains Track Grants
upon the merger or consolidation of the Corporation shall be subject to compliance with Section 102 requirements and/or the express
approval of the ITA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.75pt; text-align: justify; text-indent: -23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B>ASSIGNABILITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.75pt; text-align: justify; text-indent: -23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as Plan Awards or Shares are held by the Trustee on behalf of the Eligible 102 Participant, all rights of the Eligible 102
Participant over the Shares are personal, cannot be transferred, assigned, pledged or mortgaged, other than by will or laws of
descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B>TAX CONSEQUENCES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.75pt; text-align: justify; text-indent: -23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
Any tax consequences arising from the grant or settlement of any Plan Award, the exercise of any Option, the issuance, sale or
transfer and payment for the Shares covered thereby, or from any other event or act (of the Company and/or its Affiliates and/or
the Trustee and/or the Participant) relating to a Plan Award or Shares issued thereupon shall be borne solely by the Participant.
The Company and/or its Affiliates, and/or the Trustee shall withhold taxes according to the requirements under the applicable
laws, rules, and regulations, including withholding taxes at source. Furthermore, the Participant shall agree to indemnify the
Company and/or its Affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax
or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld,
any such tax from any payment made to the Participant. The Company or any of its Affiliates, and the Trustee may make such provisions
and take such steps as it/they may deem necessary or appropriate for the withholding of all taxes required by law to be withheld
with respect to a Plan Award granted under the Plan and the exercise, sale, transfer or other disposition thereof, including,
but not limited, to (i) deducting the amount so required to be withheld from any other amount then or thereafter payable to a
Participant, including by deducting any such amount from a Participant&rsquo;s salary or other amounts payable to the Participant,
to the maximum extent permitted under law; and/or (ii) requiring a Participant to pay to the Company or any of its Affiliates
the amount so required to be withheld; and/or (iii) withholding otherwise deliverable Shares having a Fair Market Value equal
to the minimum amount statutorily required to be withheld; and/or (iv) selling a sufficient number of such Shares otherwise deliverable
to a Participant through such means as the Company may determine in its sole discretion (whether through a broker or otherwise)
equal to the amount required to be withheld either through a voluntary sale or through a mandatory sale arranged by the Company
(on the Participant&rsquo;s behalf pursuant to the Participant&rsquo;s authorization as expressed by acceptance of the Plan Award
under the terms herein), to the extent permitted by applicable law or pursuant to the approval of the ITA. In addition, the Participant
will be required to pay any amount (including penalties) that exceeds the tax to be withheld and transferred to the tax authorities,
pursuant to applicable tax laws, regulations and rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
The Company does not represent or undertake that a Plan Award will qualify for or comply with the requisites of any particular
tax treatment (such as the 102 Capital Gains Track), nor shall the Company, its assignees or successors be required to take any
action for the qualification of any Plan Award under such tax treatment. The Company shall have no liability of any kind or nature
in the event that, as a result of application of applicable law, actions by the Trustee or any position or interpretation of the
ITA, or for any other reason whatsoever, a Plan Award shall be deemed to not qualify for any particular tax treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
With respect to Non-Trustee Grants, if the Eligible 102 Participant ceases to be employed by the Company or any Affiliate, the
Eligible 102 Participant shall extend to the Company and/or its Affiliate a security or guarantee for the payment of tax due at
the time of sale of Shares to the satisfaction of the Company, all in accordance with the provisions of Section 102 of the ITO
and the Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B>SECURITIES LAWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Plan Awards hereunder shall be subject to compliance with the Israeli Securities Law, 1968, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="proxy_001.jpg" ALT="" STYLE="height: 881; width: 680">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="proxy_002.jpg" ALT="" STYLE="height: 881; width: 680">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 66; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHK*M]=@N;IH%BD#*)SDXQ^Z<(?S)XH+C3E--Q6QJT5RUC
MXZL+_P#LKR[6Y7^TFE6+=M^7R^N[G^578O$]K-';.L$P%Q%;RKG' F8JN>>Q
M'-4X26Z-YX+$0=I1:_X'_#&Y17+ZAXXL=.EU>.2VN&.F>7YI4+\V\@#;S[]Z
MOKXBMVD*"&7(N!;]OO&'S<]>F./K1RNU[">#KI*3B[/_ "O^3-FBL&3Q5:1W
M.C0&"8MJL1EB/&$&T-\W/OVJM9>-[&^L[2YCMKA5N=VP-MR,2I'SSZR _0&C
MDEV']2Q%N;E=O^'_ ,G]QT]%8%[XLM+&SL[F2"=ENKPV:!<9#!F7)YZ94T6/
MBRTO[Q[:."=66^>Q);&-ZHS$]>F%-'+*U["^J5^7GY=/Z1OT5A+XIM6TRZOO
M(F\NWLTNV7C)5@Q '/7Y35,>.K [?]%N?FTXZC_#]P9^7K][CZ4*$GT''!8B
M5[0>AU-%9-KKT%U<&%(I P6=LG'_ "R<(?S)XK,L?'5A?_V5Y=K<K_:32K%N
MV_+Y?7=S_*CE?82PE=WM';_)O\D_N.IHK#B\3VLT=LZP3 7$5O*N<<"9BJYY
M[$<U3U#QQ8Z=+J\<EM<,=,\OS2H7YMY &WGW[T<DKVL$<'7E+EC%W_X-OST.
MHHKGY?%MI$]RIMYR;>-Y&QCD*D;G'/I*/R-+J7BRTTS5+BPE@G:2"R:]9EQ@
MHN>!SUXHY)=@6$KMV4?ZT_S1OT5@6WBRTN;59U@F"M%;R@'&<3.47OV(YHO?
M%EI8V=G<R03LMU>&S0+C(8,RY//3*FCDE>UA?5*_-R\NO_#_ .3-^BN8_P"$
MVL2EV_V:XQ;7,MLWW>6CC=R1STPA_.K.H^*K33=)O=1E@F:.TF6%U7&26"D$
M<_[8HY)=BOJ6(NH\KN]/O_X<WJ*YU?&%FVH75G]GGWVS6Z,>,$S%0N.>VX9J
M[;Z[!<W30+%(&43G)QC]TX0_F3Q0XM;DRPM:.KCYFK17+6/CJPO_ .RO+M;E
M?[2:58MVWY?+Z[N?Y5=T[Q/:ZDUL(H)E^T.J+NQQF'SN>?0X^M#A);HJ>"Q$
M+\T6K?\ !_R9N45RI\>6 5C]EN?EU$:?_#]_GYNOW>/K70:??1ZC;--&K*JR
MR1$-URCE"?S6AQ:5VB*N%K4ES5(V1:HHHJ3 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^7Z$5OX$/1?^D1*-U_R%_ /_ %YM_P"BEK(\/?\ (!T/_MI_Z5V]:]U_R%_
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MOQ9W3<>1>8C8GT!SM/X'- CLZ* <C(HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***P?&'BS3_  9X=GU?4'&U
M/EBB!PTTAZ(OO_( GM0!S_Q0^)4'@#2X1!''<ZM<D>3;N>%0'YG;'..P]3]#
M73^%]:E\1>&K#5I]/FL)+J(2&WF()7WR.H/49 .".!7@?P\\*:A\5/&-SXQ\
M4J9=-CERL;CY)F'2)1_<48SZ].<FOI,    8 H **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY#%-'[C=G=]"<4#/I>*6.>)98I%DC<95T.01Z@U!J?\ R"KS_K@__H)KY_\
M#LOB3P];2:GX&U0ZYHJ-F>P=#YL.<G#PYR/]Y#SC/05Z+H7Q5T/Q1IES:3DZ
M;J9A=3;7#<,=I^XW0_0X/M0(^9:^L_AC_P DVT/_ *]__9C7R97M^F?%G3?"
M'@#1=.MK<W^IK;9>,/M2++'&YN><<X'XXH&SW"BOGA/C]XB%QNDTO2V@R?D5
M9 V.WS;R/TKT?P5\6='\6W"6$T3:?J3?<AD;<DA]$;CGV('MF@1Z!116=K>N
MZ;X=TU[_ %6[2VMUXRW5CZ*.I/L* -&BO$-8_: VS/'HNBAHQ]V:[DP3_P
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M-OG[H/9CU)[;3Z UZ'I/P#\-1VN_7I[S5M1E^::X>=D&[O@ Y_$DFJ'CF1-
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M/?W\EL;-4":E)8[A)G(5';=T[[,8]ZYOQ!_R M _[#K_ /HZ2CPY_P AV?\
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ME+M9!G"D8Y R>/>DZB?]>G^0JF90E/FY7T[=''_(\B3K%_V*C_\ LU=CH_\
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MJZW-<("#Y=O"(L_5B6_D* T/*O WA&Z\8^(X+&*-_LB,'NY@.(X^_/J<8'^
M-?5U_&D6C7,:*%1+=U4#L IJ+1=!TSP[IZV.E6<=M .2%Y+'U8GDGW-79X1<
M6\L+$A9$*$CJ 1B@1\25UO@[XBZWX++Q631SV4C;GM9P2N?52.5/Z>U>M?\
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MU.I@OHH$@#D1^63&K KT).]CGJ.*:M_=6T5GK+74\AN[F:*2!G)C" 2% J]
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M,[LT"/6=,\4:'K-Y)9Z;JEM=7,:EWCB?+*H(!/YD#\:\5^"__)4M;_Z])_\
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M8QG(P-K?,O'/7K3_ /A(I84GBN[#RKY#%Y<"2[Q)YC%4^; QR#GCC'>G[_\
M7]?>4WB[_P##?U;^;IW+VE:?)9+<27$RS75S+YLSHA5<X"@*"3@ *.]9]KX>
MN;2Y'E7T*VL;O+$GV8>9N;. SY^903D  '@<UHZ7J+7Z3I- (+FWD\J:(/O
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MEO<PRS11+*2DJL#DD8&#U&.?3(]:U*)7ZDU_:.2=56=ETMIT"BBBI,0HHHH
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MJ.6V:!8UB*D9=&R3G_9_6I? WPTN?"/BR^UJ;4HKA+F&2,1)&5*[I%;.2?\
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MMKOQ[J N;>&8+80;1(@;'SR>M+%X*MHX;>W.JZI)9P.CI;/*GEC:05'W,X!
M[U=O_#L=[J1U"+4;^RG:(1.;610'4$D9W*?4TW)-O7O^-BJF*I2;2F]>;6ST
MNTTM[].ARABC_P"$'EBV+Y?]M;=F.,?:AQCTK=EL[6T\=Z6+:VAA#6=QN\M
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MEQ?Z;%#%Y4;.HEVLK*S 87&0<G QGTKK)]>TVWM(+J2YS%."8RB,Y('4X )
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MK^MT;W2M\O)_K^!?M4\JTAC_ 'ORH!^]?<_3^(Y.3[Y-2U46WN856."XC$2
M!1*CR/CW8ODGW-.5+T$[KBW(P<8@(Y[?QU+//:3=[_U]Q9HJKY=__P _-M_X
M#M_\71Y=_P#\_-M_X#M_\72#E7=?U\BU157R[_\ Y^;;_P !V_\ BZ/+O_\
MGYMO_ =O_BZ Y5W7]?(M455\N_\ ^?FV_P# =O\ XNG,EZ6^6XMPO'!@)_\
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M18Y1D@%1G ]L9[5+!:PVPD\I2/,;>Y+$DG &>?8"CF2%]:IJ/NQUM;_@_P#
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M.X,,_2G'XD=.#5Z\5^MOQNOS.5^V>'?^@+X3_P#!BO\ \:H^V>'?^@+X3_\
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M3EC\N ,#YSUSVK8HHYGL)5ZBBX\VC23]%JE\BO?V<>H:?<V4I98[B)HG*'!
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M+"L# GY=H)(X]>:NT4KBC.4;V>^@4444$A1110 4444 %%%% !1110 4444
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MW$$4IC;<GF(&VGU&>AI+3^O*P/4^>_$\=E8?$77SKNI:KIEK?0":(V:Y-PK
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M]9'BA%E\,ZA&XRK1%2/8T(TI04ZD8OJT:$]]:6JAKBZAB5E+@R2!05 R3SV
MI+2_L[^,R6=W!<H.K0R!Q^8KSW41+/Y>_=OL(9[!3(#RRHQ+'U! C/YUU&D1
MW$/B&\747MA=&!/*^S0F-)(@3D\DDL&.#SP"/6K<5:YVU<%"G3YN;7^OT:ZZ
M&^LT33/"LB&5 "Z!AE0>F1VS@_E4<U[:6TT4,]U#%+*<1H\@5G/L#UKE=,FN
M4U^/57MPEKJ<CQ"82;MP_P"661C@80]^K^]+XDGMK:_NW,]N)GMT#6=TG-TH
MW$"%@0P;)(XSSCCO0HZI$K!KVJIWW73OLU\G_P &VZZS[1#YDD?FQ[XP&==P
MRH.<$CL.#^5,^VVA@BG^U0^3,0(I/,&U\]-I[_A7&6\]R+U]7DM?+MM366+S
M/,W%AM_=9&..$/?J_O6=#&WV'2[ AQ%ILD4JDYY\W!3![X!D'Y4<O]?U\C6.
M7I[R_+L[_=*R^9W\&K:;=1/+;ZA:31H,L\<RL%^I!XJ2\U"RTZ-9+V[M[:-C
MM5II @)],DUQLFG7$?A@:C=O9QI%IVQ!!&5)#;#EV)[;?U-:.MZKI]T=-GM=
M6TL1+<LK3S,LL2GRVX.'7G\:?)K9&?U.#FE!MJ[3^2[VM^'WG26UU;WD"SVL
M\4\+9VR1.&4]N".*EJGI<T4^G1/#<VERO(\VT $;'/. &;'YFKE0U9G#./+)
MK^OT"BBBD2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7G-SXPU73]<GT2\G$<EG</>7%WY((.GJNX'&,;B3L_"O1JY'7/"-
MQK.LZM.T\4=M?:1]@4\EU?>S;B,8QR.]+K<:MU"'X@V!M)YKK3]1M)86@!MY
MHT$A29@L;C#8QD\\Y&#Q6W8:Y;:C)J:0I,ITZ<V\V\ ;F"ALK@\C##KBN+N?
M!?B#5+2_NKZ33H]3>*UAMXX7<Q$02;\LQ7(W'T'%=!X9T75+"'6I=4^R+<ZE
M=M<!+:1G5 45<$LH.?E]*<MG;^NPETO_ %W,A?BK8O )UT'6?*-M]L5C'%S
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M,+8#ME>0&*J#U(P,FCE0_JE);O3KJM-7IZVU.K:\MU^T;I /LXS+D'Y1C/\
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M'QAHNI2Z;%:W+.^I"1K8>6PW*F[<QR.!\IZ\T ;M%%% !112,P12S'"@9)H
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M=JG34YISIN,DN^FG]?=_2N4445)S!1110 4444 %%%% !1110 4444 %%%%
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M%!&#[UT]8'BQ96L(/*U^#1CYO,TVW#\'Y?F(^OX54?B1U8*WUB-]K^?Z)O\
M \__ +?\.?WM _\ ">;_ .+H_M_PY_>T#_PGF_\ BZTO+O/^BF:;_P"0O_BJ
M/+O/^BF:;_Y"_P#BJZM/ZO\ Y'TUZ7=_^3__ "!V_AF>WN?#MI-:>1Y#!MOV
M>W\A/O'HF3C\ZUJS= #KHEL)-2CU)L-F[CQMD^8],<<=/PK2KEG\3/E<1;VL
MK=W^?G;\@HHHJ3$**** "JNIW?V#3+FZVEC%&651U9NP_$X%6J9+%',FR6-)
M%R&PPR,@Y!_ @&@J#2DG+8X>TA5])?1+ZWE*I>6[F.Z S(DC@L3R1C>'_2K#
M:?8SZZFG&))M/BN@RQ,=RI)Y+$@>F/E./4UT5\=%GLGN=0.GR6OW'EN-A3AN
MA)X^]V]:KSQ>&5TV".XCT@6!DQ"L@C\K?S]T'C/7I6G-U/36*;UY9*]]N[W:
M\_\ @E>QNVLM#OY+5)+B."XDCM@@:4[<@=LD@,2.,\"E\'2>9HTP\R>1DO)P
M7GC9&;]X3DA@/7\.G:MF$VL%FIA,,=JB94I@(JCTQP!26<EG)$S63P/&7)8P
MD$;CR<X[G.3]:F^C.6=92A-<N[3OZ=]/ZU+%%%%2<@4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7.^+[DVVGP,M]%:$RXWR3K$#P>,M&^?I@?6NBK \6:;?ZG801:?
M;:;<2++N9;^/>@&#R!@\TX_$KG3@W%5X\[LOE^NAQ?\ :TG_ $,5G_X,8O\
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MC)G  '7/IC!I;*\MKV#S+5]R*=I&TJ5([$$ BION<U2I*4))Q>_W?AOI_P
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MQG_""^V@_P#@G_\ MM'_  @OMH/_ ()__MM=G15^TD=?]I8G^;^OO*>E6/\
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MI[RW3W1D>%II-LFV0G*Y7GKQGC%):_A^/_#@]#UBTU&TOIKN*VF$CVDODS
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M,@69T=IVDKW:<=]97>R]ZUDMEKJCEO[-U715.@W3B^M5^:SLT58&NU7YF;S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUQ]IAOV=/-1\$<?+MQ@D8QWKI:* ,K0] MM!T0:5;S7$T0:1C).P+DNQ8DD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[05!. =P8GY3G)(Y&.]-K6PEJKGI-%<LWCJRBU..REL+Z-=\4,]P47R[>:0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*KN^8G[HQSDCIS572/&%CJNN:AI7F6T<]E'&[!;E7W[EW-C'4+P"??M1O?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=K"(]-U!K: QJ02@)^]DG)X]J .LHHHH **** "BBB@ HHHH **** "BBB@
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M6_MT\Z,% ^\*<LN#ZJ"/QH P?^%D_P#4E>,O_!5_]E1_PLG_ *DKQE_X*O\
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MMY+$CN3$<@<$\'IFO5/AYX7N/"?A?['>21O>3SO<S^6<J&; P#WX44= >_\
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MX?\ BK3_  _X8%D-/;4M)O)YVCDD/EG>00<CJ!CD>]>NPB001B9E:4*-[*,
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MXUGM-=EC%FWV"V2X#$,NZ>2/R\ #^$9DQG//X5?;Q7(-%-XFFDW:WPL'M3,
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MPA@ Q";MH)VKD@9X%68/#VF6^GQ6*6[&&*87 WRNS&4-NWLQ.6.>>2<UIT4
M]3$B\(Z'#=6UQ'9%7MHQ'&/-<J  0I*YPQ 9@"<D9-3?\(WI1T!=#>V:33E
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M\N0$9,7%_/*/F&"<,YP2,C(YKH**%H#UW.8L/!&GV6K7MXS-)%-)&\-N&<+
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M 4444 %><^/OBI_P@^NP:9_8WVWS;9;CS/M7EXRS+C&P_P!WKGO7HU96I_\
M'RO^X/YF@#R7_AH?_J5O_*A_]KH_X:'_ .I6_P#*A_\ :Z]-HH"YYE_PT/\
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M'_ZE;_RH?_:Z/^&A_P#J5O\ RH?_ &NO3:* N>9?\-#_ /4K?^5#_P"UT?\
M#0__ %*W_E0_^UUZ;10%SS+_ (:'_P"I6_\ *A_]KH_X:'_ZE;_RH?\ VNO3
M:* N>9?\-#_]2M_Y4/\ [71_PT/_ -2M_P"5#_[77IM% 7/,O^&A_P#J5O\
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M?_J5O_*A_P#:Z/\ AH?_ *E;_P J'_VNNI^R^,_^@IHW_@%)_P#'*/LOC/\
MZ"FC?^ 4G_QR@#EO^&A_^I6_\J'_ -KH_P"&A_\ J5O_ "H?_:ZZG[+XS_Z"
MFC?^ 4G_ ,<H^R^,_P#H*:-_X!2?_'* .6_X:'_ZE;_RH?\ VNC_ (:'_P"I
M6_\ *A_]KKJ?LOC/_H*:-_X!2?\ QRC[+XS_ .@IHW_@%)_\<H Y;_AH?_J5
MO_*A_P#:Z/\ AH?_ *E;_P J'_VNNI^R^,_^@IHW_@%)_P#'*/LOC/\ Z"FC
M?^ 4G_QR@#EO^&A_^I6_\J'_ -KH_P"&A_\ J5O_ "H?_:ZZG[+XS_Z"FC?^
M 4G_ ,<H^R^,_P#H*:-_X!2?_'* .6_X:'_ZE;_RH?\ VNC_ (:'_P"I6_\
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M!'<5P]_%(GPI\*:B(C)!971>90,\&1NOMQC\16KI.OV5[\0==\50!O[)M-/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIW:2_/J1ZS_PD4][>R6MV-/LK2+?&Y16\\XR<^GI6SH&H2:IH5I>S*%DE3+
M# R"1G\<9KF/%>MPW>K+H+7BVEH,->3'.2.NP5UVF26<FFVYT]E:T"[8BO3
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M^7;01PQYSMC0*,_04D=I;0SO/';Q)-)]^14 9OJ>]>.?\*#\5?\ 00T;_O\
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MR_3TKG]$\,2Z=XIUC7;NY2>:^(6(*A'E1@_=)[\!?RKSO_A0?BK_ *"&C?\
M?Z7_ .-T?\*#\5?]!#1O^_TO_P ;H"Q[34*V=LERURMO"L[##2A &/U/6O'/
M^%!^*O\ H(:-_P!_I?\ XW1_PH/Q5_T$-&_[_2__ !N@+'L+V%G+,9I+2!Y6
M&"[1@L1Z9J1((HY#(D2*Y&"P4 D5XU_PH/Q5_P!!#1O^_P!+_P#&Z/\ A0?B
MK_H(:-_W^E_^-T!8]AEL;2:;SI;6"27&W>\8+8],U. %4*H  & !VKQ?_A0?
MBK_H(:-_W^E_^-T?\*#\5?\ 00T;_O\ 2_\ QN@+'M-%>+?\*#\5?]!#1O\
MO]+_ /&Z/^%!^*O^@AHW_?Z7_P"-T!8]IHKQ;_A0?BK_ *"&C?\ ?Z7_ .-T
M?\*#\5?]!#1O^_TO_P ;H"Q[317BW_"@_%7_ $$-&_[_ $O_ ,;H_P"%!^*O
M^@AHW_?Z7_XW0%CVFBO%O^%!^*O^@AHW_?Z7_P"-T?\ "@_%7_00T;_O]+_\
M;H"Q[317BW_"@_%7_00T;_O]+_\ &Z/^%!^*O^@AHW_?Z7_XW0%CVFBO%O\
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M *"&C?\ ?Z7_ .-T!8]IHKQ;_A0?BK_H(:-_W^E_^-T?\*#\5?\ 00T;_O\
M2_\ QN@+'M-%>+?\*#\5?]!#1O\ O]+_ /&Z/^%!^*O^@AHW_?Z7_P"-T!8]
MIHKQ;_A0?BK_ *"&C?\ ?Z7_ .-T?\*#\5?]!#1O^_TO_P ;H"Q[317BW_"@
M_%7_ $$-&_[_ $O_ ,;H_P"%!^*O^@AHW_?Z7_XW0%CVFBO%O^%!^*O^@AHW
M_?Z7_P"-T?\ "@_%7_00T;_O]+_\;H"Q[317BW_"@_%7_00T;_O]+_\ &Z/^
M%!^*O^@AHW_?Z7_XW0%CVFBO%O\ A0?BK_H(:-_W^E_^-T?\*#\5?]!#1O\
MO]+_ /&Z L>TT5XM_P *#\5?]!#1O^_TO_QNC_A0?BK_ *"&C?\ ?Z7_ .-T
M!8]7UO1+37M/-I=AUPPDBFC;;)#(.CH>Q%8\=QXPTE1!-86VN1+PMQ#.MO*1
MZLC?+GZ&N _X4'XJ_P"@AHW_ '^E_P#C='_"@_%7_00T;_O]+_\ &Z L=]+J
MNNSM&TW@:21HFW1E[VW)0^HR>#4-Q<ZG=R^;<_#U9I,8WRW-LQQ]2:X?_A0?
MBK_H(:-_W^E_^-T?\*#\5?\ 00T;_O\ 2_\ QNFFT7&I./PR:^;_ ,SM_M&I
M_9#:?\*^ MV;<8A=6P4GUQGK[U8@U;7K6%8;?P/+%$OW42^MP!^ :N _X4'X
MJ_Z"&C?]_I?_ (W1_P *#\5?]!#1O^_TO_QNB["52<E:4F_F_P#,[X:KKJW+
M7(\#2"=EVF47MON(],YSBI?[>\2?]";<?^#"#_XJO//^%!^*O^@AHW_?Z7_X
MW1_PH/Q5_P!!#1O^_P!+_P#&Z+DMM[L[N[O]8OXPEYX#>=5.0)+VW;!_%J63
M4=:EM/LDG@1VM\ >4;VWVX'3C-<'_P *#\5?]!#1O^_TO_QNC_A0?BK_ *"&
MC?\ ?Z7_ .-T792G)))2>FVK.]@U+6[:V^S0>!9(X,$>6E[;A>>O&ZG0ZOKU
MM"L,'@B6*)?NI'?6ZJ/H U<!_P *#\5?]!#1O^_TO_QNC_A0?BK_ *"&C?\
M?Z7_ .-T78G*3O=[G<"ZU5;TWJ^ "+D_\M1>6V[ZYS5O^WO$G_0FW'_@P@_^
M*KSS_A0?BK_H(:-_W^E_^-T?\*#\5?\ 00T;_O\ 2_\ QNBX2E*7Q.YWEUJ6
MMWT/DW?@62>/.=LE[;D9_P"^J?%JVO0P""+P/*D*C:(UOK<*!Z8W5P'_  H/
MQ5_T$-&_[_2__&Z/^%!^*O\ H(:-_P!_I?\ XW1?H'-+EY;Z'=6E]J]@'%GX
M": .<MY=Y;KG\C4C:KKKW"7#>!I&GC!"2&]MRR@]<'.17 _\*#\5?]!#1O\
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M$-&_[_2__&Z1![317BW_  H/Q5_T$-&_[_2__&Z/^%!^*O\ H(:-_P!_I?\
MXW0%CVFBO%O^%!^*O^@AHW_?Z7_XW1_PH/Q5_P!!#1O^_P!+_P#&Z L>TT5X
MM_PH/Q5_T$-&_P"_TO\ \;H_X4'XJ_Z"&C?]_I?_ (W0%CVFBO%O^%!^*O\
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MMM^[B$S_ +U?EC/(8\\+[]*\.LK?1]/L]*O=3M(4T@:W>1WC"(;3A2(@^!R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BL"QU;Q#/\ :?M?AC[+Y<#/%_I\;^;(,8CX'RYYY/ Q
M18ZMXAG^T_:_#'V7RX&>+_3XW\V08Q'P/ESSR>!BKY'_ $SI>%J*^JT_O1Z_
M/7Y;&_16!!JWB&33[N:;PQY5S%L\BW^WQMY^3AOF PNT<\]:(-6\0R:?=S3>
M&/*N8MGD6_V^-O/R<-\P&%VCGGK1R/\ I@\+45]5II\4?\_QV-^BL"#5O$,F
MGW<TWACRKF+9Y%O]OC;S\G#?,!A=HYYZT?VMXA_LG[1_PC'^F^?L^R?;X_\
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M/QI<C_IB>%FDW=:*_P 4?\]_+<W##&6+&-"S#!)49(JNNF62:D-06W1;L1&
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M/>=8&1%-[]M1<*<;FV$9XR>.^/>ER/\ IB6%FTG=:J_Q1_SW\MS7$,8! C0
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MC:E]FMWL4F9/(C?+EY 3EE)Z*/RH ]IHKY8_X6_X[_Z#O_DI!_\ $4?\+?\
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MSN@99@RL,@@ @B@#;HK&^WW/_/3_ ,=%'V^Y_P">G_CHH V:*QOM]S_ST_\
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M V:*QOM]S_ST_P#'11]ON?\ GI_XZ* -FBL;[?<_\]/_ !T4?;[G_GI_XZ*
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MZ[K>CVNGV_V..YGM+F6[E=#M=$++A1G@D _CZ5U5KX @@FL9)]:U2[^Q3I-
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MJ::<+?R?G7?"KAP^>2&;H1TI=+A;^OZ]#N?L\/\ SQC_ .^11]GA_P">,?\
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MR*/L\/\ SQC_ .^14E% $?V>'_GC'_WR*/L\/_/&/_OD5)10!']GA_YXQ_\
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MA_YXQ_\ ?(H^SP_\\8_^^14E% $?V>'_ )XQ_P#?(H^SP_\ /&/_ +Y%244
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB-T%G(H>%H25N) =K2>:<$-D?.,_ITH5K <GX)\3:]XC\=/-/<V#6)T\-)!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*** / O#W@'2O''CKQO_ &G<7D7V/4W\O[,ZKG?++G.Y3_='ZUU/_"@_"O\
MT$-9_P"_T7_QNCX6?\CU\1/^PF/_ $;/7JE SYF^*G@'2O _]D_V9<7DOVSS
MO,^TNK8V;,8VJ/[Q_2OIFO$/VA_^9<_[>?\ VE7M] !7BWQ!T"U\4?&[0M&O
M9)H[>XTP[VA8!QM,[#!((ZJ.U>TUY7KO_)QOAC_L&/\ ^@W% @_X4'X5_P"@
MAK/_ '^B_P#C=<[X\^$6@>%_!>H:S97FIR7%OY>Q9Y8RAW2*IR @/1CWKW:N
M'^+_ /R2W6?^V'_H^.@9N>"_^1%\/?\ 8,MO_12UN5A^"_\ D1?#W_8,MO\
MT4M;E CQ#]H?_F7/^WG_ -I5M_\ "@_"O_00UG_O]%_\;K$_:'_YES_MY_\
M:5>WT#/*_P#A0?A7_H(:S_W^B_\ C='P#_Y$6^_["<G_ **BKU2O*_@'_P B
M+??]A.3_ -%14 >J4444""BO,O&4X77-7N)[J:&?3X+)[ )*R8+RL'( /.[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M _!2?PH L44$@ D\ 53TS5+/6+);RQE,MNQ(5RC*&QW&X#(]QP>U %RBBB@
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MUU<R"."%#)(YZ*H&2:9#?6]Q<-!$Y:18UD(V$#:V<')&.QXH L4444 %%%%
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MY:1OIUP9$\F=%202_+AW8J[;>04P,' Z5ZKIVM:;JZ2OI][#<+$<.8VSM_\
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MX$NKWU\SV/D7S1,J%%D<S*[(HCP$/0\\UU]WXOM].\)6FO7D2*EP8E\N.0L
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M]9_[\Q?_ !RL#3O%^G^-/COX=U'3H;F*&*SD@*W"JK;A'.V?E8C&&'>O<Z*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU= \>>&O%%^]EHVI?:;A(C,R>1(F$! )RR@=6'YUE?\ "H/ G_0"_P#)N?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OG3X^?\CU8_]@R/_P!&RU]%U\Z?
M'S_D>K'_ +!D?_HV6@:.1T7X?^*/$6FC4-*TLW%J6*B3SXUY'7AF!_2N=G@E
MM;B6WGC:.:)RDB.,%6!P01Z@U[_\+9(8O &AO+I]W=O_ &LZQ&V!/D,RLOF/
M@CY "0<^HKQKQO$T/CK74:9)F^W2DNG0DL3C\,X_"F]&"U5SW#X7?\DYTK_M
MM_Z.>N@36M.?6WT9;E3J"1><T.T\+QSG&.XXSFN?^%W_ "3G2O\ MM_Z.>O.
MIM3NAX_NO$"13&UFNIK%+E>$/[LHH!ZY'!_ 4KBL>W7=W#8V<UW<OL@A0O(V
M"< <DX%4(O$6FS7&FVZ3-YVI0^?;H4.2FW=D^G%>0PW]SJND0V\NIW4@_L&>
M291<$G>LS$;N>N !SS@TMW86TJ>'HH=0N9-NCSSLZ7&6218B^P$= ",;>PXH
M>G]>O^06/<JKWU[!IUC/>W+%8($,DC!22 .O KPRRUO4I[9=7DU:[.K6]Q:0
MV]OYQQ+&5YRO\6<#)_/K70:9%</X1\3:\^IZ@UY&\]M&#<,510RD$#J".1U[
MTWH"5VCU>":.YMXYXB3'(@=201D$9'!Y%25XU;W;W.O6LECKM[YEIIZ7-RDM
M\2LUQY8*Q(AZ\CGKWK,TK4O$5OHM_J5M>EEEL7:?-^)9=V_'F!,[D(SCVZYH
M!(]KAU6TGU:YTR.0M=6R+)*NT@*&Z<]_PK.@\9^'[G5I-+BU%&NT+ H$;!*Y
MR <8)&#TKD_AU#;P>)=46UNY+N-K*U<RR2^8=Q!+#/L21CM698WEIX>UUK72
MKNTU+3+]K@PLB@SV<NTYPW7:<#GN!D>X]/Z]01ZGIVHVVK:?#?6;E[>9=R,5
M*DCIT/-6J\2;4+J^TS0(+_5KN"#^SKFY$HN"C23*[[06SST  ]^.M4-%O]1D
M\C4I-4OWG@U"QA16N&*;9%);(/7.W]30M78&K'O;,%4LQP ,DU4TO5+36=/C
MO[)S);R%@C%2N=K%3P>>H->/V&J7&J^-5EAN+V&UU%KJ$J]^9'"[&_A_@ )R
MO7IQG!I=#N4TS1/"LD&JSH)=4/VR,W)V1KN. 1GY00,X/7.:06/:Z*\,\)R:
MAK&HW+SZGJ,C6%G)>01BY8AY$D.T,#G(/3%/\.2:]=6=W-%K,5M'=64AGEN-
M25V5]W#E2<Q]ESVSFF%CW"BN&^&-XDVE7EFSW375K,%F$USYZ D<>6PXVG!.
M.>O4U-)I/CXRL4\2V 0L=H^QC@?E0(WM;\2:1X=2%]6O!;+,2(R8V;<1C/W0
M?45%I'BS1=>NOLVF7GVB3RC,<1LH"AMO\0'>LWXC+_Q;W4]^&=8T^;'?>N:\
M_P#%D)37]3NX)Y[>:STFWFB,$A3YMZ+SCJ/FS]<4(9[!:ZG:7MY>6D#LTUFZ
MI,"A 4D9&"1@\>E7*\4UF[U.]N]9)U5Q%!=0R-:&\\EI5V$D1DG (ZX'MP>*
M[U;O^T_AB)]/U&6U,MIM2[O9?G4@X)9_4D$9]\TN@6.NHKP=M8N?["M-(AFO
M0POPEZ)-1^0_*-H2;HJ$[CW^IXK1CEU"ZDT32?$.M/:6 @GE6ZM[P,'*D[<R
M X8C&,=?SIA8]2E\1:9#)J:-,V=,C62ZQ&QV!@2.W/ [5HP31W-O'/$28Y$#
MJ2",@C(X/(KQXPP6%]XQGM]:NWG2VC:V<W?,X9"2_'WL#&".F?>LY-8U!LZH
MVJ78U2VN+2&VMO..)(RG.5_BW8!)]_>DM0:ZGNU%>.>&KF]'BC2[Q]1O9'N=
M3N[61))V9/+500-I]V_05L?$5KB7Q'9VJ7MW!"-.N9RL$S(&>-&9<XZ\J*+Z
M)A;6QZ717@,VI:G86\JQ:K?M]HL[6[D=[ABV]F&3G/ P<5KZK=WM_:ZQ)#K!
M:VAUF1A!]N\HSQ  XB8G''4 >O0TP/6K;5;.\U*]T^"0M<6>SSQM("[P2!GO
MP.U(FKV3ZT^D)+F]CA\]T"GY4R .>G>O-_AJ;&Z\4:G>1ZA?,S1PF*.ZN=SS
M90[BP_C*XX/;/O5'QWMC\::S="^EM+FVTZ*2W:*4H6?>HQQUX)X]L]J.P6W/
M9**\374?$6I>,)+F.Y$5W!<PJD<M\(5V$<H(C][=[?UKJO&\HNO%VEZ7?:I-
MIVF&UDG,T<OEYD&<9/?&!Q[^] CT*BO'?%M[(VK7X_MNZC33M-AETZ1+C'VA
MB5R^1]\G)Y']*Q;!K[4TLYKG5M35[VXO(IE6Z8#;'&KJH'IEC2_K^ON'8]\J
ME::M9WU_>V5O*7FLBJSC:0%+9P,]^E>/3ZA<ZCIOAM;_ %>Z@BDTRY>1UN"F
M]XR^S//)RJCU-4;'5M33PIKMU'-*+BXFLDGF#E6VE6R2W;.!D^],+'M^HZK9
MZ7]E%W(4-U.EO" I.YV. ..GUJ[7A\UE>2:;IBZGJ#)91ZRD<+PZBLWDHP!;
M,@Z%< @G&,FFZ#J/B%]3DU*UN]\R/.)(YK\,TB*IP!">3C&<\Y_"@+'LKZK:
M1ZQ%I32'[9+$TRIM.-@."<].M07?B'3K'6K72)I'^VW0W1HL;,,9(R2!@<@U
MYKX!$;^+-*NOM\UW<W.F2R7)EF\PI)YF,>W !Q5CQO%/9>,M2U"SNKM+F/1?
M/01RD 'S!&1@?P@$MC^]S0]+ E>YZM17@]YJ-WI]I>V6FZQ>36C0VDS2BY8E
M)6QN 8'C.3D>WM7JFHZ$]EX%O-*L+R],L<+M%,TQ,Q8$N!N&._'TH>@'245X
M5!JVHZ]<65S?ZA=VVF7MU%9S,+AD"^7&N_O@;B<T^QU_41]D2?5+G[.EKJ$4
M4KSL/-"HVPDYY.3@=^!BAZ!8]RHKR7PI%<:[XHT]+W4]0,=MI=O=JBW#8>0$
M?>!SD')SW]ZTOB7J=_H%_9ZA:W%P(KJUFLVC1R%#D?*V,X#9;KUXH>@+4](J
MEIVJV>J_:C9R&06T[6\A*D8=0"0,]>O6O&I;O4K"ZN)YM5N_[7TZ]MK6"W,[
M$2IC#94GY@Q&3]?>E9I-&\,^(/L.HW7VIM5-M(AN<%8<C]X?0D_*6_"@+'N#
M,%4LQP ,DU4TO5+36=/CO[)S);R%@C%2N=K%3P>>H-<?X*M]1E\-:O9WMR&M
MF9TMFAO5N'B4KROF#N."/K7&:88X_"WAZQ&K7,5K?WSB_*W./) 8A5_V PYY
MZ]:.M@Z'L]]?6VFV,U[=R>7;PKOD?!.!^%.M+F.]LX+J$DQ31K(A(P=I&1_.
MO-+6]NKWX-ZS]IGDG$+2PPS2$EGC##!)/7J1^%<L^IWVE:/?6.E:A<2VDEO9
M-(WGD^2SK\X#?P\\'\CTH"Q[U17&?#I=2CTV]BO)HY;=)_\ 1MMXMR44CE"X
M]./SKBX-1F_L;6==;7;I->+7$8L1/@;<@<)U&T$D8],]C0P2N>ST5X1=ZE>:
M;:WEKINL7D]GY-I<-+]H9C'*Q&X!@>,Y.1[<]*T;J]NM3U<VBZK>?9+GQ$\&
MZ"Y8?NF X4@XQSQVH ]9N=5L[34[+3I9"+J\W^2@4G.U=Q)/0<5=KPF)Y9XO
M#E[<ZC=K)%'>I&YN"IS'N*#/J20I]1@4W2M2\16^BW^I6UZ666Q=I\WXEEW;
M\>8$SN0C./;KF@+'M<.JVD^K7.F1R%KJV19)5VD!0W3GO^%7:\O\"2Z=I6O:
MK*=3#VQLK5FN+FX##>PY&X_[1QBNW\06NO7<4 T+4K>R=23*9H1)N';'IWH8
MC9K!M?&?AZ]U<Z5!J2-?!VC\ID=?F'4 D $\>M.\/V?B*U:<Z[JEO>JP7RA#
M"(]IYSGCGM7F2RV\ENMI"\9U4^*F>%01O5<C+>H7/\O:CK8?2Y[0S!5+,< #
M)-5-+U2TUG3X[^R<R6\A8(Q4KG:Q4\'GJ#7C]AJEQJOC598;B]AM=1:ZA*O?
MF1PNQOX?X "<KUZ<9P:Q;9[D:=I%A9ZA-LFBFF>-]1\A(Y0[!>3P, !L'KD^
MM(+'T-17)3ZG=Z;\,3?:H[RW268#R6TX#,3\JLL@SSR#GFO,(M3U.VT+6K=;
M^YC GM'4I>M*R[RV<./7C(]N>E/K872Y[Q//';6\MQ,VV*)"[MC. !DGBJD6
MLV,NB+K'G!+%HO.\UP1A.N<=:\5EDD.M:AH%WJ]ZFF6<EX82]R07=5&U2QZ\
MCI_M''6O0[*#3[GX16T.J7 MK)[!!),?X.F#[\XX[]*.EQ];&I;>.?#MW937
M<%^7BA=$DQ"^Y2YPORXS@GO715XK-K=W9>']1TB.YADFLY;;R]2L?D,\710Y
M'4@8'X'TR8[#4;J74;:_?5KO[?<W=VES;_:"%15C)3Y,\#KCZ<=* L>W5@77
MC;PY8ZLVEW6IQPWBN$9'1P 3C&6QM[CG-<+\/)[M?$&F-)?WD_V_2Y)IUGF+
M@LLI48STP%_4UC>+PY\0>)F:]MDMH[JV>6S<@27'RX&P]1@$YQZT/1H$MSW*
MJ6F:M9ZO'/)92F1(9F@=MI'SKC.,_6O)[J^UZ^\?7DMM<>3/;7L<<,<U\(AY
M?]P1-][=QT_K65;3O-=S:?<ZA/8V GO;@/%*8]TR@;03WQ@<>_O2N%CWJBO
M=1UOQ+]GL1'>WIFO[*.Z.)F! BW@D<]U3<?7WKU+X>7%W?\ AEM3O)7=[ZZE
MG4,Q;8N=H49Z ;3Q3$=91110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %:.E?\M?P_K6=6CI7_ "U_#^M
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MS?\ /&3_ +Y-;"7=O).T"7$33+]Z-7!8?4?B*IMKNGIK$VEO<(ES# MP^]@
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MOZ=16=I?B;3]66>2 O'!#G,TNU4.'9#@Y]4/7U% 6(OL\W_/&3_ODT?9YO\
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M9'CCEC=X\;U5@2N?4=J ,7[/-_SQD_[Y-7]-C>/S=Z,N<8R,>M7Z* "BBB@
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MB+HB7$C28*G ^1ER!P>@]*ZW7!=^(_#*20Z7(XBOU=[.1@#<112\_>P/F"Y
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MF98KNQ\V,+LC4[1O&&S&2#_M8P<5T=]X@C2WTEM/V7#:K,B6['.W85+LY^B
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MZ(ZAFUL)?)CO6C2*9C)&;=B 95[!NW-=0/%^F"^:Q8SM<*""8X&96D";S&I
MY?:<X%'2X/1V-^BN;MO&^DWEU!:01WKW4KLC0BV8O%M*@EQV'S+S[YJYIOB;
M3=5U&6QM7E,J!RK/&564(VQRA/W@&X- &Q17,7_CW1=-NKR"Z^U(;5G1W\@E
M&=4#E5;H3M.<4QO&MM!<3M<0W*0JD!2 VKB?=*[H,J3W*\#&?SH6H'545RNB
M^-(==\2/I]I:S_91:K,LSPLN'WNK*V>F"N/J#Z5)<^+HAXILM%M(9)"]P\%Q
M,8FV(5B,FU6Z%ON\>AHML'<Z:BN.N_'UNE_8VEK8WKRRWBV\\<EJZNBLC,&
M]]OZ-Z5LZ;XFTW5=1EL;5Y3*@<JSQE5E"-L<H3]X!N#0M0>AL45R6D^/+&YM
M;MM1#VDMM]HD;,3;'BCE*%D/\1&%SCN:#X[L3J*H=T-I%:W$UV9XV66%HS'\
MI7W$F>^>,4 =;17*-\1- C$GGR7$#Q$"2.:$HR$LJX(/?YU/T.:Z#3=2M]6L
MA=VI8PEW0%AC)5BI/TR#185RW1110,**** "BBB@ HHHH **** "BBB@ HHK
MF]?U^_T[7--TZTALU%VK-YUY(R([ @>4I .'()(SZ=#1UL'2YTE%<DWCO3[&
MP,U^999 ]QN%I;LVR.*0H6;T .!GN>>E7/\ A,M+&JS:;LO#/&SQY6W9E=U0
M2%%(ZMM.<4 =#17'IX]M[C7+*RMK.[,,J3F=GMV#1-'MX/8##9)]U]:MMXZT
M<6IG473J$MG"I"69A/\ ZL #DDXZ4 =+16':^+-,N]433E^T1W#G8/-A95$F
MP.8R>F\*<D4[3=:GNM8UJSN[>*VBT]DV/YF=Z,I;<W0#IT[4 ;5%9MAXBT35
M+C[/I^LZ?=S[2WEV]TDC8'? ).*YFX\;W=OXJFTSR+*2!+P6@19C]HYB$GF;
M,8*#.": .XHKE/#GCFPUN#3XY-R7ES$I;9&WE>;Y8D,8;NP4YQ4A\=Z0LI@,
M.H?:O-$0M?LC^:V5+9"XSC"G\L=:;33L!T]%8T?B?3)=;_LE7E^T;S&&,1$9
MD"[RF[IN"G.*S8O'%E'JFLV5\1&=/D<DQJ6VPJB-O?T)+D #KCZT@.KHKG6\
M::2MD+@B[\PS- ;86[><'5=Y!3KPOS9]*-.\:Z-JFI)96LD[&5MD4QA(BD;8
M)-H;IG:<XIV Z*BLB?Q#:1ZQ)I,:3R7:1"1V2%FCB!#%=[#@9VG_ ":R-)\?
MZ7J"649,TDT\?,L5NRP[Q%YC*">AV\XS_6EY_P!?UH!UU%<O;^/=)N=/EO(8
M-098ECD9!:-OV.I97Q_=(4\^WN*AT[QW:WE]?I);SI:17,$%O.(2!)YH3:23
MZE_RP:=G>P=+G745SL?C72II;2.)+N0W/FE2D!(18WV.S$?=4'N:L:9XITW5
MK:ZGM3.1;QB9D>(HS1L"5=0>H8 X^E+I<.MC:HKCKSXBZ,+&Y:RN-UQ''N&^
M(LJ_N?-!(!!QM';OQ5>Z\>3P3:D@TZ5A9WUM;!O)8[UDV;L<\M\QP/3!IV8=
M+G<T5R,?CW3G>:<&62U"0!(X[=O.#R2/'M(SR=R8P!Q@]:FU7QC%;>%(M<T^
MWEN4EN(X0AB;<I,FQ@5Z@@Y'UQ2L'D=117*Z=XTM[C7+W3+R&2V9+AHH':)@
MK!8ED(9N@8 L<>@J_IWBBPUBTNYK$REK>(3;)HS&61@2CC/56P<'VH>BN"U=
MC;HKDM)\>Z?>: E]=I/#=+% TMN(&W,TH^3RQU8,<@?2I[?QWHES>6MI$]P;
MB[(6&(PD,QW,K<'^Z4;=Z?B*;33L*^ESIJ***0PHHHH **** "BBN;N=?OU\
M:1Z+%#9QP>4DNZYD97G!)W>5@8)3 R/?MUHZV#I<Z2BN1L_'NG-.+6X,LMQ]
MK-LS6]NWEQL96C0,3T)*G\L]Q5FW\<:5=27$<,-\\D*NP06S$R!)/+8IZ@-P
M3VH Z6BN+U#XB65E/ILRVUU+IMU;33R3+;L6CV,%P1VP2<YZ<>M:<_C+3()3
M$(KR:47;68CA@+L9%3>< =MISFBP'0T5CZ;XGTW5=1EL;9Y?-0.5+QE5E"-L
M<H3]X!N#52RUO4V\7RZ->061B\AKA6MI&9H5#!5$F0!E@21C^Z>O6A ='167
M+XET&&^-C+K>FQW@<(;=[I!)N/0;<YS[5B>,/%MUX<O+>*W2P*M:S7+&[F,>
M[RROR(0#ECNX^E ['7T5Q6D?$2RN-#MM0U.&6UDG:9C"D3,88HY-A>3^Z!QD
M^IK6U/QCI6CW<D%_]IA"1-()3 WEN%7<0K=SCT]_2FU81OT5SUSXSTNR@MY;
MI+R'SD:0H]LP:*-6"L[C'RJ"1S[TW5_%4.C^(K#3YU#17<#/'L!:1Y/,1551
MW^^2?89[46 Z.BN:?QWH:231F2<LC%8P(&_TA@_ED1_WL.0./Y<TD_CS1+>&
MVF8W31S1/*62W8^4J.$<OW7:QP:2U Z:BLN]U^SL=3M-.9;B6YNEWHL$+2;4
MR!N;'098<UC-X\T^QL3-?&65P]QN%K;LVR.*0H68<X .!GN>>E"U ZVBN>T_
MQEI>IS3PVZ7GF0QR2A6MVS*L;;&V8^]AN./6J">/;>XURRLK:SNS#*DYG9[=
M@T31[>#V PV2?=?6@#L**Y8^/]'\ZWABCO9I;B.*2*.&W+LPD1G7@?[*G/IB
MM'3?$^FZKJ,MC;/+YJ!RI>,JLH1MCE"?O -P:=F%S8HKFKWQWH>GW4UK<S2K
M/$90R;,D^6%+8^H<8]:SX_'$S:C9VHM#,LZWA:6*%@JF%]H!R>/]H_3UI=+A
M8[6BN)TKQ_!J5OI6Y3!<SA&N89('!PT+R QG/0[&P3GI[ULZ1XLT_7+2YGLD
MNMT$*SF*2$J[(RDJ5!Z@X./I3DK7OT!:F[17 V?Q(!M]*NM0L9H+:ZLI+F9U
M@8^65=%S_N?,?F^E=-IOB?3-6U"2RM9)#(@=E9XRJRA&VL4)^\ W!HLP-BBN
M1'CRQM-4U6TU4-:QVEP\<4WE,4<+$LA&[IOP6X]!5F7QWHEOIQOKE[BWA28V
M\OG0E&AD";PK@\C(QCUR!WI=+AUL=+145M.+JUBN%1T65 X5QA@",X([&I:-
M@W"BBB@ HHHH **** "BBB@ HHHH *R?$>CRZYI/V2"Z6UF6>*=)6B\P!HW#
MC*Y&1\OK6M7B'Q-\._\ "5_&/1=$^U?9?M.F?Z[R]^W:9W^[D9^[CKWH ZS4
M/ABU^JL^J023R&1[F6XLO,_>.X<O$N\>6?E"]^*M7WP^>]M/)DO+.81:A+>0
M)<V7F1XDW;E==XW<MD$8Q@5Q/_#/'_4T_P#E/_\ ME'_  SQ_P!33_Y3_P#[
M91Y#/4+[09#!HAL/(272ID9$"^7&R;3&Z@#.WY6)'7D 5DM\/]UL\/\ :?WH
MY8\^1TWW GS][MC;^OM7"_\ #/'_ %-/_E/_ /ME'_#/'_4T_P#E/_\ ME.[
M%96L=T_@ M;21#4^6BECSY']^X$^?O=L;?U]J$\':@^D6;"^AMM62YGN9I#$
M9HV,P8,,94G 88.1]T5PO_#/'_4T_P#E/_\ ME'_  SQ_P!33_Y3_P#[92\A
M];G86'@#4=%6V-CJT,R60::"&2V*EYS;^3R^XX7@-C:3R>:DOO!>^'P=8K&\
MBZ;,&N95.%*A=S;O7=(J'%<7_P ,\?\ 4T_^4_\ ^V4?\,\?]33_ .4__P"V
M4^9WN*RM8Z>[\'3-9>-YHK6<SZA(!9(&^8%0'#+S\H\UF/X9K0U7P<DP\'V,
M,+F'3)E\YU.%\M$SAO7+JG%<1_PSQ_U-/_E/_P#ME'_#/'_4T_\ E/\ _ME)
M:6\K?A_PXWK^/X_\,>K:)I,MFVIW%Z8WGU"Z:9U7E54 (B\]?E49]R:UHX8H
MB?+B1,]=J@5XD?V>E#!3XJ )Z#[!U_\ (M+_ ,,\?]33_P"4_P#^V4"/25\'
MPKX8U72%G19=1-P7NA  P\UV89&?FV[L=><=JR+_ .&D-W?:E.EQ9I]M4D2O
M9;IXG*!3B3</D..5QW(S7&_\,\?]33_Y3_\ [91_PSQ_U-/_ )3_ /[90,[&
MW^'5Q;I;I'J-A"J7OVPFVTXQ-$?ERL)$GR A<$'((/2M7PWX,@\.ZK>7<?V)
MQ*SF.1;39. [[B'DW'<!T' Z"O.?^&>/^II_\I__ -LH_P"&>/\ J:?_ "G_
M /VRG<5D=5>^!-0U^_UI;R\2TL);V2>V40[G9F@6+>3N^Z/F^7 .1G.*Z#4O
M"7]H:N]_]N\O<;,[/*S_ *B1GZY_BW8]L=Z\U_X9X_ZFG_RG_P#VRC_AGC_J
M:?\ RG__ &RA-JUN@/6YZ/H/A*;0M7>\34$EAEB=)(S 0Q)FDE4AMW&/,(/!
MS@=*@F\%W,NO27BZL([)KB6Z$*V_[U9)(3$<2;L8'WA\N<]Z\_\ ^&>/^II_
M\I__ -LH_P"&>/\ J:?_ "G_ /VRD,[#2?AS/I,D$\.I623Q7$$P$5@41A&C
MQDL/,R68.26SU'0UK>&_!D'AW5;R[C^Q.)6<QR+:;)P'?<0\FX[@.@X'05YS
M_P ,\?\ 4T_^4_\ ^V4B_L]!E#+XJ!!Y!%AU_P#(M.[%9;';+\.WFAO;:^U1
M9;>2"YAMA';[#$)Y?,8MECN(( '3@4D?PXB^R&)KBSMF:UG@86%EY*DR&,A\
M%SR/+'USVQ7%_P##/'_4T_\ E/\ _ME'_#/'_4T_^4__ .V4D[#.NO?A@FKR
MBZU74EENY))I+AHK?8C[XEC4 ;B0%V(W)/([5U'A_1KG0K&WL#>I/:6]M'$B
M^3M8N,[W)W'[V1QV]37E/_#/'_4T_P#E/_\ ME'_  SQ_P!33_Y3_P#[93N+
M<]OHKQ#_ (9X_P"II_\ *?\ _;*/^&>/^II_\I__ -LI >WT5XA_PSQ_U-/_
M )3_ /[91_PSQ_U-/_E/_P#ME 'M]%>(?\,\?]33_P"4_P#^V4?\,\?]33_Y
M3_\ [90![?17B'_#/'_4T_\ E/\ _ME'_#/'_4T_^4__ .V4 >WT5XA_PSQ_
MU-/_ )3_ /[91_PSQ_U-/_E/_P#ME 'M]%>!:U\"?[(T+4-3_P"$C\W[';27
M'E_8=N_8I;&?,.,XZXKT7X0?\DMT;_MO_P"CY* .XKGO%/A^]\16RV4>HQV]
ME(-MQ&]L)&/((9&R-K#'!Y'.<<5T-?,UIX,_X3CXK^*-,^W_ &+RKF[N/,\G
MS,XGVXQN'][KGM0,]0\0>"-2@TLQ:1<&YGNOM%O*K0C;Y<\OFY)+C;MZ9^;/
M]VM+6?AZ=6CN0-5,)FO)+K(@SC= (MI^;D<9/J#CCK7#_P##/'_4T_\ E/\
M_ME'_#/'_4T_^4__ .V4[Z6$=QI7@&;2[F&:._M$&^X,L4%EY<>R94!6-=YV
MX,8Y.>IXIFF?#ZYM(@MUK$<S(UEL,=H4PELQ*@_.<EAU/&/2N*_X9X_ZFG_R
MG_\ VRC_ (9X_P"II_\ *?\ _;*$V@LK6/1K3P9!9^,;G75^Q2">0S?O+3,\
M;E0I"R[N%XSC;W/-:]GI(M=8U._,V\7WE?N]F-FQ=O7/.?PKR+_AGC_J:?\
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M"XM-5L-2.MEKBSD:10+?",9'9I\C=T;< /[NT=:X?_AGC_J:?_*?_P#;*/\
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MY5, VB.>;S222XV[>F?FS_=KF/\ AGC_ *FG_P I_P#]LH_X9X_ZFG_RG_\
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M8D'L!C)]ZY^R_P")]XYNK\_-9:*IL[?T:X8 RM_P$;4_%ZZN@ HHHH ****
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M?]#9HW_?I?\ XQ0!ZI17E?\ 87QD_P"ALT;_ +]+_P#&*/["^,G_ $-FC?\
M?I?_ (Q0!ZI17E?]A?&3_H;-&_[]+_\ &*/["^,G_0V:-_WZ7_XQ0!ZI17E?
M]A?&3_H;-&_[]+_\8H_L+XR?]#9HW_?I?_C% 'JE%>5_V%\9/^ALT;_OTO\
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MSPW$?E[9$.",R*#^A-<GK6O:K!8>"'BOID:]5?M)#?ZW_5=?^^C^==)\2/\
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MIG_;7_T4]07O_)2;C_L+M_Z.-=+A'G>G3_,]Z>&H?7*D>16]FGLM[R\CT_\
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M#3_QS_\ 39UOQ/\ ^1'N?^NL?_H0KA_ '_(I^,_^O$?^BY:[CXG_ /(CW/\
MUUC_ /0A7#^ /^13\9_]>(_]%RU5+^"_7]4;9?\ \BB7^./_ *5 @^%/_(Y?
M]NTG\Q6UX5_Y%/QO_NS_ /HMZQ?A3_R.7_;M)_,5M>%?^13\;_[L_P#Z+>JK
M?&_^W?S.S,_X]7_N%_Z69.I?\D8T?_L(-_[5KTGQ+_R3Z^_Z\?\ V6O-M2_Y
M(QH__80;_P!JUZ3XE_Y)]??]>/\ [+6=3=>K_-'GXWXZ7_7V?_I43SGX0_\
M(V77_7B__HR.L/P%_P CQI7_ %U/_H)K<^$/_(V77_7B_P#Z,CK#\!?\CQI7
M_74_^@FNF6\_3_,]NO\ Q<7_ ((_^DS.OB_Y&'X@?]>,W_H)K)U+_DC&C_\
M80;_ -JUK1?\C#\0/^O&;_T$UDZE_P D8T?_ +"#?^U:RANO5?D<='^)3_Q4
MO_33/2?$O_)/K[_KQ_\ 9:\Y^$/_ "-EU_UXO_Z,CKT;Q+_R3Z^_Z\?_ &6O
M.?A#_P C9=?]>+_^C(ZSI?P9GGX#_D58KU_R,/P%_P CQI7_ %U/_H)KKXO^
M1A^('_7C-_Z":Y#P%_R/&E?]=3_Z":Z^+_D8?B!_UXS?^@FMJWQ_)?FCU\R_
MWF7^"/\ Z<B9.I?\D8T?_L(-_P"U:])\2_\ )/K[_KQ_]EKS;4O^2,:/_P!A
M!O\ VK7I/B7_ ))]??\ 7C_[+6-3=>K_ #1Y.-^.E_U]G_Z5$\Y^$/\ R-EU
M_P!>+_\ HR.L/P%_R/&E?]=3_P"@FMSX0_\ (V77_7B__HR.L/P%_P CQI7_
M %U/_H)KIEO/T_S/;K_Q<7_@C_Z3,]$\)_\ )3/%'^?XA7*:1_R1SQ!_U^1_
M^A15U?A/_DIGBC_/\0KE-(_Y(YX@_P"OR/\ ]"BK&.__ (">;#X_G0/2?#7_
M "3ZQ_Z\?_9:\D^&_P#R/VF?]M?_ $4]>M^&O^2?6/\ UX_^RUY)\-_^1^TS
M_MK_ .BGI4OAJ?UW,\!_!QWS_P#;B"]_Y*3<?]A=O_1QKT3_ )K9_P!N?_LM
M>=WO_)2;C_L+M_Z.->B?\UL_[<__ &6JJ]/\/^1UYA\,?^O,O_;#E-(_Y(YX
M@_Z_(_\ T**O2?#7_)/K'_KQ_P#9:\VTC_DCGB#_ *_(_P#T**O2?#7_ "3Z
MQ_Z\?_9:SK[/U_1'GYQ\,O\ KZ__ $F)Y)\-_P#D?M,_[:_^BGJ"]_Y*3<?]
MA=O_ $<:G^&__(_:9_VU_P#13U!>_P#)2;C_ +"[?^CC74_C?I_F?0S_ -]J
M?]>U^<CT3_FMG_;G_P"RURFD?\D<\0?]?D?_ *%%75_\UL_[<_\ V6N4TC_D
MCGB#_K\C_P#0HJPALO\ MW]3QZ/\.G_W _\ 2I'I/AK_ ))]8_\ 7C_[+7DG
MPW_Y'[3/^VO_ **>O6_#7_)/K'_KQ_\ 9:\D^&__ "/VF?\ ;7_T4]*E\-3^
MNYG@/X..^?\ [<=5X(_Y*QXC_P"WG_T>M>J5Y7X(_P"2L>(_^WG_ -'K7JE9
M8CXEZ+\CRL[_ -YC_@A_Z2@HHHK \<**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I:G9&^@B5
M F^.>*4,_8+(K''O@&KM8NNZM+I-S8RY06A9C<EAR%P "/\ @3#\,TUN:T(S
ME42AN5X-"O;-'9+B*YD%R)U$B[-YV%6+$ \G.>G:IETN]LX8$LS;RLMFEJ[3
ML0%V]&P =W4Y'&>.:R=-U[5[F>%9P5<W"1. B^4.3N!;[V< X]3CUK7N=8EA
M\2P62J3:E0DK>62!(P)7YN@^Z!COO%59['=4CB%+EE9Z-_=;^D45\+7$4")%
M<$.]M);SLUQ(P =T),:MD+\H;@ <X_!K>%[O%R@N0\:JPMU:5E$@+;RD@50-
MI)9<#/':B76]0AM[@&3=<S8%KB(.ARV-R;"2R@')!^;BJL_BR]"3M&L:F6"-
MK9'7!5P 9@?< ]/8TUS,UBL9+9K^O^'MZ7[%V#P_J%K/%=I-'+,Q$T\;R83S
M=S'"D+G&)'Y//"_AI36%Y=6]OYIMUF1Y7<)G:-R.H ..<;AD\9Y/M6>^J:I]
MJG:,.8([DQ,6C4(J[@!@YR3SBKQNKU_$#VZ1W!M4V9>,1;%R"3NW-N_(&IU9
MA4=9OFDU=*__  /Q,Z#P[>R0PQ3NUKY2N \.I33MDJ ""X&!Q]T<5.NEWMO/
M;S"&WC2&--XMY7(VJN"GEXP_3Y6X(S[<P7VOWR:C?6UL%"@".V>2([#*"N[+
M=#G>1@<C8:@3Q%?74FJS1RK#'8Q^9Y+H#\P52R,>OWMPXJO>D:\N)FN9VM_G
M;_,FE\-75U;:?\\,;Q6L=O,&R<H01(G3N,?E4VD^';C3I+.6259&B9MZ&5BB
M@K@,HQC=V^C&G:UK=WINHI'&(_)EMB$5NOGL3Y8SZ':1^55M$UK4;Z[M%F+%
M)2V\M&JH0$S\I!SNR1P>V?2CWGK_ %U$WB94>:ZY=_S_ ."7%T2[74Y=0$\9
MDG,J21OR@C*@)@;<D_(F03CEL>]0^&[V\B^SW,PM[4!F"17#3,K[2HPSKG;\
MS$#M@8]K6FZY-=S:D)-J)&&EMFD0HIC!*Y)/WAE0V1V<51GU_4;2RV$2R7HD
M#F,P!F\L*6;&PD%3C /;<,TE?8(?6>;E5KJWY:>6FPZ'PS?F]BNIY;7/G)<R
MHF3^^#\L#@?P9'Y5:CT&XL[:UE@V7%[ ^<3W#+'MYR%.TXZCMVK-NO%-]&;B
M.%H2WVD/$V/^7?[N?<[^/H16KI5_J,UY ER'\B6(NK2QJK$@#/ /3GCZT.XZ
MOUE1YIM6[>7]/\/(;;Z=JD%Y>7 A@628.R-_:,S(K%1@>5LV]1][KCG':JT?
MA2>!Q''=!H8U$D$LA_>)-M49P !CY!WR<MGK6AI%]=RPSW-ZMPD*!F#R"((0
M">5VL6Z#^("LJU\2WY2&2>+:$=WN4:(HPA(5E8 _W=V">^QJ-28O$MR4;:6O
M]VG?T^?F6;70]2AB@M'^R>0!:F242,7#1!<A5*X()7KD=>E(_AJX.K_:A+ (
M3<BY*<Y\P/\ >SCKL)7\J2TUB_EMH+QYT*G[(K1;!A_-"[B".<Y;(^E5;_Q+
MJ%M-=VRF+S4NLQG'2W^[GW._CZ$4WS7+4<5*;46K]?OU-*RT2\T[,D,J23&U
M>-?-E<B-R<C;P<*>,_[HJ.+P]<V5E+:0NMS 6CD7S93&^X+M;#(!M/"D$<DY
MSUS4^BZG<SI=O>,ZQPQHQ\Y%5P2I9CA3C;C&#]?2JEIK6H7FD2$JT=Z)U 3R
MPCE&&\! ^ 6 R.>#M-+78SOB.9W:W5_T^[]1DGAS4IE-Q)=1F[0".--_R&/:
MP;<=F<_O&^N%)]DA\*740F7SH=IC,$6W*E(@Z,J].V'_ #%))XDN4GB5"7B$
M#++)Y! $Q#%<GHI&S!'<N,5%'XEU&:%A\@DAM0)C&N3]H#JK@ ]L,"/K3]XV
M2QENEC6?2;JUN938QPRQ7$6R:2XN6#ALGYONMNX(XR.E16VD7ZZ%<:>ZK"\H
M6,N+^6X^4X#D&1?E.,X XSZ5)9WVH;KQ;D%1'"9(?,0*Y'."P!QVHM]2O(=!
MN+^[ANA(D>Y$F6/+G' 41D]20.>:F[L<S=9*VC=U\WTZ_H9USX3NY+:\BBN(
M@P1TM)7/(5RQ97 4  [V''HIQQ6EI.F7UO<6[W@MD6UADAC\F0N9-S*<G*C;
MC:.!GKUK(E\3ZA;V$DTH3]S;.DS&,H5G!8(VT\A6P.#_ 'A6MI.H7<UQ:)<3
M+*MU;R38V &,JRCMV.[OZ57O6-:WUGV3Y[6_X&OX?GIN;M%%%9GE!1139)%B
MB>1SA$!9CZ 4 .HK(\/^)]'\4VDMUHUY]JAB?RW;RG3#8SC# 'H:UZ "BBB@
M HHHH **** "BBB@ HHHH *^=/CY_P CU8_]@R/_ -&RU]%U\Z?'S_D>K'_L
M&1_^C9:!H\KHHHH&?8?@O_D1?#W_ &#+;_T4M;E8?@O_ )$7P]_V#+;_ -%+
M6Y02<K\2/^1!U/\ [9?^C4KB_$'_ "#?AY_N+_[1KM/B1_R(.I_]LO\ T:E<
M7X@_Y!OP\_W%_P#:-=5'X5ZO\CZ;*/X-/_'/_P!-G6_$_P#Y$>Y_ZZQ_^A"N
M'\ ?\BGXS_Z\1_Z+EKN/B?\ \B/<_P#76/\ ]"%</X _Y%/QG_UXC_T7+54O
MX+]?U1ME_P#R*)?XX_\ I4"#X4_\CE_V[2?S%;7A7_D4_&_^[/\ ^BWK%^%/
M_(Y?]NTG\Q6UX5_Y%/QO_NS_ /HMZJM\;_[=_,[,S_CU?^X7_I9DZE_R1C1_
M^P@W_M6O2?$O_)/K[_KQ_P#9:\VU+_DC&C_]A!O_ &K7I/B7_DGU]_UX_P#L
MM9U-UZO\T>?C?CI?]?9_^E1/.?A#_P C9=?]>+_^C(ZP_ 7_ "/&E?\ 74_^
M@FMSX0_\C9=?]>+_ /HR.L/P%_R/&E?]=3_Z":Z9;S]/\SVZ_P#%Q?\ @C_Z
M3,Z^+_D8?B!_UXS?^@FLG4O^2,:/_P!A!O\ VK6M%_R,/Q _Z\9O_0363J7_
M "1C1_\ L(-_[5K*&Z]5^1QT?XE/_%2_]-,])\2_\D^OO^O'_P!EKSGX0_\
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M *_(_P#T**L8[_\ @)YL/C^= ])\-?\ )/K'_KQ_]EKR3X;_ /(_:9_VU_\
M13UZWX:_Y)]8_P#7C_[+7DGPW_Y'[3/^VO\ Z*>E2^&I_7<SP'\''?/_ -N(
M+W_DI-Q_V%V_]'&O1/\ FMG_ &Y_^RUYW>_\E)N/^PNW_HXUZ)_S6S_MS_\
M9:JKT_P_Y'7F'PQ_Z\R_]L.4TC_DCGB#_K\C_P#0HJ])\-?\D^L?^O'_ -EK
MS;2/^2.>(/\ K\C_ /0HJ])\-?\ )/K'_KQ_]EK.OL_7]$>?G'PR_P"OK_\
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MY-.3O*Z_I?Y]O\A15EK_ %_77R\['2^&(]8;3FO-;E/VNZ?S1:@#;:H?NQC
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MW%X+2WF,R.'7>6.[J=N,?,>WI74T4>TDNI"QV)334WI9_<K+IT6A2OM+@O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
D% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_002.jpg
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,I"Q78_W6+8P!_*KGASQEHWBMKA=*FED:WP7\R%D&#G!!(P0<'\J -^BBB@
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MCI82[VLXIV'G*K22>8"4'/#!?U7UKZ+HJ4K#N>%W/@34Y='MM6M-%UF"YCU
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXY9 RQQ1/)L#L3Z^PR<>U0CQMIBZK)'->Z;'I@M4G2]-\GS%FQC9U _VNG]
M#IZ*Q+'QCX<U*[@M++6[&XN)P3'%',"S8Z\=C[58TSQ%HVLW$]OINIVMU-!_
MK$BD#%??W'O0!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX1FX*] 3GVKN]9LHM1T._L9E#17%M)$X/<,I!_G0!=5@ZAE(*D9!'<4M<YX
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MM8L)+F%6:2);A"R!?O9&>,=\]*R='\:V^N:3IU_:"TVW-T8)8WO4#0@;B/\
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M.K=>2.G'K0!L452LM8TW4;BX@LK^VN9K=MLR12AFC/H0.E7: "BBB@ HHHH
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M?^R=.C:. L#D;Y"=\G;CY1QTKM;>V@L[:.VMH8X8(E"1QQJ%5%'0 #H*EHH
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MAO0XI+J2/2+%'NU*7#+;J#*IZAN.0>]2+H6D+>V]ZNF68NK>,1PS"%=T: 8
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MT<MYD@_NO.V#@\Y"J.O6NJTK2;#1-.AT_3+2*UM(1A(HEP!ZGW)ZD]35RB@
MHHHH X?X0?\ )+=&_P"V_P#Z/DKN*X?X0?\ )+=&_P"V_P#Z/DKN* "BBB@
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M_E$@_P :/^$8\=_]%%_\HD'^-=Q10!P__",>._\ HHO_ )1(/\:/^$8\=_\
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M !H_X1CQW_T47_RB0?XUW%% '#_\(QX[_P"BB_\ E$@_QH_X1CQW_P!%%_\
M*)!_C7<44 </_P (QX[_ .BB_P#E$@_QH_X1CQW_ -%%_P#*)!_C7<44 </_
M ,(QX[_Z*+_Y1(/\:/\ A&/'?_11?_*)!_C7<44 </\ \(QX[_Z*+_Y1(/\
M&C_A&/'?_11?_*)!_C7<44 </_PC'CO_ **+_P"42#_&C_A&/'?_ $47_P H
MD'^-=Q10!P__  C'CO\ Z*+_ .42#_&C_A&/'?\ T47_ ,HD'^-=Q10!P_\
MPC'CO_HHO_E$@_QH_P"$8\=_]%%_\HD'^-=Q10!P_P#PC'CO_HHO_E$@_P :
M/^$8\=_]%%_\HD'^-=Q10!A^#_#O_"*>%K+1/M7VK[-O_?>7LW;G9_NY./O8
MZ]JW*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "JM_J=AI4 GU&^MK.$MM$EQ*L:D^F6(&:M5E>(]"M?$N
M@7>DW8_=SI@-CE&ZJP]P<&D[I:#5KZC(?%OANYG2"#Q#I,LTC!4C2]C9F)Z
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M![9'YUX5X:TV&[\12+J<%H;9K?4);4>0"9W5V!60GJ5^\/3 J*6S\OPQIO\
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MJ6;4]<31(+J/P]YE^\A62R^VH/+7YOFWXP>B\#^][4N1_P!,3PL^ZWM\4?\
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MTP>%J*^JT_O1Z_/7Y;&_16+I^IZY<6E[)>>'OLDT4>ZWB^VI)Y[8/RY PO(
MR?7VJ*#5O$,FGW<TWACRKF+9Y%O]OC;S\G#?,!A=HYYZTN1_TQ?59W:NM+?:
MCU^>OF^G4WZ*P(-6\0R:?=S3>&/*N8MGD6_V^-O/R<-\P&%VCGGK1_:WB'^R
M?M'_  C'^F^?L^R?;X_]7MSYF_&.O&.O>GR/^F/ZK4O:ZWM\4?\ /;SV-^BL
M#^UO$/\ 9/VC_A&/]-\_9]D^WQ_ZO;GS-^,=>,=>]']K>(?[)^T?\(Q_IOG[
M/LGV^/\ U>W/F;\8Z\8Z]Z.1_P!,/JM3NM[?%'_/;SV-^BL"?5O$,>GVDT/A
MCS;F7?Y]O]OC7R,'"_,1AMPYXZ43ZMXACT^TFA\,>;<R[_/M_M\:^1@X7YB,
M-N'/'2CD?],%A:CMJM=/BC_G^.QOTUD1OO(IXQR.U84^K>(8]/M)H?#'FW,N
M_P ^W^WQKY&#A?F(PVX<\=*+[5O$,'V;[)X8^U>9 KR_Z?&GE2'.8^1\V..1
MP<T<C_I@L+4;2NNOVH]/G]W?H;],:&)PH>)&"G<H*@X/J*P[[5O$,'V;[)X8
M^U>9 KR_Z?&GE2'.8^1\V..1P<T:EJWB&UU"6&Q\,?;;9<;+C[?''OX!/RD9
M&#D?A1R/^F$<+4=K-:_WH_Y_\.;IC1B244Y&#D=:/+3^XO7/3OZUA:EJWB&U
MU"6&Q\,?;;9<;+C[?''OX!/RD9&#D?A4MQJ>N1ZV+6#P]YU@9$4WOVU%PIQN
M;81GC)X[X]Z7(_Z8EA9M)W6JO\4?\]_+<UXX8HBQCC1"YW-M4#<?4^]*L:(2
M515)ZX&,UA?VMXA_M;[/_P (Q_H7G[/M?V^/_5[L>9LQGISCKVH_M;Q#_:WV
M?_A&/]"\_9]K^WQ_ZO=CS-F,].<=>U/D?],?U6IW6U_BC_GOY;F[L39LV+M_
MNXXIH@B ($2 'K\H]<_SYK)M]3UR36S:S^'O)L!(ZB]^VHV5&=K; ,\X'';/
MM46FZMXANM0BAOO#'V*V;.^X^WQR;."1\H&3DX'XTN1_TQ/"S2;NM%?XH_Y[
M^6YN&&,L6,:%F&"2HR15==,LDU(:@MNBW8B, D'!V$Y(QTZ@5EV.K>(9_M/V
MOPQ]E\N!GB_T^-_-D&,1\#Y<\\G@8HL=6\0S_:?M?AC[+Y<#/%_I\;^;(,8C
MX'RYYY/ Q3Y'_3&\+45]5I_>C_GK\MC;,$)D:0Q1^8PVLVT9(]"?2E,,1E\T
MQ)YFW;OVC./3/I6'8ZMXAG^T_:_#'V7RX&>+_3XW\V08Q'P/ESSR>!BB#5O$
M,FGW<TWACRKF+9Y%O]OC;S\G#?,!A=HYYZTN1_TP>%J)M773[4>OS^_MU-2^
MTVSU*QDLKRW26WD4*\9X! .<<>XJR8T8@LBDKT)'2L*#5O$,FGW<TWACRKF+
M9Y%O]OC;S\G#?,!A=HYYZT0:MXADT^[FF\,>5<Q;/(M_M\;>?DX;Y@,+M'//
M6GR/^F#PM17U6FGQ1_S_ !V^XW/*CW[_ "UW?WL<T"*,9Q&HR,'CJ*P_[6\0
M_P!D_:/^$8_TWS]GV3[?'_J]N?,WXQUXQU[T?VMXA_LG[1_PC'^F^?L^R?;X
M_P#5[<^9OQCKQCKWHY'_ $P^JU.ZWM\4?\]O/8VS;P%]YACW[=F[:,[?3Z>U
M/"J"2% )ZD#K6#/JWB&/3[2:'PQYMS+O\^W^WQKY&#A?F(PVX<\=*)]6\0QZ
M?:30^&/-N9=_GV_V^-?(P<+\Q&&W#GCI1R/^F"PM1VU6NGQ1_P _QV-PPQ$
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M!T%87]K>(?[)^T?\(Q_IOG[/LGV^/_5[<^9OQCKQCKWH_M;Q#_9/VC_A&/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5Y+\4/$'CO2?$UM!X86]-DUFKOY%@LZ^9O<'Y
MBC8. O&?YUZU65J?_'RO^X/YF@#P3_A-/B]_<U7_ ,$Z?_&J/^$T^+W]S5?_
M  3I_P#&J]LDD2)"\CJB#JS' %-BGAG!,,L<@'78P./RH"YXK_PFGQ>_N:K_
M ."=/_C5'_":?%[^YJO_ ()T_P#C5>W44PN>(_\ ":?%[^YJO_@G3_XU1_PF
MGQ>_N:K_ ."=/_C5>W44!<\1_P"$T^+W]S5?_!.G_P :H_X33XO?W-5_\$Z?
M_&J]NHH"YXC_ ,)I\7O[FJ_^"=/_ (U1_P )I\7O[FJ_^"=/_C5>W4Q)HI'=
M8Y49D.&"L"5/OZ4@N>*?\)I\7O[FJ_\ @G3_ .-4?\)I\7O[FJ_^"=/_ (U7
ML[WEK&DKO<PJD/\ K&+@!/KZ?C4P((!!R#T(H"YXE_PFGQ>_N:K_ ."=/_C5
M'_":?%[^YJO_ ()T_P#C5>W44PN>(_\ ":?%[^YJO_@G3_XU1_PFGQ>_N:K_
M ."=/_C5>TS7,%N8Q/-'&9'"('8#<QZ >IJ6D%SQ'_A-/B]_<U7_ ,$Z?_&J
M/^$T^+W]S5?_  3I_P#&J]NJ*"Y@NH_,MYHY8]Q7=&P89!P1D>AXH"YXM_PF
MGQ>_N:K_ ."=/_C5'_":?%[^YJO_ ()T_P#C5>UF:)95B,J"1AD(6&2/I09H
MEE6(R()&&0A89(^GX4!<\4_X33XO?W-5_P#!.G_QJC_A-/B]_<U7_P $Z?\
MQJO;J.@R: N>(_\ ":?%[^YJO_@G3_XU1_PFGQ>_N:K_ ."=/_C5>S1W]G*D
M+QW<#K.Q6(K(")",Y"^O0]/2K% 7/$?^$T^+W]S5?_!.G_QJC_A-/B]_<U7_
M ,$Z?_&J]NJ+[1!]I^S>='Y^S?Y6X;MN<9QUQGO0%SQ;_A-/B]_<U7_P3I_\
M:H_X33XO?W-5_P#!.G_QJO:Y)HHBHDD1"QPH9@,GVI],+GB/_":?%[^YJO\
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M$Z?_ !JO;J* N>(_\)I\7O[FJ_\ @G3_ .-4?\)I\7O[FJ_^"=/_ (U7MU%
M7/$?^$T^+W]S5?\ P3I_\:H_X33XO?W-5_\ !.G_ ,:KVZB@+GB/_":?%[^Y
MJO\ X)T_^-4?\)I\7O[FJ_\ @G3_ .-5[=10%SQ'_A-/B]_<U7_P3I_\:H_X
M33XO?W-5_P#!.G_QJO;J* N>(_\ ":?%[^YJO_@G3_XU1_PFGQ>_N:K_ ."=
M/_C5>W44!<\1_P"$T^+W]S5?_!.G_P :H_X33XO?W-5_\$Z?_&J]NHH"YXC_
M ,)I\7O[FJ_^"=/_ (U1_P )I\7O[FJ_^"=/_C5>W44!<\1_X33XO?W-5_\
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M3S9%A"R%B@SDXSG/6GTN(YK0/B%K^IPR:G=:/;)HUN)?M%Q&QW!E3<  6[G
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M4!8[7_A+/#G_ $,&E?\ @9'_ (T?\)9X<_Z&#2O_  ,C_P :XK_AGC_J:?\
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M /[90%CM?^$L\.?]#!I7_@9'_C1_PEGAS_H8-*_\#(_\:XK_ (9X_P"II_\
M*?\ _;*/^&>/^II_\I__ -LH"QVO_"6>'/\ H8-*_P# R/\ QH_X2SPY_P!#
M!I7_ (&1_P"-<5_PSQ_U-/\ Y3__ +91_P ,\?\ 4T_^4_\ ^V4!8[7_ (2S
MPY_T,&E?^!D?^-'_  EGAS_H8-*_\#(_\:XK_AGC_J:?_*?_ /;*/^&>/^II
M_P#*?_\ ;* L=K_PEGAS_H8-*_\  R/_ !H_X2SPY_T,&E?^!D?^-<5_PSQ_
MU-/_ )3_ /[91_PSQ_U-/_E/_P#ME 6.U_X2SPY_T,&E?^!D?^-'_"6>'/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ(<EI"2<*0/90!_O&JEO84==3F=*\0>(]<T'1/#']J7:)?ZE)%]K+'S3  G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E>)->M_#.@76L744L
ML-L%+)$!N.6"\9('>M6N+^+/_),M9_W8O_1J4#6Y-X8^(>E^)]2?34M+^POE
MC\U8;V((9$]5P3GL?H>,\UUI=0I8L HZDGBOG_Q?X6UZ7PH_B;Q%=V3/%:06
MUI!9AAM0NO+$]\$^O7VK3U'PAI5KXJ\+>$1]I31+U9;R?,Y!DF\O')_X O\
MWT<=:!'MU%?--S>26W@*QU2#4I!J>FZM/8V$H/S/;[ 2,]2!N_#=BM:>"V\%
M^'_!GB_1PLV89(KJ7/WY'5N#Z[277_@-%^H['T!7!?\ "V-%;Q)_9$=EJ$B?
M:!:_;(X=T?F9QC@Y(X/;MTJU\+-*;2O -@TBXGO,W<G.<E_N_P#CH6N+O+Q_
MAUK[:MHNJVVH>'M1U$Q7-D&#/!,?O;<=P._T!SP:=M;"Z'LVY=VW<-V,XSS7
M)V_CI;UYQ9:-J%RL&J#3G,2@E3CF0C/"C_\ 7BO'+MG;1]2\:O=3P^(H=?\
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MT4K)E.< XZXR:Z>B@#)C\-Z;%X8_X1U(W&G>28-F\[MAZ_-U[UF>'OA_X?\
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M<CCOR*[FB@#D[_X;>%]2U\ZS<Z>6N6<22()"(Y&'=EZ'^O?/-=9110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8, '3!!Y&XH3TYQ3>G]>O^0+7^O0]T9E7&Y@,G R>IJA::Q;7FKZAIL0?S[
M1^<2,+EP6 'KP/UKR#7]+C,6I2WTB7U[8>&[62"\YR'$C8D7/(/ ]ZZ[PS;:
M9!\3O$3/%"FHRPV\L)(P[(T8\QA[%L9]Z$M?O_K\!7TOZ?I_F>@%U#!2PW'D
M#/)H#*6*A@2.HSTKQ;Q?J$<_CM6V:=:WMMJMO;HOE-]KFC*C+[\XV'<1C'XU
M2TNS.G:#;/H\30W5YX6N)93!D-*X=<,?4@$X-):QN5;6W]=/\SV:VUJUN];O
M-*BWF>TBCED; VX<M@ YZ_*<UHUYI\.?[$/BG6SH @^Q&RL\^1]W?A]WX^OO
M6#=6FH_VMK^CV4<H;0X;VZM2@YS<!2FWW :3%-Z:>7^8EK^'XV/6-8UJTT32
M)]3N2SP0X#>4-Q)+!0!^)%7RZC;E@"W0$]:\+O[;1[KP[XA.B0I)HL5G8R/L
M!*+<A_G//\6P_-^M7?%EM:W/B"VAM;[2['3&TV$:5/<1R,$;><FW*$ /]SUX
MQVHMK;S_ $_JP=+_ -=/\]3UG5=8MM(%G]H#DW=TEK$$&?G;IGVX-%EK-I?Z
ME?V,)836,BQ2[A@%BH;Y?7@BN1^)%I8R:5X>FUA(9((-3@%Q+(/D"$$/GT!.
M/TKFM1LK-?$VJ:I#"@NX=?T^*&=>&2-DC!4'T(/(HBKNWG_E_F#VOY?Y_P"1
M[%N4L5##<!DC/-!=0P4L S= 3R:\?\+VMQ+\0GEGU'3X-3BU"Y,\!CD%W-$<
M@*S9VE-NTKQC@5J>,I--LO'^FWTK6FH79,$/]G3!O.CS(=LL!'&<GYAW I+7
ME\P>E_([W2=9M-9BGDM2V(9Y(&#C!+(VUB!Z9J^'5B0&!*\$ ]*\;TBV@L-=
MT[5;:V'VV;6]3CE9.&F0+(0A]1D"N5EFMM0N',8TQ8[ZUMY+JUL(V01L;N/Y
M),L=SC<1GCK1%<UEW_X'^8/2[[?\'_(^C1)&0I#KAN%YZ_2EWKOV;ANQG;GG
M%>->,]'AM?%*:;%/IFDV*V,8TY[F*0^5(9&+&#81B3.W/7M6M$]A8_%:$F2S
MU2^NY DG#"YL7$."1V,1'Y$TUK8'H>GEE4@%@"3@ GK67!KT%SXCNM%AMKEY
M+2-7GG"KY2%AE5SG.2.>F/>O._B)]C_M_4_[3W?:/[+3^Q/O9^T;VSY>/X\^
M7[XK<\(Z= GC[Q-=RV\8OECM%:3'(+1 O^9 /X4HZZ^O]?UY ]/P-Z^\7Z;8
M3ZC#*LY:P>".7:@Y:8X0#GW&?K6[YB;-^]=G][/%>*>+;#1U\2^*(IK>!;R>
MYT]HE(PSQLZ>81[$XS[T:K;?8K*_L+86D&C6_B0K+'=(S6T2&$$!U4@[-Y!Q
MG&2*%K&XVK,]MZC(HKSV&RFB^"^HVT=Y%J -E<&"2V5MI0[BJJ&YP.@]@*X_
M4+W3];AUEK6>.ZMFAT>%RAR"?-PR_P!*=KRLA=+GN'F)LW[UV?WL\50TC6K3
M6=/^W6^](?.DA'F@*24<H>_J.*\JG@T^PEGL+M(XO#EOXE9)X6_U,:& %0P[
M+O(..F:QO+BD\.>'XVFT^#1"^H!'OT=K=7\T[/ND$-MSM)]^]);7]!VZ'OQ9
M5QN8#)P,GJ:JWM\+2U:>.WGNRKJACM@&?D@9P2.F<GV%>=Z+HMK<>,$.KR1W
MT]CH-J\=X0<A@[_O!GG. #SS7.V#Z?;^']6TZP%G=K#/8O\ VI:A@;@&X&%E
M!Z2#G/KFG;6W];V)OI?^MKGN 92Q4$9'49Z4!E+%0P)'49Z5XI9'3CXPTTR>
M7_PD U74!=EO];Y>R39G_9V[<?I5;1[*2PT6U;1(6AO;WPM<22>3D-+('7#>
M[#)Q2Z7*MK8]S#HRE@P('4@U1TW6;75;B_BM@^;&X^SR,P&"VU6^7U&&%>.V
MEND/A#4[BVU'3IM+DDLA>6VFQR(D2!QYA<,3R5^]CTYKJ_AWJF@VNHZQIVFR
MQ+#=ZG*UE' C%&1(HRQ! P ,]R.O%5;5HF^EST>JLMX8K^"U%K<.LJNQG108
MX]N.&.<@G/''8UY=\2;'4)?% M-/RIU*S$[..S6N^0?F605+X7B^W:CX=O+J
M(9U:'4KN6-N<B1DP#_P' J5JK_UU_P BFK?UZ?YG;:?XQTS4GTU8?.7^T$FD
MA+J  L;;6)YXR2,?6N@KP+0M(T*^@T>T:SMY9(['4FNH]O*S*5V[O]H#'Z5Z
M59ZE-:_!ZWU!H/MLJ:0CF-\GS/W8SGOCUIO2-PM[UCH[_6+73Y+*.0L[7ER+
M:/9@@.03SZ#"FH8?$-E/I>H:B!*+>PDFCE)7G,6=V!^!Q7C_ (:> >*X(;2?
M3Y;4:K9NO]G1F. ,8)LX4D\\ $YYQ7:6EJEY\//%L#Q>:&N]1PF,Y8.Q'Z@5
M,KJ+?E_D.*3DEYK]3J8O$MC+<:5!B17U*V:ZAW  *@"D[CG@_,*V"RJ0"P!;
M@ GK7C(TS0=3M/"T$-M;3V:Z+>2%5&5\X+'N/U#9_&LR^2YU$:(+_4K*T$NA
MVOV.ZOTD9EES\QA*D8DSMSG)QBK:]ZWG^K_R(3NK^7Z'O)(4$D@ <DFD+H%#
M%E"GH2>#7!?$4:>L'A<:ZT#60U)!<M+_ *LCRGSGVS7(QC35TO11KX/_  CF
MS4/LGG9\O._]S^.S=M_2IZ/^OZ\AKI_7]>9[;32Z@@%@"3@ GK7A6KV.N2VF
MC6G[U;O4M(BGF=_O![4/(N?<[D%9R6UQJ%V+V_O;#3_[6A-[9S7J2,8Y'F8_
MN2A&) !'Z\8[4[:V#I<^ARRA@I8 GH,]:%=77<C!E/<'->81:+IEWJ/CB\U2
M1(+F+9"=0526A5K90Q7\S6I\.&L[OP_J5A;VEBL,4YA>XL ?(NLH/G4'H<8!
M'K2Z/TN'^9WE9UIK=I>ZAJ%E#O\ .L76.0$ ;F*A\+SSP17AVFV^JW&H6%M.
MK&VNKB/0G4]EMGC<M^($@K?URRME\2:WJBPJ+Z'7["*.<?>5&1 R@^A!.://
M^NG^:#9V_KK_ ),]9LKW[780W4D$UH9!GR;D!70^A )&?QJ&RUFTO]2O[&$L
M)K&18I=PP"Q4-\OKP17E4)TH:)X-_P"$EQ_87]G3Y\S=Y?G_ "[<X_BV[MO?
MKBB]LK(>(=1U2WAQ<PZ]IT<$YSO6-DC!7)YY!YS^-5;WK?UT7Z@]%_7G_D>J
MW>L6UEJVGZ;('-Q?F3RMHX 1=S$G\OSHTG6;368IY+4MB&>2!@XP2R-M8@>F
M:Y+QG:Z6?'GA&ZU.&'RB\\?F2CC?M!C'UW=/>N7TBRBMM=T[4+.%8]0N=;U.
M%YEX:10LA"GU&0#4K:_K^8VOZ^\]D#*Q(# D'! /2EKR/X6VTAU=+DZCIXN5
MM&2_M((Y%G:0OG=/N)!<'(SQU/:H]=O;:W\3ZKI\TRI>7'B#3IH86X9T C!8
M>V0>:=M4N_\ FO\ AQ=WV_X/^1Z_N7=MW#=C.,\XK/M]:M+K6KS2XMYFM(HY
M9&P-F'W8 .>ORG->)ZI9M:V+ZCI<31ZI<:GJL+S0Y$CH%D.WWZ9'O4LG]FFQ
M\3?\(O\ 9Q8FVT[SS"&*;=Q\W<%Y(Q]['.,TEJK_ -=/\QM6_KS:_0]V#H4W
MAALQG=GC%(94Z!@S;=P4'DBO&[;2+2ZL]#M9KK3=1TNZU_*PV2.MO&/)?<BA
MB>,C.,XY-:?EZ1I'Q/2*T6ROI9V\D1!6%QIVV' V]C%M'X$T/_/\KB_K\3TN
MQO/MEE!</;S6K2KGR+@!9%]B 3S5@LH8*6 )Z#/6OGF^.G'PJ5UCR_,_L"$Z
M7YO_ #T\Q]_E_P"U]W/M[5T5[96P\0ZEJ@A47T.O:=''./O*C)&&4'T()S56
MNP>G]>I[)N4L5##<!DC/-9[ZU:IK\.C?.UU+ ]P" -JJI4$$YZY85Y5H-M>2
M^-[F4ZC80:O%>79D@\N07<T9!"JQSM*8V%>,<"I?AV=*/BW2&LO+_M Z++_:
M1&=_G^8F[S/]K.:4=;!+2Y[#32Z@@%@"3@9/4UXMXR_M'3/&6I2V:MY&G/'K
MQ Z.2$B9?R#FJVJ6-KING):ZL&^V+H4+:1G=G[6S,S^7C^/<4]\4EJK_ -?U
MN-JSM_7]:H]TK,M->L[RQO+Q-ZPVLTL+EQ@EHSAL?B#BO*]2O8[?6K[3[Z94
MU*XUS3)EA;AG 6,,P]L@\U7OCIWVF1==\O\ LLW&K^6)O]7]H\P;/^!8W8_2
ME+1-A%7L>QZ5J,.KZ3::E;JZPW42S('&&"L,C/O5KS$\OS-Z[.N[/'YUY?K'
MD#X%Z.;K'V?RK#S=W3;OCSG\*RL:6+9BNS_A##X@RV,_9_+\G_T#S?PS5R5I
M-+HR5LG_ %U/92Z* 68 $X&3U-+O7?LW#=C.W/.*\,O380>%]+O;N6UGAMI;
MMK#2[\/MN;4R?)Y9ZAP,;?8U8\53Q6WB/4)M*2&_U:^@94B 87FG.(/X>QCV
M]NQ/'-2_Z^Z_]=BDM;?UO;^NY[4)$*E@ZE1U.>!1YB!58NN&X4YZ_2O%=+T[
M3YO">L%O$.D6VGS+;!DM(I1!'*IR/-5B?O<!^1TYJ/4KS1YO"NC:C):Z9%]D
M^T*FD2;_ "+P;\,\#=0Q(ROUQ3MK;T$M3V>[NVM9+9!:W$_GRB,M"H(BX)W-
MDC"\8[]15/2M>@UB_P!1MK:VN0EC,8'N'51&\@^\J\YXXZ@5D>)G\RX\)/Y9
MCW:I&=C=5S#)P:S_  -IUG:P^*YX+>..5]5N8V=1R57H/H,G\Z3T3;Z7_"PU
MK;SM^-SNPREBH8$CJ,]*%97&58$=,@YKP7PZ(3H2GPM_Q_\ _".W O\ [-G/
MG;ALW?[?WL=ZEAL;=_!VHM!?Z7<6,\^GQR6FGQR(D;^:H)8,3\Q!PV#VIVUM
M_6]B;Z7_ *VN>YB6,[<.IW?=YZ_2G;E+%0PW 9(SS7E7B.ST+P]XRTDVL-A<
M-'Y$":2ZL)(09"1+ 1QG))8=P*HV/D_\)1;^7N_X23^U;S^T.N_[+M?;N_V,
M>7M[=,4KZ7]2K'L892Q4,"1U&>E4+_6+73Y+*.0L[7ER+:/9@@.03SZ#"FO'
MM!\GP]IEC?6.GI(\_AF>>YA&<7#"1<%\=< G\*B\-/ /%<$-I/I\MJ-5LW7^
MSHS' &,$V<*2>> "<\XJE'WK?UN+I<]HTO5;?5XKB6V#A8+B2W;>,99#AL>V
M:O5XKJAN],L)-8T^)GN)-5U'3#MZ_OW(0_@ZC\Z]>TG3X])T>ST^$?N[:%(E
M_P" C%2M8W_K9,):.W];V+E%%% !1110 4444 %%%8WBC77\.Z&^H16@NY!+
M'$L)E\O<7<*/FP<=?2@#8(# @@$'@@TH  P!@5PK^/-22)+4:%$VKG4O[.>W
M^V8C5C'Y@</LY&,<8%1:5\3$OM=BTZXL[:/S9)+=1#>+),)8P2VZ/ (0D,%;
MO@<#- '?;5WEMHW$8SCG%+7!VWQ%D?PK=Z_=:=;10(Z1P(E\&)=FV[)<J/*(
M.,YS@'VID'Q&FO+&W%EIMK=:A+J/]GE(K\&#=L+AUD"G<N!Z ]?2@#OE55SM
M4#)R<#J:3RTV;-B[/[N.*\Y'BW5]7USPE+9V0CBN6NDN;<W>U2\?R-DA?F"X
M+#USVZUZ0>!1TN'6PC*K##*".N"*"JE@Q R.AQTKR?Q+\1;^XT[5M.LHK)+J
M*-)$GL=2$NQ/.5&#$*-K<CCT8\\5W>O7NI6W@?4+U(%AU!+)Y-B39$;!3DA]
MO..O3G':DW:/,-*\E$W2 P((!!X(-  4    < "O+SXB\26P\*RQVJS2OI4\
M\UL]Z0LH54(D9MO+8).,=6Z]ZO:G\5+6Q2SECM8#')917TZSW:Q2!'Z+&I'[
MQQR<<=/>J:L[>=B4[JYZ'2*JHH55"J.@ P*YOQMJLUGX-N)]/F,=U=>7!;2
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M4&MZ]\<3VFL30_V4&TVTN8;.[NO/PT<LF,;4Q\RC<H)R.O3BG;^ON_S#I?\
MKK_D=%/HUG<ZQ::G*K&>UB>*(9^4!RN>/7Y16A7 ZMXMU:]\/^(;JPTXP:?;
M074<&H+<CS!+%D$[,< D'!!/3M69+XQU/5--\/W&C0[XVU-+5"UT5%YMA8MO
M^4E5W#WSC-):_P!=P>G]=CT\1H%*A%"G.1C@T&-"@0HI4=!CBN(3Q]>7FGZ=
M_9VBK/J5RD[RVTESL2)86VO\^TYRV ..]10>,HWU&\UO=.=-30(KY;;/1B[Y
MXZ;N ,^U ['?4FU=V[ W8QG'.*\I/C[5-*\1Z@=6MK>":>*TCM;66_Q;Q[A(
MQ=I"H"\#GCJ *W+;X@76JKH\>CZ1#<W&H).7$EZ%2(Q,%;#!3O!SP1C/%.W]
M?UZ">AW6U=V[ W8QG'.*6N8\.^*;K7M8U&V^P00VMI*\18W69@RMCYXMH*AN
M2#GH*A\1^,KC1=0N+>TTL7D5A:K>7TAG\LQQ$D#8,'<V%8XXZ>]+MYAW.L55
M1=JJ%'H!BEKAM OM0U/XD:X\AE-A;00K !=ML4.@8'RL8);KD\C&.<USNL>.
M;_0_&/B^Q>:5T-K&--0G(6?8H"K[DOG\*'I]UQI7V\OQ/60B!2H5=ISD8X-!
M1#MRH.W[O'2O+=!\8S6.D6EW=+>7U\^DVQ >Z.R:229D4;2,*<]7YX[<5T^H
M^)]:TW3]-$V@PG5+Z\-HMO\ ;0(P=K,'W[3D';T(!IM6)1UC*K## $>A%+7%
M3^.;NUU%HYM(3[%:SP6E]<+<Y,4TH7A5V_,H+*"<CKTXK#T_Q]>Z%%>3ZU:M
M/ISZA>Q178GW2;HRS!-F.!A<#FD,]0VKO+;1N(QG'.*"JE@Q4%AT..17F7B/
MQIK3^%]5MSIPT[5(8[><>5=[OW,KXR&VCYL@J1[Y!KL-?O+V#P)J=XR_9+Y+
M"23$4N_RG"$\-@9P>^!0]$WV'%7:2Z_U^IO4@55SM &3DX'>O&=,\?ZAJ-WX
M+LS<S(Z%AJISRS ,%#_4(S8KH]-^*UG>)>2SVT*Q1V4E[ +>[69RB'!610/W
M;G(..>OM3:M^/X"6OX?B>AE58@LH)!R,CH:-J[]^T;L8SCG%>6R>(M6DO]<D
MU>&>V6./3C%:VE^0$$DI&0^T8SD;ACG&,UU^B^([_6M3N/*TE5TB.66!+PW
MW%XVVG*8X!.<$$].:+ =&55B"5!(.1D=*6O+M6^(-Q>B]TN+[)#/&T$B3Z??
MB?Y/M"1LK$*-IPW3T-=7XQO;FR.@?9IY(O.U>"&38<;T(;*GV.*2UMY@]/Z[
M'2[5W;L#=C&<<XH90RE6 (/4'O7$V'CZXN=9BM[G2$M[":ZN;2*Y6YWL7AR2
M2FT8!"GN:UO"^OZCX@@^V3Z2+33YXQ+:3"X#LZDG 9<#:<8/<<]:%JK@]#H0
M !@# I%557"@ #L!7(>/M2U73DT+^RX][3:I%'(OG^5O')"$X/!QR?;H<TV]
M\<3VFL30_P!E!M-M+F&SN[KS\-'+)C&U,?,HW*"<CKTXH6O]>G^8/3^O7_([
M%E5U*LH8'L1FAE5QAE##T(S7)>.-0U.PF\/C2QOFGU(1F$R^6LH\MSM9L'C(
M!Z=JR[OXG+;Z982"QMHKZX,XEAN[U88XS"VUP)"/F)/"C'-'2X6/0J155<[5
M R<G ZFN+\5>(9KGX=V^M:0TL;73VK1@/L8AY$!4GMD$@U!<?$62STR4WEA:
MVVIIJ)T\Q2W@6 ,%W[S*5X7:?3.>*+6OY!O8Z>30+2;Q#%K,TD\D\*%88V?]
MW$2,%@H'WB.,DGVQ6K7F\GCU+A](UP>8EFME?2W%M%*'5GBVC (X89S@^AS6
MEX3U;6-2\8:RFJPBU"6EJ\5M'<&5$#;SD' P3QGCM32Z>H/N=H$0*5"J >HQ
MUJ%K"U:]AO#"IN(8VBC?^ZK8R!]=H_*N6O\ QO+9ZW<0IIGF:7:74-G=7AGP
MR2R8QM3'*C<N3D=?:H],\=75]KT%G/HZ065S>7%E#<+=;V,D.224VC (4]S2
M6NP/0[6BN \5S75OXQM&U#5]3TO1VB1;:YLV B6XWG(FX(P1@#=QUJ;4/B/;
M6'BIM),-NT$5Q%:RR-=JLV^0#!2+&609&3GN?2A:V_K^O^&!Z'<!57.T 9.3
M@=Z6N'L_'=_=:FL#:)'':SW=Q8V\PN\EYHMQ^9=GRJVT\\XKGM&^(FH:7X4T
MO^T(+66]NO/E26\U$1K)&C'.69>&R=JKSTSD=*.EQV/6%554*H  Z "EKSW4
M?B9-#%]JT[15NK--/AU"622Z\ME21BNT+M.6!'K574_%^N7=S86L-@EMJ5OK
M"6TUJEV3%,K0M(H+[>G(SQVIV=["Z7/2U554*H  Z "@JK$%E!(.1D=#7GUW
M\3EM],L)!8VT5]<&<2PW=ZL,<9A;:X$A'S$GA1CFM*P\:76M:U96FDZ4DMK-
M9PWLMQ-<[#''(2,!-IRPQZT)7!Z;G0ZCH]IJEQ8S709C93^?$ < MM*\^HPQ
MJZ45E"E00.@(KE_$MS?VOBCPPL%])':7%VT4UNJ@"3]V[ D]>PXZ5TMU$TUI
M-$D[P.Z%1*F-R$C[PR",CWI=+^H=;$M(55B"R@D'(R.AKR<:CJFG6.LG2M:U
M&]TR6:VL[:_O9!(PG>39*T1(Y4 CVSTK=TV.ZM[GQ)X;N?$&H+;6D<-Q%J$L
MRM/%&X)8%V'JIY/(!HZ7#R_K^KG>4BJJ*%50H'8#%>565WJ\MA:Z;%JNIC3=
M5U?R;.^GD_THVHC+,0Y&1EE(4GG!^E=9X.O[E;#5K*_NY;HZ5>RVXN)3EWC
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M5]I#,3TZ9%0KXFUC3O$7C.XN;,3V6FV\<J1_:\;<1E@JC;_%R2>WO2_K\O\
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M%9A*L?1E!;Y&Y([]?:NZHIW=[BMI8PO$/AF#Q$--@NFC-C:7 GEMFBW+/A2
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M23R/(<V \I?+5UPR%SN#!SGI@UT%GX7D@U32=1FO(6FL8)HG6&U$2RF0J=P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI7]Q?([+;VZ*70H<.I&>HP3QGBN;O_AIXAU.SFOKZ'2YM1;4VOC9^:_DR(Z
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MW:Z/J+W4UVUD+.,*T@E"@@=>^1[^U2Z#\4=.UO5[:P.FWMHMTS10SS!=K2J
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M'T(HL)'U')(D4;22,$1 69F.  .I-4M'UK3]?TY-0TRX%Q:N2JR!&7)!P>&
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MPP2I/0U>HH RM,\/:=I?AR'08XO.L(XS$4G ;S 22=W&#DDYX[U=:PLWT_\
ML]K:(V?EB+R"@V; ,!<=,8JQ10!D0>%]!MM*;2X=)LUL6?>T'E JS9SD@]3P
M/RJ]%IUE!?3WT-K"EU< ":94 :0#ID]\59HH J6^F6-I#/#;V<$45P[23(B
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MBB@ HHHH **** "BBB@ HK/UG6K'0-.>_P!1E,4"L%R%+$L>  !6A0 4444
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M<_E7N=MX4\/VD<<<&CV2+$CQIB$<*XPPSZ$$Y]:;=^$?#M\MJMUHMC*MHH2
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MHXKU?_A O"?V9[?_ (1[3_+=M[?N!G/UZBK+^$O#SWEM=MHEA]HM@!"X@4%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M44 6?M]S_P ]/_'11]ON?^>G_CHJM10!9^WW/_/3_P =%'V^Y_YZ?^.BJU%
M%G[?<_\ /3_QT4?;[G_GI_XZ*K44 6?M]S_ST_\ '11]ON?^>G_CHJM10!9^
MWW/_ #T_\=%'V^Y_YZ?^.BJU% %G[?<_\]/_ !T4?;[G_GI_XZ*K44 6?M]S
M_P ]/_'11]ON?^>G_CHJM10!9^WW/_/3_P =%'V^Y_YZ?^.BJU% %G[?<_\
M/3_QT4?;[G_GI_XZ*K44 6?M]S_ST_\ '11]ON?^>G_CHJM10!9^WW/_ #T_
M\=%'V^Y_YZ?^.BJU% %G[?<_\]/_ !T4?;[G_GI_XZ*K44 6?M]S_P ]/_'1
M1]ON?^>G_CHJM10!9^WW/_/3_P =%'V^Y_YZ?^.BJU% %G[?<_\ /3_QT4?;
M[G_GI_XZ*K44 6?M]S_ST_\ '11]ON?^>G_CHJM10!9^WW/_ #T_\=%'V^Y_
MYZ?^.BJU% %G[?<_\]/_ !T5<L)Y)_,\QMV,8X ]:RJT=*_Y:_A_6@#1HHHI
M#"BBB@ HHHH *^=/CY_R/5C_ -@R/_T;+7T76=J'A_1=6G6?4=(L+R95V"2X
MMDD8+DG&6!.,D\>] 'S3X/\ B9>^%-)?3CIUKJ$"RF>V\_.8),8R/;VXZGGF
MN0U"^FU/4KJ_N2#/<S/-(5&!N8DG ^IKZZ_X0OPK_P!"UHW_ ( 1?_$T?\(7
MX5_Z%K1O_ "+_P")H'<XKX7?\DYTK_MM_P"CGI\OP_TN:U\EYK@D:@VH+)\N
MY7;&5''W3@>_'6O1+73+"QMDMK2QMK>!,[8H8E15R<G  P.234WV>'_GC'_W
MR*/,1Y?%\.=-CU1[K[7=M;AY)8K0L/+BD<8+#CZ8^@ZU>T;P78Z)>6-S!<7+
MO9VK6J"0K@JSER3@=<DUZ%]GA_YXQ_\ ?(H^SP_\\8_^^136@;G$ZUX<LM=N
MM-N+LN'L)Q/'MQACQP<CIP*R;3X>Z;::XM^+JZ>WCF>>&R9AY4<C=2.,^GY#
MK7IGV>'_ )XQ_P#?(H^SP_\ /&/_ +Y%(#RV#X<645G!:/J=_+#;W!GA5F7"
M=?E QTY)/J:D3X<Z2MK%;M/=21QV+V0#,O*LY?=T^\">.W'2O3OL\/\ SQC_
M .^11]GA_P">,?\ WR* U/)OA_X<U72;S4;W5!,GG)'#"D\RR2;$SR2O '0
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MP_\ /&/_ +Y% &#6CI7_ "U_#^M7?L\/_/&/_OD4Y(TCSL15SUP,4ACJ***
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MU'P#K<B2:AKFCR21H4C==35&0%E;*E7&#E%(/48JK>'X=W\=NEUK^G2"",Q
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M^AET;_P/B_\ BJ/^$T\*_P#0RZ-_X'Q?_%4 ;E%8?_":>%?^AET;_P #XO\
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M)"E"FT?/T"L0!VJP+7X9B5)?[9TG>D2Q*?[57A5B\H#[_P#<./UZT/R S_\
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MZ5L:1I#OU-'.6))Y9B<9/2K'_":>%?\ H9=&_P# ^+_XJI W**P_^$T\*_\
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M<+-L$EQ*L:EL$XRQ S@'CVK-_P"$T\*_]#+HW_@?%_\ %4 ;E%8?_":>%?\
MH9=&_P# ^+_XJKVG:UI6K^9_9FIV=[Y6/,^S3K)LSG&=I.,X/Y&@"]1110 4
M444 %%%% !7COC71[#7_ (\>'],U.#S[.;3#YD>]EW8^T,.5(/4#O7L5>5Z[
M_P G&^&/^P8__H-Q0!N?\*@\"?\ 0"_\FY__ (NC_A4'@3_H!?\ DW/_ /%U
MW%% '#_\*@\"?] +_P FY_\ XNC_ (5!X$_Z 7_DW/\ _%UW%% '#_\ "H/
MG_0"_P#)N?\ ^+H_X5!X$_Z 7_DW/_\ %UW%% '#_P#"H/ G_0"_\FY__BZ/
M^%0>!/\ H!?^3<__ ,77<44 </\ \*@\"?\ 0"_\FY__ (NC_A4'@3_H!?\
MDW/_ /%UW%% '#_\*@\"?] +_P FY_\ XNC_ (5!X$_Z 7_DW/\ _%UW%% '
M#_\ "H/ G_0"_P#)N?\ ^+H_X5!X$_Z 7_DW/_\ %UW%% '#_P#"H/ G_0"_
M\FY__BZ/^%0>!/\ H!?^3<__ ,77<44 </\ \*@\"?\ 0"_\FY__ (NC_A4'
M@3_H!?\ DW/_ /%UW%% '#_\*@\"?] +_P FY_\ XNC_ (5!X$_Z 7_DW/\
M_%UW%% '#_\ "H/ G_0"_P#)N?\ ^+H_X5!X$_Z 7_DW/_\ %UW%% '#_P#"
MH/ G_0"_\FY__BZ/^%0>!/\ H!?^3<__ ,77<44 </\ \*@\"?\ 0"_\FY__
M (NC_A4'@3_H!?\ DW/_ /%UW%% '#_\*@\"?] +_P FY_\ XNC_ (5!X$_Z
M 7_DW/\ _%UW%% '#_\ "H/ G_0"_P#)N?\ ^+H_X5!X$_Z 7_DW/_\ %UW%
M% '#_P#"H/ G_0"_\FY__BZ/^%0>!/\ H!?^3<__ ,77<44 </\ \*@\"?\
M0"_\FY__ (NC_A4'@3_H!?\ DW/_ /%UW%% '#_\*@\"?] +_P FY_\ XNC_
M (5!X$_Z 7_DW/\ _%UW%% '#_\ "H/ G_0"_P#)N?\ ^+H_X5!X$_Z 7_DW
M/_\ %UW%% '#_P#"H/ G_0"_\FY__BZ/^%0>!/\ H!?^3<__ ,77<44 </\
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M^%0>!/\ H!?^3<__ ,71_P *@\"?] +_ ,FY_P#XNNXHH X?_A4'@3_H!?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >(?$G_DNOA'_MS_ /2EZ]OK
MQ#XD_P#)=?"/_;G_ .E+U[?0!4U348-(TRXU"ZW_ &>W7?(47)"]SBL2Z\>:
M':2RQR27#>2[K(T<+.$5-N]R1T4%P"?7Z5N:G;I=Z5>6TL9DCEA=&11RP((P
M*X/3_AY='PMIUJ;\VES)8O;:B)(_-:196#O@[AAP>,\CVH6^H=#K=-\4:;JM
MY%:VK2-)+'+*N4P"L<GEMS_O5E:WX]L=,BU2&&.8WEFDH3S8F$4DJ1^9LWCO
MM.:/#G@N;0=:%XVI1SVT44T-O +?8RK)*)3N;<02#QP!Q65=^!=0UV_UM;R[
M2TL)KN66V40[G9GMUBWD[ONC+?+@'(ZXIJUT"\SH=0\9Z;I$C1WZ7<;+ 9MX
MMVV/A=S!3W./Y'N*NZ?K]KJFG75W:QW&;5F26&2(K(KJ =NT]R"/SKDM2^&+
M:CJ5Y<G4X$$XDPYLMTPWQA-IDWC*+C(7'>NNTO1O[-DU1_/\S[=<F?&S;L^1
M$QU.?N9SQUI/X7W$MT8.A?$/3]1L]/\ MD5Q;W5RL?F#[.WEQM(2$RW8,00#
MWK>UG7[308XI;R.Y,3G!DBA9UC&0,L1T'/\ /TKEK'X>7=J+:&368Y+1#;^=
M&MIM9Q Q:/#%SCMNX.<<8J_XN\$MXIO()OMD$2I"8BL]KYVS+!M\?S+M?C&>
M>#3=M/4;ZE.#X@3R_8\Z3<CS]6EL3B!N$7?@CGEOE&?3GTK2F\?:)#(Z9NG8
M2>7&$MV/G'S/+/E_WL.0#CUJ)/"-Y$(A%J< \C57U"'=:DX#[]R-\_)^<X(Q
MT'!JA:_#:"UO'ECFLE O$NHY5LL3X$PE*/)N^8<8' XQUH72_P#6W_!"7E_6
M_P#P"WK/Q L+/P\;^PCFN+B2"66*(P-\FQMC&3'W0&X-7=6\32Z;K^GZ:MG)
M*MS:S3M(L9(4IMP,]AR<GMQZUD7OP]N)K'[-:ZQ'"98KF"=I+7?NCFE\WY1O
M&&!XSDY]*W]4T&:_U6PO8;Q(?L\$UO(CPE]Z2!<X.X8(*CU[TGMIO_P'^HU:
M^O\ 6J_0R-+^(NFW6DVTUU%<I?R11.]K';.68NA?*#NN%8Y]JZVTNH+ZSAN[
M:0203()(W'1E(R#7!W?POCN!9N;ZVFEM;>W@1+JS\R)_*1T)9-XSG?D<\%>I
MKN[*U2QL;>UC6-4AC5 L:;%  QPO8>U5*VMB5<GHHHJ1G%_$[PAJ'C3PW;Z=
MITUM%-%>+.6N&95VA'7'RJ3G+#M7,67A;XNZ=86]E:^*=&CM[>)88D\L':BC
M &3!D\ =:];HH \K_L+XR?\ 0V:-_P!^E_\ C%:OPX\&ZYX7O]>O==N[.YN-
M4ECF+VS,<N#(6)!50,E^WOTKOZ* "BBB@ HHHH **** "O*]=_Y.-\,?]@Q_
M_0;BO5*\KUW_ ).-\,?]@Q__ $&XH ]4HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@##\:?\B+XA_[!ES_Z*:L/X0?\DMT;_MO_ .CY
M*W/&G_(B^(?^P9<_^BFK#^$'_)+=&_[;_P#H^2@#<\:?\B+XA_[!ES_Z*:N'
M^ ?_ "(M]_V$Y/\ T5%7<>-/^1%\0_\ 8,N?_135P_P#_P"1%OO^PG)_Z*BH
M ]4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q#XD_
M\EU\(_\ ;G_Z4O7M]>(?$G_DNOA'_MS_ /2EZ]OH @O;J.QL;B[E.(X(VD8^
M@ R?Y5P6A?$&^F\-64][8?:]3FN98)(H'5 NU#*#R<?<Q7;ZOID.LZ3=:;<2
M2I#<QF.1HB VT]0"0?I6.G@;2(=1-Y;^=;@R>:((=JQ!O*,1(&WC*GUZ@4NX
M]-"CIOQ#M]2N8UCTRY2VF++%<,ZX9Q")MI7J/E/7UJ.;XDV<-B]RUGM"V]O<
M8ENHXLB9&8 %B,D;<8&<Y^M7].\!Z5IL5M'%/=NMO*95\QUY)@$&#A1QM&?K
M^59T7POT^%UE36-5\](U@24M"2D01DV >7C&UB,D$\9S52M]D2\S4\.Z_-K4
M>LW(;]Q#*GV92H!5&@CD /J<L:X72OBY-.NCM>*,):W$VJ!(\'<H)C"YX&X#
M/XUZ/HWARST.UN;>VDG=+C;O,K D;8UC&, =D'XYK&7X:: MJMO_ *25$?EL
MV]0SCR?*!)"]0.>,<_E0[<VFW_#B6VN__#%=OB?I2Z.M[Y:&0W36Q3[5%Y>Y
M4WD^;NV$;<8YZG%5K/QO>ZB+^[2.2+3Q>V<=K(OEEBDOE_*0?7?DGL#@<BMZ
M;P?'<:?:P2:K>FZM9C-%>;81(I*E2,;-A&#CE?>E;P=:/-<N][>%+B:WN'CR
M@'F0[=K?=SSL7(Z=<8H5KZ_UM_P1]/Z\_P#@&6OQ&C,PA;1[H2S.T=H!(A$[
M+-Y)YS\OS$'GM72:!K UW2([_P"S/;%GDC:)V#%2CE#R..JFL*_\!636J26L
M]X+NU$KVK"5%Q(\PFSDH1]X <@C!.0:O>%_#]WHVF6,=WJ$KS1+,9HD8&)WD
MD+DGY021D@'CJ>*%:P/?0Z*BBBD 4444 %%%% !1110 4444 %%%% !1110
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MR<?>QU[5N44 4=:T[^U]"U#3/-\K[9;26_F;=VS>I7.,C.,],UX]_P ,\?\
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M_P!^8O\ XY0!ZI1573-0BU;2;/48%=8;N!)XUD #!74, <$C.#ZU:H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5'/$)[>6$G D0KGTR,5)12:NK,$[:G+^!_
M!5OX(TVXLK:\EN5GF\TM(H!!P!CCZ5U%%%4W<+!1112 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
